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ABSTRACT 
 
Oil from flaxseed (Linum usitatisssimum L.) contains hydrophobic cyclic peptides or 
cyclolinopeptides (CLs) comprising eight or nine amino acids. These bioactive compounds have 
potential therapeutic applications and may be used as scaffolds for increased utility. Two steps 
were undertaken to increase the potential utility of these compounds. Initially multigram 
quantities of flax CLs were highly enriched from flax oil. Subsequently new synthetic procedures 
were developed for modification of the CLs through the methionine group (Met). Finally, the 
utility of the modified CLs was tested in a number of applications. CLs were recovered from a 
crude oil extract that contain five CLs (CLA, CLC, CLE, CLJ and CLK). Oxidation of this 
mixture reduced the complexity of the mix to just three CLA, CLJ and CLK. CLJ and CLK were 
enriched then characterized by NMR and MS-MS methods. CLs containing methionine sulfoxide 
groups (Mso), CLC and CLE were isolated from crude mixture then selectively reduced to afford 
Met containing analogs: CLB and CLE'. The Met of modified CLs was used as a point for 
attachment of tags and couplers for various applications. Cyclic peptide modification through 
Met groups has not been reported previously. Synthetic methods were devised to introduce 
activating functional groups such as -CN, -COOH, -OH and -NH2 to the sulfur atom of Met. The 
modified CL conjugates were characterized using spectrometric techniques including 1D and 2D 
NMR spectrometry, as well as mass spectrometry. After activation the CLs were covalently 
linked to molecules or materials of interest including fluorescence tags (coumarin), affinity 
chromatography media and bovine serum albumin (BSA) for production of polyclonal 
antibodies. Fluorescence studies were performed in methanol, ethanol, dimethylformamide and 
acetonitrile to study the solvent effect. CLs attached to solid affinity matrix showed specific 
binding to apolipoprotein A1 after incubation with chicken serum. These CLs also act as hapten 
and have been used to couple BSA to produce polyclonal antibodies. Met modification was a 
satisfactory approach to produce a range of useful peptide products where more conventional 
methods of molecule attachment are not available. 
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CHAPTER 1 
INTRODUCTION 
 
Flaxseed oil (Linum usitatisssimum L.) contains hydrophobic cyclic peptides or 
cyclolinopeptides (CLs) comprising eight or nine amino acids. To date, eleven CLs (CLA–CLK), 
having molecular weights of approximately 1 kDa have been isolated from flax oil. The CLs 
(CLA, CLC, and CLE) have immunosuppressant activity and induce apoptosis in nematodes and 
a cancer cell line. CLs are thus bioactive compounds with potential for use as therapeutics. 
Methods to isolate CLs from flax oil in multigram quantities were investigated. The isolated CLs 
containing methionine sulfoxide (Mso) will be chemically modified and specific changes to the 
methionine (Met) or Mso group in a systematic fashion, without changing other amino acids. The 
Met group in modified CLs will be used as a point for attachment of tags and couplers for 
various applications. Modification of cyclic peptides through the Met has not been reported 
previously. The CLs will be systematically linked to molecules or materials of interest including 
fluorescence tags, affinity chromatography media and bovine serum albumin (BSA). 
Specifically, synthetic methods will be devised to introduce different activating functional 
groups such as -CN, -COOEt, -OH and -NH2 to the sulfur moiety of Met. In addition, these 
modified CLs will be completely characterized using spectrometric techniques including 1D and 
2D NMR. The coupled CL-fluorescent dye can be used to monitor CL in biological samples. In 
addition, the CL affinity matrix can be used to purify CL-binding proteins from complex 
mixtures. Finally, polyclonal antibodies generated from CL-protein conjugate to develop 
competitive indirect enzyme linked immunosorbent assay (CI-ELISA). 
1.1 Hypothesis 
In the process of oil extraction from flaxseed CLs are dissolved in flax oil that has similar 
properties to low polarity organic solvents like ethyl acetate. Silica gel is a polar adsorbent that 
readily adsorbs polar molecules like CLs from low polarity organic solvents. It is expected that 
CLs that are bound to silica gel can be extracted and enriched from the silica gel
 
 
 
2 
using polar organic solvents such as methanol or blends of methanol with less polar solvents 
such as chloroform and dichloromethane.  
Second hypothesis 
Amino acids that contain heteroatoms such as a Met group are known to be reactive and, 
it may be possible to modify Met without affecting the amides present in CLs. Reactive Met 
occur in CLs such as CLB, but may also be accessed by reduction of CLs containing Mso (e.g. 
CLC).  
Third hypothesis 
CLB related reduced Met-containing CLs, may be modified by reacting with activated 
haloalkyl groups such as iodomethylene. CLs produced in this way may contain reactive -NH2, -
COOEt and -OH groups, which can be used to selectively couple intact CLs with other reactive 
functional groups present in fluorescent labels, affinity media, and carrier proteins. Coupled CLs 
may be used for fluorescence energy transfer from a chromophore to a metal bound to a CL or 
for purification of proteins from crude cell extracts. In addition, coupled CLs may also be used to 
produce antibodies by utilizing the CL as a hapten. 
Fourth hypothesis 
The Met modified CLs may be converted to more stable methionine sulfone (Msn) CLs. 
Msn CLs are shown to be stable than Met in terms of thermal and chemical stability. This will 
help to produce stable Msn CLs containing reactive side chains of -NH2, -COOEt and -OH 
groups. 
1.2 Objectives  
 The objectives of this research are to: 
 Develop methods for isolation and purification of CLs from flax oil in multigram 
quantities. Specifically, Mso containing CLC and CLE will be isolated from silica that 
was previously equilibrated with flax oil. 
 Develop a synthetic strategy to chemically modify the reactive side chains of these CLs. 
These new CLs will be completely characterized using 1D and 2D NMR techniques. 
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 Develop coupling methods to attach the above-modified CLs to dyes, solid matrix and 
protein. Dye linked CLs can be used as fluorescent tags. CLs linked to a solid matrix will 
be used to purify CL-binding proteins from complex mixtures and CLs bound to proteins 
will be used to induce the production of antibodies. 
 Develop synthetic strategy to oxidise Met CLs to more stable Msn derivatives.  
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CHAPTER 2  
LITERATURE REVIEW 
2.1 Flaxseed 
Flax (Linum usitatissimum L.), a member of the family Linaceae, is cultivated for 
production of oil seeds and fiber, and is one of the oldest crops (Jhala & Hall, 2010). The 
proximate composition of flax averaged 40% fat, 20% protein, 30% total dietary fibre, 6% 
moisture and 4% ash. These compositions vary with seed processing, genetics, growing 
environment and method of analysis (Daun, et al., 2003). Flax is rich in polyunsaturated fatty 
acids (73%) followed by monounsaturated (18%) and saturated (9%) fatty acids (Cunnane, et al., 
1993). The major polyunsaturated fatty acid in Canadian flax is α-linolenic acid (ALA, omega-3, 
57%) followed by linoleic acid (omega-6). Variance in the ratio of fatty acids depends on the 
temperature and variety of flax (Morris, 2007).  
Seed proteins are classified based on their solubility in aqueous solvents. Globulins are 
insoluble in water but soluble in concentrated salt solutions, while albumins are soluble in water 
or dilute salt solutions. Globulins (11–12S) and albumin (2S) type constitute the majority of seed 
proteins (Care, 1954). Seed globulins are high molecular weight proteins (252–294 kDa) 
constituting 66% of total protein and these proteins are rich in aspartic acids, glutamic acids and 
arginine. However, seed albumins are low molecular weight proteins of about 16 kDa molecular 
weight and constitute 20% of the total proteins. The albumins are richer in glutamic acids, while 
arginine content is similar to globulins. However, albumins contain half the aspartic acid 
observed in globulins (Bhatty, 1995). The amino acid composition of flax is similar to soybean 
protein, which is considered to be one of the more nutritious plant proteins. Both flaxseed and 
soy contains higher amounts of glutamic acid (+glutamine), aspartic acid (+asparagine), leucine 
and arginine. This high content of amides serves as storage role in the seeds by providing 
nitrogen for seedling growth and germination. The amino acids that are essential for human 
nutrition are shown in Table 2.1 (Morris, 2007; Wanasundara & Shahidi, 2003). However, lysine 
is the limiting amino acid with 60% less concentration as found in soy protein (Bhatty, 1995). 
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Flaxseed also contains both soluble and insoluble dietary fiber and their proportions 
range between 20:80 and 40:60 depending on the extraction methods and chemical analysis 
(Mazza & Oomah, 1995). The soluble fiber consists of mucilage gums and insoluble fiber 
consists of lignin and cellulose (Mazza & Biliaderis, 1989; Vaisey-Genser & Morris, 2003). 
Mucilage gums constitutes about 8% of flaxseed dry weight and they are made up of both neutral 
and acidic polysaccharides. The neutral polysaccharide consists of D-xylose, D-galactose and L-
arabinose, while acidic consists of L-galactose, L-fucose, L-rhamnose and D-galacturonic acids 
(Westcott & Muir, 2003). When these gums are dissolved in water it becomes viscous. Cellulose 
is main plant cell wall carbohydrate and lignin is a highly branched complex present within the 
plant cell wall. Lignin provides rigidity and strength to the cell wall (Morris, 2007). 
Flaxseed also contains lignan substances, which are formed by coupling of cinnamyl 
alcohols (Westcott & Muir, 2003). Secoisolariciresinol diglucoside (SDG) is a principal lignan 
and has shown to have phytoestrogen effects. Flaxseed lignan is present at higher concentrations 
(75–200 times) than in other lignan containing foods (Johnsson, et al., 2000; Mazur, et al., 1996). 
SDG is a principal lignan in flaxseed, a phytochemical antioxidant that acts as a precursor of 
mammalian lignans and a phytoestrogen. The mammalian lignans are produced by conversion of 
plant lignan by gastrointestinal microbiota (Adolphe, et al., 2010; Prasad, 2004; Saggar, et al., 
2010). SDG can prevent the development of atherosclerosis and diabetes in model animals 
(Fukumitsu, et al., 2008; Prasad, 1999, 2009) and additional benefits include lowering of 
cholesterol levels (Fukumitsu, et al., 2010). In addition, the other group of lignans identified in 
flax include aryltetralin and arylnapthalene (Westcott & Muir, 2003). 
Flaxseed also contains cyanogenic glycosides. These glycosides contain a cyanohydrin 
that is stabilized by the linkage of a carbohydrate to the free alcohol. The glycosides can be 
hydrolysed by enzymes or under acidic conditions releasing the cyanohydrin, which decomposes 
to hydrocyanic acid and the resulting aldehyde or ketone. These glucosides are classified into 
monoglucoside and diglucosides. Monoglucosides (linamarin and lotaustralin) are present in 
developing embryos, germinating seeds, leaves and flowers while diglucosides (linustatin and 
neolinustatin) occurs in mature seeds and developing embryos (Westcott & Muir, 2003).  
Flaxseed contains flavonoids (flavone C- and O-glycosides) and phenolic acids (ferulic acid, 
chlorogenic acid, gallic acid and 4-hydroxy benzoic acid). Flaxseed also contains phytic acid and 
linatine.  
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Table 2.1 Amino acid composition of flaxseed (Bhatty & Cherdkiatgumchai, 1990; Friedman 
& Levin, 1989; Oomah & Mazza, 1993). 
 
Amino acid Brown flax 
(Norlin) g/100 g protein 
Yellow flax 
(Omega) g/100 g protein 
Soy flour 
Alanine   4.4   4.5   4.1 
Arginine   9.2   9.4   7.3 
Aspartic acid   9.3   9.7 11.7 
Cystine   1.1   1.1   1.1 
Glutamic acid 19.6 19.7 18.6 
Glycine   5.8   5.8   4.0 
Histidine1   2.2   2.3   2.5 
Isoleucine1   4.0   4.0   4.7 
Leucine1   5.8   5.9   7.7 
Lysine1   4.0   3.9   5.8 
Methionine1   1.5   1.4   1.2 
Phenylalanine1   4.6   4.7   5.1 
Proline   3.5   3.5   5.2 
Serine   4.5   4.6   4.9 
Threonine1   3.6   3.7   3.6 
Tryptophan1   1.8  NR2  NR2 
Tyrosine   2.3   2.3   3.4 
Valine1   4.6   4.7   5.2 
1Essential amino acids for humans. 
2NR: not reported. 
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Phytic acid also binds to starch and proteins. Linatine is a glutamyl derivative of D-
proline and acts as a vitamin B6 antagonist. In addition, flax contains minor amounts of vitamins 
such as vitamin E [tocopherols (α-, β-, γ-, δ-)] and vitamin K. Phosphorus and potassium 
constitutes major mineral components and other minerals reported include manganese, zinc and 
iron (Daun, et al., 2003). 
Polyunsaturated fatty acids, lignan, mucilage and CLs are major functional classes of 
compounds present in flax. The edible oil, linseed oil or flaxseed oil is obtained by extraction of 
flaxseed. Flaxseed oil is an important health food product because of its high level of 
polyunsaturated fatty acids such as linoleic acid (C18: 2) and ALA (C18: 3). These fatty acids 
cannot be synthesized by the human body and are known to have physiological functions. They 
act as intermediates in production of hormones like eicosanoids which help in immune function 
and regulate inflammation in animals (Oomah, 2001). Consumption of flaxseed oil increases the 
concentration of ALA in human blood plasma (Barceló-Coblijn, et al., 2008; Kaul, et al., 2008). 
ALA is a precursor of the polyunsaturated fatty acids (PUFA) like eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA) that reduce the risk of cardiovascular diseases (Gebauer, et al., 
2006).  
2.2 Plant Cyclic Peptides 
Plant cyclopeptides are made up of peptide bonds consisting of 2–37 proteinaceous or 
non-protein amino acids and mostly they are present in higher plants in L-configuration. For 
example, arenariphilin A isolated from Arenaria oreophila consists of two amino acid residues, 
cyclo-(Thr-Gly) (Jia, et al., 2003). The role of cyclic peptides in plants is not known, but cyclic 
peptides have biological activity in mammals. For example, diandrine A has shown antiplatelet 
activity and Segetalins A, B, G and H have shown estrogen activity (Hsieh, et al., 2004; Morita, 
et al., 1995; Tan & Zhou, 2006; Yun, et al., 1997). During the past half century, about 455 
cyclopeptides have been identified from higher plants and they arise from to 26 plant families, 65 
genera and 120 species. These cyclic peptides were classified based on their skeleton and 
distribution in plants. They are divided into two classes homo- and heterocyclopeptides, based on 
their peptidic bonds i.e. made up of proteinogenic amino acid or produced from non-
proteinogenic amino acids. These two classes are further divided into five subclasses based on 
number of rings. Finally, these subclasses are divided into eight types based on their source and 
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characteristics of rings (Figures 2.1 and 2.2). According to Tan and Zhou, 455 cyclopeptides are 
divided into these eight types (I, II, III, IV, V, VI, VII, VIII containing 185, 2, 4, 13, 9, 168, 23 
and 51 number of cyclic peptides, respectively). Types I and VI contains largest number of 
peptides among other types (Tan & Zhou, 2006). 
In a recent review it was suggested that the name Orbitides replace the term 
Caryophyllaceae-type homomonocyclopeptides (Type VI). Orbitides are circular peptides 
composed of five to twelve proteinogenic amino acids linked in an N to C terminal fashion. 
Orbitides have been identified in nine individual plant families including the Rutaceae, 
Phytolaccaceae, Euphorbiacea, Annonaceae, Caryophyllaceae, Lamiaceae, Linaceae, 
Schizandraceae, and Verbenaceae (Arnison, et al., 2013). 
2.2.1 Methionine Containing Peptides 
Most of the peptides are rich in hydrophobic amino acids such as Pro, Phe, IIe, Leu, Val, 
Tyr and Trp. A review of plant cyclic peptides showed that very few had Met in their backbone 
structure (Tan & Zhou, 2006). Met containing orbitides isolated from higher plants are listed in 
the Table 2.2. Many of the Met peptides are also observed as the corresponding partially 
oxidized Mso form. But it is not certain, if Mso containing peptides are present naturally in 
plants or if they occur as an artifact of peptide isolation. Some of the examples include flax CLs 
(CLD', CLE', CLF' and CLG') detected in flax oil (Stefanowicz, 2001). These are reduced CLs of 
CLD, CLE, CLF and CLG. 
2.2.2 Conformational Study of Cyclic Peptides (Orbitides) 
The biological activity of the cyclic peptides is closely related to the conformational state 
of the molecule. This conformational study helps to predict the active binding site of the 
molecule. In general, a peptide backbone tends to be flexible with many possible conformers. 
However cyclic peptides present in higher plants are often rich in proline (Pro) residues. Hence 
the restricted rotation of the backbone is due to intramolecular hydrogen bonding and rigid Pro 
residues that may lock the conformation of the molecule (Morita, et al., 1999).  Conformation of 
peptides can be determined in both solution and solid state by using NMR and X-ray diffraction. 
NMR protocols such as 1H, 13C, COSY, HSQC, HMBC, NOESY, TOCSY provide the ability to 
determine many aspects of conformation. The one dimensional NMR such as 1H and 13C helps in 
the assignment of protons and carbon atoms in the framework of organic compounds.
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Figure 2.1 Classification of plant cyclic peptides. Adapted from (Tan & Zhou, 2006) 
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Figure 2.2 Structures of plant cyclic peptides. Adapted from Tan & Zhou (2006) 
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Table 2.2 Met containing cyclic peptides. 
 
Cyclopeptide (Source) Amino acid sequence (cyclo-) Mol. formula 
Cherimolacyclopeptide A 
(Annona cherimola) 
Pro-Gln-Thr-Gly-Met-Leu-Pro-Ile C38H63N9O10S 
Cyclosquamosin B              
(A. squamosa) 
Pro-Pro-Ile-Thr-Gly-Leu-Met-Gln C38H63N9O10S 
Cyclosquamosin G             
(A. squamosa) 
Pro-Met-Thr-Ala-Ile-Val-Gly-Tyr C39H60N8O10S 
Chevalierin A              
(Jatropha chevalieri) 
Gly-Ile-Pro-Ile-Leu-Ala-Ile-Met C39H68N8O8S 
Cycloleonuripeptide A     
(L. heterophyllus) 
Gly-Pro-Pro-Pro-Tyr-Pro-Pro-Met-Ile C47H67N9O10S 
Cyclolinopeptide B     
(Linum usitatissimum) 
Met-Leu-Ile-Pro-Pro-Phe-Phe-Val-Ile C56H83N9O9S 
Cyclolinopeptide D'     
(Linum usitatissimum) 
Met-Leu-Leu-Pro-Phe-Phe-Trp-Ile C57H77N9O8S 
Cyclolinopeptide E'     
(Linum usitatissimum) 
Met-Leu-Val-Phe-Pro-Leu-Phe-Ile C51H76N8O8S 
Cyclolinopeptide F'     
(Linum usitatissimum) 
Met-Leu-Met-Pro-Phe-Phe-Trp-Val C55H73N9O8S2 
Cyclolinopeptide G'     
(Linum usitatissimum) 
Met-Leu-Met-Pro-Phe-Phe-Trp-Ile C56H75N9O8S2 
Cyclolinopeptide H     
(Linum usitatissimum) 
Mso-Leu-Met-Pro-Phe-Phe-Trp-Ile C56H75N9O9S2 
Cyclolinopeptide I     
(Linum usitatissimum) 
Met-Leu-Mso-Pro-Phe-Phe-Trp-Val C55H73N9O9 S2 
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  However, chemical shifts similarity of different amino acid residues may result in 
spectral overlap making 1H and 13C assignments difficult (Silverstein, 2005). Multi-dimensional 
NMR protocols such as COSY, HSQC, HMBC, NOESY, ROESY and TOCSY may be 
employed to determine and identify the relationships of protons in different environments. The 
tertiary structure of the polypeptide chains is determined using Nuclear Overhauser 
Enhancement (NOE) spectroscopy. NOE gives information about the protons, which are distant 
from each other but in close (< 5Å) space (Pomilio, et al., 2006). For example, the protons 
attached to the heteroatoms were assigned from 1H NMR, and their coupling to amide protons 
and carbonyl carbons employed NOE and HMBC correlations. These spectra provided the amino 
acid sequence of the cyclic peptide. Sequential assignment of β, γ and δ protons were done using 
1H-1H COSY and elucidation of bonds between these protons and carbon atoms was performed 
by HSQC. X-ray crystallography provides the static structure of the molecule in a crystal and it 
is complementary to NMR studies but the information gathered from X-ray and NMR may 
differ. The structure analysis of compounds by X-ray diffraction requires either a high quality 
crystal or a powder. The densities of electrons surrounding atoms in the crystal diffract the path 
of the X-rays in a pattern that can be interpreted to provide the structure. This technique can be 
applied to macromolecules (> 100 kDa). In contrast, the conformational environment of 
individual atoms in dissolved molecules may be monitored with NMR. The development of 
cryogenic NMR has made them more sensitive towards higher molecular weight biomolecules. 
However both techniques are complementary to each other and have been used together to 
determine molecular structure (Brünger, 1997; Feng, et al., 2011; Sikic, et al., 2010). Some of 
the examples of cyclic peptides involving structure determination in both solid and solution 
states are: - cyclolinopeptide A has shown five intramolecular hydrogen bonds and four turns 
with a cis geometry between Pro-Pro bond in the crystal structure, while the other peptide bond 
has a trans geometry. The solid-state structure of CLA was obtained in different mixture of 
solvents such as isopropanol-water, methanol-water and methanol-isopropanol. The crystal 
structures show inclusion of solvent molecules through hydrogen bonding (Di Blasio, et al., 
1989; Matsumoto, et al., 2002; Quail, et al., 2009). However, solution state of CLA was 
determined in DMSO, methanol, isopropanol and chloroform. Various temperatures were used to 
minimize the conformers. NMR studies at 214 K in chloroform shows similar conformational 
structure as solid state. (Di Blasio, et al., 1989; Matsumoto, et al., 2002). Yunnanin A has also 
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shown similar conformation in both solid and solution state. It shows three intramolecular 
hydrogen bonds with two β turns and β-bulge unit with trans amide bonds (Morita, et al., 1997). 
However, Segetalin A shows different conformation in solid and solution state. In solid state, 
molecule shows two β turns (types I and VI) fixed by two trans-annular hydrogen bonds between 
Val and Gly. But there were two types (II and VI) of β turns present in solution state. This result 
shows that Segetalin A took different backbone conformations in solution and solid state. 
(Morita, et al., 1995).  
2.2.3 Biological Activity 
The cyclic peptides belong to orbitide family have shown interesting biological activities 
such as antimalarial, immunomodulating, immunosuppressive, antiplatelet and antifungal 
(Arnison, et al., 2013). Some examples of plant hydrophobic cyclic peptides are: -
Cycloleonurinin is a cyclic dodecapeptide isolated from fruits of Leonurus heterophyllus that has 
shown potent suppression of human peripheral blood lymphocyte proliferation and, therefore, 
may be immunosupressive. It showed the inhibitory effects on concanavalin A stimulated human 
peripheral blood lymphocytes with an IC50 of 28 ng/mL, which is comparable to well known 
immunosuppressive agent, cyclosporine A (IC50 3 ng/mL) (Morita, et al., 1997). Curcacycline B 
is a cyclic nonapeptide isolated from Jatropha curcas latex has shown to increase the rotamase 
activity of human cyclophilin B i.e interconversion of cis and trans isomers of peptidyl-prolyl 
amide bonds. This peptide contains one proline and act as peptidyl-prolyl cis-trans isomerase 
(PPIase) substrate by increasing PPIase activity of cyclophilin-B of 60% at 30 µm (Auvin, et al., 
1997). Diandrine A was isolated from the plant D. diandra has shown antiplatelet activity. It 
inhibits platelet aggregation induced by collagen and the motif of Gly-Pro-Trp-Pro may interfere 
with the interaction between collagen receptor and collagen, but the mechanism has not been 
discussed (Hsieh, et al., 2004). Since collagen plays an important role in platelet aggregation by 
providing the site for platelet adhesion and also stimulating the secretion and adhesion of 
platelets (Asselin, et al., 1997). Dianthins E and 4-methoxydianthramide were isolated from 
Chinese medicinal plant Dianthus superbus and have shown cytotoxic activity against human 
hepatocellular carcinoma Hep G2 cancer cell lines with IC50 of 2.37 and 4.08 µg/mL. These 
studies were conducted concurrently with doxorubicin, an anticancer drug with an IC50 of 0.19 
µg/mL (Hsieh, et al., 2004). Segetalins A-H were isolated from the seed of Vaccaria segetalis, 
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which has been used as a traditional Chinese medical treatment for regulation of menstrual 
disturbance, stimulating blood circulation and promoting milk secretion (Huang, 1993; Morita, et 
al., 2006; Morita, et al., 1994; Morita, et al., 1996; Morita, et al., 1995; Yun, et al., 1997). 
Segetalins A, B, G and H have shown estrogen activity by increase in uterine weight in 
ovariectomized female rats. It has been proposed that the sequence of Trp-Ala-Gly-Val in 
segetalins A, B and G and Phe-Ser-Gly in segetalin H might be responsible for estrogen activity 
by comparing the biological activity of homologous cyclic peptides (Morita, et al., 1995; Yun, et 
al., 1997). Segetalin E has shown moderate cytotoxic activity against P388 leukaemia cell lines 
with an IC50 40 µg/mL (Morita, et al., 1996). Segetalins F, G and H containing basic amino acids 
such as arginine and lysine show potent vasorelaxant activity against rat aorta induced 
norepinephrine. In contrast, Segetalin B with no basic amino acid residues have shown estrogen 
like activity in ovariectomized rats with a increase in the uterus weight and the mode of action of 
these peptides are under study (Morita, et al., 2006). Dichotomins A–K were isolated from the 
roots of Stellaria dichotoma L. var. lanceolata Bge. and the roots were used for treatment of 
fever in folk medicine (Morita, et al., 2005; Morita, et al., 1996; Morita, et al., 1997). 
Dichotomins A, B, C, E, H and I have shown cytotoxic activity against P388 leukaemia cell lines 
with an IC50 of 2.5 µg/mL, 3.5 µg/mL, 5.0 µg/mL, 2.0 µg/mL, 3.0 µg/mL and 2.3 µg/mL 
respectively. The first three cyclic peptides differ with only one amino acid residue present at 5th 
position in the cyclic sequence (dichotomin A: Val, B: Thr, C: Ala). In addition, the sequence of 
Tyr-Ala-Phe in dichotomin E is similar to dichotomins A, B and C (Phe-Leu-Tyr) in which a 
hydrophobic amino acid is located between two aromatic amino acids. Dichotomins D, F and G 
have shown moderate cyclooxygenase inhibitory activity (72% inhibition at 100 µm for D and F; 
62.6% inhibition at 100 µm for G) (Morita, et al., 1996; Morita, et al., 1997). Dichotomins J and 
K have shown moderate vasorelaxant activity on norepinephrine induced rat aorta (Morita, et al., 
2005).  
RA-VII is an cyclic hexapeptide isolated from Rubia akane, which has shown cytotoxic 
effects against P388 lymphocytic leukemia cells, MM2 mammary carcinoma cells and KB cells 
(Itokawa, et al., 1984). It has also shown antitumor activity against various tumor cell lines 
(Majima, et al., 1993). Astin B isolated from Aster tartaricus showed antitumor activity against 
Sarcoma 180A, (Morita, et al., 1995) and induced apoptosis in human papillary thyroid 
carcinoma cell lines (Cozzolino, et al., 2005) (Figure 2.3). 
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2.3 Chemical Modification 
Cyclic peptides belong to important class of naturally occurring biologically active 
compounds. For example, gramicidin S (Kratzschmar, et al., 1989) and tyrocidine A (Mootz & 
Marahiel, 1997) produced by the bacteria Bacillus brevis are used as antibiotics whereas 
cyclosporine A (Emmel, et al., 1989) is used as an immunosuppressant drug. Cyclic peptides are 
more stable than linear peptides and resist protease degradation. By cyclization of the mobile 
ends of amino acids, they are stable towards N- and C-exopeptidases (Driggers, et al., 2008). 
Selective transformation of functional groups on biomolecules such as carbohydrates and 
peptides is important in biomedical research to prepare analogues and study structure-function 
relationships. However, chemical modification at a specific site is often a formidable challenge. 
The individual group has to be selectively activated by utilizing reactivity differences among 
functional groups in a compound. Modified cyclic peptides may be produced by several 
approaches. In a classical approach, amino acids are sequentially added to a solid phase support 
(Merrifield resin), and then they are released by a reaction that results in cyclization (Merrifield, 
1963, 1965, 1969). A second approach requires backbone modifications of the peptide at 
carbonyl and amide linkages (Deska & Kazmaier, 2008). Third approach utilizes the active 
functional groups present in the side chain of peptides for modification. The third approach is 
particularly efficient in peptides that have few heteroatoms in side chains and are cyclic and thus 
do not need the addition of protective groups to the carboxylic and amine functionality of the 
peptides (Kotha & Lahiri, 2005). Bis-cysteine cyclic peptides were synthesized from covalent 
bonding of the two non-adjacent cysteine amino acids present in the peptide chain. These 
compounds were prepared under highly dilute conditions in presence of DCC as coupling 
reagent. (Wang, et al., 2006). A further advantage of side chain modification is realized with 
mild reactions that preserve the chirality of the peptides. Where this is possible, efficient 
modification of a parent peptide and generation of many derivative compounds may be achieved. 
This approach can help to generate families of analogs that are suited for studies of 
structure/function activity relationships of biologically active peptides (Jamonnak, et al., 2010). 
There are about 13 proteinogenic amino acids having hetereo functional groups in their side 
chains available for chemical transformations. 
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Figure 2.3 Structures of RA-VII and astin B  
 
 
Figure 2.4 Reaction of tyrosine with allyl acetate 
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2.3.1 Chemical Modification through Active Side Chains 
Peptides have been modified with various non-peptidic groups such as carbohydrates 
(glycopeptides or phosphopeptides), phosphoryl groups, terpenoids, polyketides etc. There are 20 
standard proteinogenic amino acids present in the nature with different side chains. These side 
chains do not participate in the peptide bond formation and hence may be free to react. The 
amino acids containing active heteroatoms include lysine (-NH2), serine (-OH), threonine (-OH), 
cysteine (-SH), tyrosine (-OH), tryptophan (indole group), aspartic acid (-COOH), glutamic acid 
(-COOH), arginine (guanidine group), histidine (imidazole group), asparagine (-CONH2), 
glutamine (-CONH2) and Met (-SCH3) (Hermanson, 2008). Lysine is widely used for side chain 
modification of peptides and it readily reacts with the aldehydes or ketones, activated carboxylic 
acids and isothiocyanates/isocyanates (Antos & Francis, 2006). Cysteine containing sulfhydryl 
group reacts with various reagents such as vinyl sulfones, α-halocarbonyl compounds and 
maleimides to form thioether bonds (Klok, 2005). Carboxylate group of aspartate and glutamate 
is activated by carbodiimides to react with other functional groups to form ester, amide, thioester 
and hydrazide derivatives. Tyrosine amino residue can also undergo both nucleophilic and 
electrophilic reactions on the phenolate ion and aromatic ring respectively (Gauthier & Klok, 
2008; Hermanson, 2008). Hydroxyl groups in serine have been used as a reactive centre in 
elimination-addition (Sommerfeld & Seebach, 1993) and metal cross-coupling reactions (Dunn, 
et al., 1995). This side chain approach using natural amino acids helps to synthesize various 
analogs. However the limitation will be to design chemoselective modification reagents for the 
specific amino acid in presence of other amino acids. The greater the number of amino acids in 
the peptide chain with the same functional group creates difficulty in synthesis where it is 
desirable to modify just one of the amino acids. 
Non-canonical (non natural) amino acids have been incorporated in the peptide side 
chains by using transition metal catalysis. In these types of reactions, vinyl or aryl halides are 
activated by Pd (0) to form a Pd complex that reacts with specific functional groups. The special 
functional groups include boronic acids, organotin compounds, esters, terminal alkynes and 
alkene. For example, Alkylation of tyrosine residue of the protein was achieved using pi-allyl 
palladium complex allyl acetate (Tilley & Francis, 2006) (Figure 2.4). In addition, 1,3 dipolar 
cycloaddition between the azides from the side chain and alkyne forms 1,2,3-triazole derivatives 
using Cu (I) catalyst regioselectively under mild conditions (Tanaka, et al., 2007). Another 
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strategy was used to convert threonine to allo-threonine using oxazoline intermediates. allo-
threonine amino acid has inversion of configuration at the β-carbon of threonine (Wipf & Miller, 
1993) and it is found in biologically active peptides such as cyclodepsipeptide complex CDPC 
3510 (Flippin, et al., 1989), viscosin (Burke Jr, et al., 1989) and phytotoxic syringopeptins 
(Ballio, et al., 1991). These amino acids were prepared by first coupling of threonine with 
Burgess reagent to form oxazoline intermediate and finally hydrolysis of this intermediate leads 
to inversion of the β-carbon atom (Wipf & Miller, 1993). 
2.3.2 Chemical Modification through Methionine 
The modification at the Met residue is comparatively rare as it is less reactive the more 
commonly modified amino acids. Alkylation of Met residues was reported in proteins such as 
ribonuclease A and chymotrypsin using α-halo acetic acid and its derivatives (Gundlach, et al., 
1959a; Lawson & Schramm, 1962). Iodoacetic acid was used as alkylating agents for sulfhydryl 
groups. This reagent can also react with ε-amino group of lysine, phenolic hydroxyls of tyrosine 
residue and the imidazole of histidine residues. However the reaction is slower at slightly acidic 
or neutral pH compared to sulfhydryl group (Korman & Clarke, 1956).  
The reaction of Met and iodoacetic acid yields a sulfonium salt. The sulfonium salt from 
L-methionine was characterized by the elemental analysis and confirmed by decomposition into 
various products in presence of strong acid (Gundlach, et al., 1959a). It was also reported that 
Met can be regenerated from sulfonium salts using mercaptoethanol (Naider & Bohak, 1972). 
This approach was used for isolation of Met peptides under acidic conditions (Grunert, et al., 
2003). The plausible mechanism for the alkylation of Met with iodoacetic acid is to first form a 
sulfonium intermediate (carboxymethylsulfonium salt) at 40 °C for 24 h. This sulfonium salt can 
be decomposed to different products depending on reaction conditions (Figure 2.5). Alkylation 
of L-methionine to S-carboxymethylhomocysteine occurred at 110 °C for 20 h using 6 N HCl. In 
addition, the sulphonium salt decomposes to homoserine at 100 °C for 1 hour in the presence of 
0.2 M phosphate buffer and pH 6.5. In addition, when the sulfonium salt was heated at 100 °C 
for 1 hour at pH 2.2 using 0.2 M citrate buffer, homoserine lactone was formed along with 
homoserine (Gundlach, et al., 1959a). The rate of L-methionine alkylation in ribonuclease A is 
independent of pH. Met residue of ribonuclease A are efficiently alkylated at pH 2.8 and 40 °C. 
(Gundlach, et al., 1959a; Gundlach, et al., 1959b).   
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Figure 2.5 Decomposition of sulfonium salt. Adapted from Gundlach et al. (1959a) 
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  The acidic hydrolysis of sulfonium salts of L-methionine and protein ribonuclease A leads 
to different products. After hydrolysis, Met, S-carboxymethylhomocysteine and homoserine (and 
its lactone) products were formed (Gundlach, et al., 1959a; Gundlach, et al., 1959b). 
2.4 Flax Cyclolinopeptides  
Flaxseed oil contains natural hydrophobic cyclic peptides (cyclolinopeptides/CLs) 
comprising eight or nine amino acid residues (Figure 2.6, Table 2.3). The first discovered CL, 
and indeed first discovered plant CL 1 was isolated in 1959 (Kaufmann & Tobschirbel, 1959). 
Since then, eight other CLs (2–9) were isolated and detected from flaxseed and characterized by 
NMR and MS methods (Brühl, et al., 2007; Matsumoto, et al., 2001; Morita, et al., 1999; Morita, 
et al., 1997). In addition, there are two CLs 10 and 11 were also chemically synthesized from 
parent CLs 5 and 3, respectively (Matsumoto, et al., 2001). However, these compounds were also 
detected in heat treated flax meal and additionally obtained from silica that has been in contact 
with flax oil (Jadhav, et al., 2013). 
Crystal structures of CLs 1, 2 and 11 have been reported (Di Blasio, et al., 1989; Jadhav, 
et al., 2011; Matsumoto, et al., 2002; Quail, et al., 2009; Schatte, et al., 2012). However, another 
CL containing the non-proteinaceous amino acid N-methyl-4-aminoproline was isolated from 
linseed mill cake (Picur, et al., 1998). CLs were previously numbered from prolyl residue as the 
first amino acid in the sequence based on mass spectrometric fragmentation (Stefanowicz, 2004). 
Recently published flaxseed DNA sequences such as gene cyclolinopeptide-51 showed the 
embedded sequences of 1 (ILVPPFFLI), 2 (MLIPPFFVI) and 5 (MLVFPLFVI) and gene 
cyclolinopeptide-65 showed the embedded sequences of 4 (MLLPFFWI), 6 (MLMPFFWV) and 
7 (MLMPFFWI). These DNA sequences have revealed that isoleucine (Ile) is the first amino 
acid residue in 1, whereas Met is the first amino acid residue in sequences of the remaining CLs 
(Table 2.3) (Covello, et al., 2012; Gui, et al., 2012). 
2.4.1 Biological Activity of Cyclolinopeptides 
Kessler and coworkers reported the first biological activity of 1 and they have shown that 
it inhibits cholate uptake into hepatocytes  (50% inhibition at 3 µm). This inhibitory property of 
1 might prevent phalloidin intoxification of hepatocytes by inhibiting uptake of bile acids.  It has 
been suggested that the tripeptide Pro-Phe-Phe fragment present in 1 is similar to bioactive 
fragment in somastostatin and antanamide responsible for this activity (Kessler, et al., 1986). 
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Table 2.3 The amino acid sequences of CLs (1–15). 
CL (number)  Old 
name 
Amino acid sequence (cyclo-) Molecular 
formula 
[M+H]+  
A (1) CLA Ile-Leu-Val-Pro-Pro-Phe-Phe-Leu-Ile C57H85N9O9 1040.6900 
1-Met-CLB  (2) CLB Met-Leu-Ile-Pro-Pro-Phe-Phe-Val-Ile C56H83N9O9S 1058.6461 
1-Mso-CLB  (3) CLC Mso-Leu-Ile-Pro-Pro-Phe-Phe-Val-Ile C56H83N9O10S 1074.6382 
1-Mso-CLD  (4) CLD Mso-Leu-Leu-Pro-Phe-Phe-Trp-Ile C57H77N9O9S 1064.6001 
1-Mso-CLE  (5) CLE Mso-Leu-Val-Phe-Pro-Leu-Phe-Ile C51H76N8O9S   977.5822 
1-Mso,3-Mso-
CLF  (6) 
CLF Mso-Leu-Mso-Pro-Phe-Phe-Trp-Val C55H73N9O10S2 1084.5359 
1-Mso,3-Mso-
CLG  (7) 
CLG Mso-Leu-Mso-Pro-Phe-Phe-Trp-Ile C56H75N9O10S2 1098.5535 
1-Mso,3-Met-
CLG  (8) 
CLH Mso-Leu-Met-Pro-Phe-Phe-Trp-Ile C56H75N9O9S2 1082.5236 
1-Met,3-Mso- 
CLF  (9) 
CLI Met-Leu-Mso-Pro-Phe-Phe-Trp-Val C55H73N9O9S2 1068.5534 
1-Msn-CLE  (10) CLJ Msn-Leu-Val-Phe-Pro-Leu-Phe-Ile C51H76N8O10S   993.5826 
1-Msn-CLB  (11) CLK Msn-Leu-Ile-Pro-Pro-Phe-Phe-Val-Ile C56H83N9O11S 1090.6395 
1-Met-CLD  (12) CLD' Met-Leu-Leu-Pro-Phe-Phe-Trp-Ile C57H77N9O8S 1048.6048 
1-Met-CLE  (13) CLE' Met-Leu-Val-Phe-Pro-Leu-Phe-Ile C51H76N8O8S   961.5904 
1-Met-CLF  (14) CLF' Met-Leu-Met-Pro-Phe-Phe-Trp-Val C55H73N9O8S2 1052.5132 
1-Met-CLG  (15) CLG' Met-Leu-Met-Pro-Phe-Phe-Trp-Ile C56H75N9O8S2 1066.5627 
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Figure 2.6 Structures of CLs (1–15) 
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1 has also shown immunosuppressant activity comparable to cyclosporine A. The effect 
of 1 on the primary and secondary humoral response was studied by plaque forming cell tests 
(PFC) in both in vitro and in vivo. Based on PFC, 1 inhibits both interleukin-1α and interleukin-
2. In addition, the cellular immune response in mice by 1 was determined using skin-allograft 
rejection, graft-vs-host reaction and delayed-type hypersensitivity. 1 influences the proliferation 
of human lymphocytes in vitro and alleviates the post-adjuvant polyarthritis in rats and 
hemolytic anaemia of New Zealand Black mice and the studies on these animals have shown 
little toxicity at a dose of 230 mg/Kg, i.v. (Wieczorek, et al., 1991). Gorski group also showed 
that 1 suppresses the activity of phosphatase in T cell activation to inhibit the activation and 
proliferation of T-lymphocyte (Gorski, et al., 2001). The molecular mechanism of 1 and CsA is 
reported to be similar, i.e. first they complex with cyclophilin, interact with the calcineurin 
system and inhibiting its phosphatase activity (Siemion, et al., 1999). Several analogs of 1 were 
synthesized and tested for immunosuppressive activity, but they have shown lower activity 
(Siemion, et al., 1999). 
CL 1 and its analogs have also shown antimalarial activity. It has been proposed that 
strong hydrophobicity of these CLs helps in the inhibition of human malarial parasite 
Plasmodium falciparum in culture and the influence of 1 on cell membranes might lead to 
antimalarial activity. The substitution of L-Phe to D-Phe produces a CL that has less activity 
(Bell, et al., 2000). 
Other CLs have exhibited different biological activity. CLs 2 and 5 inhibit the 
proliferation of mouse lymphocytes induced by concanavalin A with an IC50 of 39 µg/mL and 43 
µg/mL, respectively (Morita, et al., 1999). Reaney et al. have shown anticancer activity of CLs 
where CLs 1, 3 and 5 induces apoptosis in a human lung epithelial cancer cell line (Reaney, et 
al., 2013). A recent review described two new potent immunosuppressant CLs 10 and 11, which 
had an inhibitory effect on concanavalin A with an IC50 of 28.1 µg/mL and 25.2 µg/mL 
respectively (Morita & Takeya, 2010).  
2.4.2 Isolation and Detection 
Isolation and purification of CLs is as a prerequisite to performing meaningful biological 
assays (Reaney, et al., 2013). Various groups have isolated CLs from flax such as, Kaufman et 
al. showed the recovery of CLs from precipitated slime, obtained from flaxseed processing 
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(Kaufmann & Tobschirbel, 1959), while Morita et al. showed the recovery of CLs (2–9) from the 
methanolic extracts of flaxseed, press cake and roots (Matsumoto, et al., 2001; Morita, et al., 
1999). The latter method involves extraction of CLs using hot methanol, removal of solvent 
followed by column chromatography using diaion HP-20 media. The methanolic fractions were 
subjected to silica gel column fractionation using a CHCl3: MeOH gradient to obtain small 
quantities of these CLs (recovery-0.007% of 1, 0.0002% of 2, 0.0037% of 3, 0.0015% of 4, 
0.0058% of 5, 0.0008% of 6, 0.0024% of 7, 0.0002% of 8 and 0.00007% of 9 from dry roots of 
flax) (Matsumoto, et al., 2001; Morita, et al., 1999). These CLs were characterized using two 
dimensional NMR, 1H-NMR, 13C-NMR, IR and HR-FABMS. Stefanowicz (2001) extracted CLs 
from ground flaxseed (5 g) using acetone (100 mL) overnight. After removal of acetone the 
residue was dissolved in methanol and hydrolyzed with 10% sodium hydroxide. The solvent was 
removed and CLs were extracted using ethyl acetate. This protocol has lead to the recovery of 
CLs with Met in its reduced form along with other CLs. These reduced CLs contains Met in 
place of Mso and includes 12, 13, 14 and 15 characterized using tandem MS fragmentation 
patterns (Stefanowicz, 2001). But this process does not allow isolation and separation of all the 
CLs. Reaney et al. (2013) have developed a method to recover all reported CLs using a solid 
phase extraction process. The method involves extraction of oil from plant material and use of 
silica gel chromatography to separate CLs from oil. This method allows the recovery of 146 mg 
of crude CLs from 100 g of flaxseed oil (0.146% of starting material) (Reaney, et al., 2013). The 
recovery of CLs from flax oil is less laborious and potentially much less expensive using this 
concentrate. 
2.4.3 Chemical Synthesis 
Another approach to obtain CLs is through chemical synthesis. Various analogs of CLs 
were synthesized to study structure activity relationship studies. For example, Wiezorek et al. 
described synthetic preparation of 1 using Merrifield resin. This process requires protection of 
each amino acid with t-butoxycarbonyl group before coupling (Wieczorek, et al., 1991). 
Previously various analogs of 1 were synthesized by changing amino acid residues to form both 
cyclic and linear analogues. Some of the examples include substitution of each amino acid with 
alanine (a method called alanine scanning) to form linear analogs. The other examples include 
exchange of Phe with PheSO3Na, D-tyrosine, tyrosine, D-tryptophan and tryptophan and 
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substitution of all the aliphatic amino acids with threonine to form both linear and cyclic analogs 
(Siemion, et al., 1999).  Zabrocki et al. have synthesized various analogs of 1 and 2 to perform 
structure activity relationship studies. The two dipeptide segments (Val-Pro and Pro-Pro) of 1 
were substituted with tetrazole derivatives to form both linear and cyclic analogs using solid 
phase peptide synthesis and linear chains were cyclized using O-(benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium tetrafluoroborate (TBTU) reagent (Kaczmarek, et al., 2002). In another 
example, α-hydroxymethyl-leucine was used for substitution of Leu and α-hydroxymethylvaline 
for Val residue in 1 (Zubrzak, et al., 2005) Analogs of 1 were also synthesized by replacing Pro 
with β-isoPro and β-homoPro and substitution of Phe with β3-Phe, homoPhe and N-
benzylglycine to perform structure-activity relationship studies (Drygala, et al., 2009; 
Kaczmarek, et al., 2009; Katarzyńska, et al., 2008; Zubrzak, et al., 2004). In addition, the 
dipeptide fragment of Phe-Phe was also replaced with D-Phe-D-Phe and Phe-Phe containing 
ethylene bridge between nitrogens of adjacent Phe residues (Katarzynska, et al., 2011). An 
analog of 2 was synthesized using solid phase synthesis where the Met residue was substituted 
with α-hydroxymethyl methionine (Witkowska, et al., 2004).  
2.5 Potential Applications of Cyclic Peptides 
Peptides have found various applications in different fields including biomedical 
applications, biomaterials, fluorescence labeling, protein purification, antibody production and 
many more (Cai, et al., 2008; Fairman & Akerfeldt, 2005; Kemmer, et al., 1997; Manea, et al., 
2008; Santos, et al., 2012). Peptides have self-assembled and self organized structure with non 
covalent interactions such as hydrophobic, van der Waals, hydrogen bonding, aromatic pi-
stacking, electrostatic and metal-ligand interactions. These features help them in binding to 
receptors and their use in medical applications. The biomedical applications ranges from drugs, 
drug delivery agents to active ingredient in nutraceuticals and functional foods (Santos, et al., 
2012). They are also used as biomaterials such as hydrogels, filaments and fibrils, surfactants, 
peptide hybrids and nanomaterial (Fairman & Akerfeldt, 2005). 
2.5.1 Fluorescent Labels 
Fluorescent labels such as dyes, quantum dots and green fluorecent proteins are used to 
study the dynamic behaviour of compounds. Fluorescent labels may be categorized based on the 
fluorophore chemistry. Fluorophores may be organic compounds (e.g. coumarins, squarylium 
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dye, cyanine dye, fluorescein, Figure 2.7); inorganic particles (such as quantum dots) and 
fluorescent proteins (green fluorescent proteins and their mutants) (Katritzky & Narindoshvili, 
2009). A protein of interest may be labeled by selective chemical or enzyme mediated synthetic 
chemistry. For example, -COOH group present in coumarins, fluoresceins and squarylium dye 
was used to attach the molecule of interest. For example, the peptide Cys-Leu-Ser-Tyr-Tyr-Pro-
Ser-Tyr-Cys was labeled with fluorescein for in vitro optical imaging (Katritzky & 
Narindoshvili, 2009; Lee, et al., 2010; Thapa, et al., 2008). Tagging genes with genes encoding 
fluorescent proteins is possible through genetic engineering (Katritzky & Narindoshvili, 2009). 
The molecules tagged with fluorescent labels provide a mechanism for tracking, quantifying, and 
visualizing molecular distribution and movement of molecules in living cells. The interaction of 
a compound of interest with complex biological systems is possible with fluorescent labels by 
providing both temporal and spatial resolution of cellular and organ events. Labels may be used 
both in vitro and in vivo to monitor the movement of compounds and their interactions with 
molecules and structures of living cells (Lee, et al., 2010). 
The selection of fluorescence labels depends on the in vitro and in vivo applications. For 
example, for in vitro studies, fluorophores such as fluorescein isothiocyanate, 7-amino-4-methyl 
coumarin and 5-carboxytetramethylrhodamine with the wavelengths between 400 and 600 nm 
are suitable. However, for in vivo imaging, fluorophores with higher wavelength range between 
650 and 900 nm such as polymethines and heptamethine cyanines are often preferred. The 
photons emitted by higher wavelength fluorophores interfere less with the background, which 
may contain hemoglobin, water and deoxyhemoglobin, and penetrates into the tissues more 
efficiently than photons produced by fluorophores that emit lower wavelengths (Ferro-Flores, et 
al., 2010; Lee, et al., 2010; Weissleder & Ntziachristos, 2003). 
2.5.2 Fluorescence Labeled Peptides 
Peptides can be labeled with fluorophores for optical imaging. They have an added 
advantage over proteins and antibodies because of their inherent small structure. They often are 
less toxic than antibodies while having good permeability and low immunogenicity.  Naturally 
occurring linear peptides are subject to tissue and blood proteases and peptidase and thus have 
low metabolic stability (Ferro-Flores, et al., 2010). 
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Figure 2.7 Structures of fluorescent dyes 
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The stability of linear peptides may be increased by incorporation of unusual amino 
acids, D-amino acids, amino alcohols, N-terminal alkyl groups or by cyclization (Ferro-Flores, et 
al., 2010; Lee, et al., 2010). Biologically active peptides play a regulatory role in the body and 
perform their function through receptor binding. Such receptors and peptides have been selected 
as molecular targets for optical imaging. For example, receptors of integrin, gastrin releasing 
peptide, somastostatin, glucagon-like-peptide-1 and alpha-melanocyte stimulating hormone have 
been identified for tumor receptor imaging and specific receptor binding peptides (Cai, et al., 
2008; Drygała, et al., 2009; Korner, et al., 2007; Miao & Quinn, 2007; Reubi, 2003, 2007). To 
understand their mechanism of action through structure function analysis these specific peptides 
may be obtained from combinatorial libraries and coupled with fluorophores (Aina, et al., 2007). 
An example of fluorescent-labeled peptide includes peptide-dye conjugate [arginine-
glycine-aspartic acid (RGD)-Cy5.5], which has shown affinity to integrin receptor as contrast 
agent in vitro, in vivo, and ex vivo (Figure 2.8). Integrins αvβ3 and αvβ5 were significantly 
expressed in tumor cells as compared to normal cells. Hence dye conjugated to receptor peptides 
were used in optical imaging for visualization and quantification of integrin levels in tumors. 
Cyanine dye has an absorbance maximum at 675 nm and emission maximum at 694 nm. The ε-
amino group of lysine residue present in RGDyK peptide was coupled with N-
hydroxysuccinimide ester of cyanine 5.5 dye to use as a fluorescent probe to detect U87MG 
glioblastoma xenograft with high contrast (Chen, et al., 2004). In another example, Hsuing et al. 
identified the peptides from the phage display libraries that specifically bind to dysplastic colonic 
mucosa. This peptide, Val-Arg-Pro-Met-Pro-Leu-Gln was labeled with fluorescein by 
conjugation at N-terminal of peptide using aminohexanoic acid linker. Peptide dye conjugates 
were monitored in vivo using confocal microscope and this study showed strong binding of these 
peptides with dysplastic colonocytes as compared to normal mucosa. It has been proposed that 
this conjugate will be useful for detection of early-stage colorectal cancer (Hsiung, et al., 2008).  
Peptides were also used in determining the proteolytic activity of enzymes by using 
fluorescence resonance energy transfer (FRET) technology. In this process two fluorophores 
(donor and acceptor) were attached to the either side of the peptide chain. When the peptide is 
intact, the donor molecule transfers the non-radiative energy to the acceptor molecule and shows 
low fluorescence. But during the proteolysis peptide chain breaks down and leads to high 
fluorescence of the donor molecule. FRET peptide are sensitive tool for rapid determination of 
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enzymatic activity on the surface of cells in culture, crude extracts or biological fluids. For 
example, the enzymatic activity of prolyl oligopeptidases was determined using FRET peptide 
Abz-GFSPFRQ-EDDnp, where Abz acts as donor and EDDnp acts as acceptor (Figure 2.9). This 
enzyme cleaves at the P-F peptide bond.   
The biological activity of CLs makes them good candidates for fluorescent tag labeling. 
CLs contain intrinsic fluorophores such as Phe and Trp in their cyclic structure. CL 1 has been 
reported to fluorescence energy transfer to Tb3+ through Phe (Chatterji, et al., 1987). However 
these amino acid fluorophores have limitations in terms of high background absorbance of both 
the excitation and emission wavelength, which would make detection of fluorescent signal in 
living tissues difficult. Attachment of a fluorescent tag that adsorbs and emits light at 
wavelengths where there is little background interference is desirable. Nevertheless there are no 
prior reports of the attachment of fluorescent dye to CLs. CLs contain amino acids such as Trp 
and Met that may be suited for chemical modification to attach of fluorescent dye. Hence CLs 
tagged fluorescent label can potentially be used in therapeutic monitoring and fluorescence 
energy transfer. 
2.5.2 Protein Purification using Affinity Chromatography 
Affinity chromatography is a liquid chromatographic technique, which uses strong and 
specific non-covalent interactions (or affinity) between a stationary phase and solutes to achieve 
a separation. Affinity chromatography includes all kinds of adsorption chromatography, covalent 
chromatography, immobilized metal-ion affinity chromatography, hydrophobic interaction 
chromatography, and so on (Batista-viera, 2011). For instance, in covalent chromatography the 
protein of interest is covalently bound to the matrix such as thiol proteases bind to thiol 
derivatives of agarose. Hydrophobic interactions between the hydrophobic groups of protein and 
matrix are utilized in hydrophobic interaction chromatography. In addition metal ions are also 
immobilized on matrix for purification of biomolecules. Affinity chromatography relies on the 
principle of molecular recognition for selective separation of molecules. Biomolecules attached 
to chromatographic matrix interact with highly specific affinity to those in solution (López De 
Alda & Barceló, 2001; Rhemrev-Boom, et al., 2001). Therefore, there is little binding of non-
target molecules. Affinity chromatography is used in purification of different molecules such as 
nucleotides, (Sander, et al., 1966) antibodies and enzymes (Silman & Katchalski, 1966).  
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Figure 2.8 Fluorescent labelled peptide RGD-Cy5.5 
 
 
Figure 2.9 FRET peptide Abz-GFSPFRQ-EDDnp 
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2.5.2.1 Affinity Media 
Some of the important characteristics of affinity media are: availability of simple activation 
methods for addition of ligands, chemical stability to the conditions of ligand addition and 
subsequent chromatography, low resistance to flow of biomolecules and structure that allows 
ready diffusion of biomolecules, high surface area that is accessible to ligand and stable to 
solvents. Chromatography media are divided into two groups: single composition matrices (for 
example- agarose, cellulose, glass) and second generation matrices (for example agarose coated 
polyacrylamide, glycidoxy-coated glass) (Figure 2.10) (Scouten, 1981). Agarose gels are made 
up of alternating residues of D-galactose and 3-anhydrogalactose, while these agarose gels are 
also crosslinked with polyacrylamide to form second-generation matrices. Similarly controlled 
pore glass is used as an inorganic matrix for immobilization and this glass can be derivatized 
using triethoxy propyl glycidoxysilane. These affinity media are functionalized with various 
activated groups. For example, agarose beads have many hydroxyl groups and polyacrylamide is 
functionalized with primary amides. When using these matrices as affinity media, hydroxyl 
groups are activated to attach spacers that can be used to attach a ligand (Varilova, et al., 2006). 
2.5.2.2 Ligands 
Ligands should interact reversibly and selectively with the molecule of interest. It is 
possible to predict potential binding site of a protein and produce a selective ligand for affinity to 
that protein. For example an anthraquinone-biomimetic dye-ligand was developed for L-lactate 
dehydrogenase binding (Labrou, et al., 1999). An example of an affinity ligand is folic acid, 
which contains -COOH functional groups that can easily be attached to amine containing media 
using carbodiimide process. This coupled folate is used for binding proteins such as 
dihydrofolate reductase (Kaufman & Pierce, 1971). In addition, biotin was also used to   purify 
avidin (protein from egg white) using agarose column (Figure 2.11) (Cuatrecasas & Wilchek, 
1968). It is also possible to select ligands based on functional groups (Labrou, 2003). For 
example, analogs of phenyl boronic acid are used as ligands for glycoproteins (Labrou & Clonis, 
1994) and iminodiacetic acid is used as a ligand for metal binding proteins and metalloproteases 
(Clonis, et al., 1987). In the last 10–15 years, combinatorial approaches have been used in ligand 
selection, where libraries of compounds were constructed and subsequently used in affinity 
studies (Gaskin, et al., 2001). Many researchers have developed libraries from polypeptides, 
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polynucleotides and substituted triazines using combinatorial methods (Maclennan, 1995; 
Romig, et al., 1999).  
The general reaction in the affinity chromatography is between the ligand (L) and target 
(T) to form ligand-target complex (LT) as shown in equation 1, where [L] and [T] represents 
ligand and target concentrations at equilibrium. Hence the dissociation constant KD can be 
expressed in equation 2. The ratio of bound target to total bound is shown in equation 3, where 
L0 is the concentration of the ligand in moles per volume “v”. Here v represents the volume of 
solution entrapped with in the pores. The ratio of bound to total must be near 1 to achieve 
efficient binding and therefore KD should be smaller than L0. The parameter such as temperature, 
ionic strength and pH affects KD and they can be altered for binding and elution of target from 
the ligand. In the forward reaction (adsorption) of equation 1, KD ranges between 10–6 to 10–4 M 
and represents more binding and less elution. However, in reverse reaction (desorption) KD 
ranges between 10–2 to 10–1 M and represents less binding and more elution (Magdeldin & 
Moser, 2012). 
 
Bound target = [LT] 
Total bound = [LT] + [T] 
2.5.2.3 Immobilization of Ligands 
The attachment of ligands to solid matrix can be performed by three methods: covalent, 
non covalent and coordinating. In the covalent methods, activated functional groups present in 
L    +     T LT
KD           =       [L] * [T]
[LT]
Bound target
Total bound
≈ L0
KD
+ L0
(1)
(2)
(3)
adsorption
desorption
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the ligand such as amine, hydroxyl, sulfhydryl, carboxyl and aldehyde can be use as mode of 
attachment with the matrix (Table 2.4 and Figure 2.12). Non-covalent methods consist of non-
specific or biospecific adsorption onto surface and entrapment within the pores of the matrix. In 
addition, ligands can also be immobilized by coordinating with metal ions in case of metal ion 
affinity chromatography (Kim & Hage, 2005; Magdeldin & Moser, 2012). 
2.5.2.4 Peptide Affinity Tags 
Peptide tags are important class of affinity ligands and they are used for immobilization, 
purification and detection of proteins. They have advantage over other tags like antibodies and 
proteins in terms of cost and stability. Peptides can be readily synthesized from amino acids and 
various analogs can be prepared. Sometimes they also belong to class of hydrophobic 
chromatography in which hydrophobic amino acid residues play important role. Activated solid 
matrix can be coupled with peptides containing compatible functional groups and regenerated. 
However, the challenge in peptide affinity chromatography is to obtain specific peptide for the 
protein binding. But by screening ligands from biological combinatorial libraries (phage display 
library) or from solid combinatorial libraries (one bead one peptide library), specific peptides can 
be obtained (Baumbach & Hammond, 1992; Huang & Carbonell, 1995; Tozzi, et al., 2003). The 
amino, hydroxyl, carboxyl groups present in the amino acids such as lysine, serine, threonine, 
tryptophan, aspartic acid, glutamic acid are mostly used for coupling with the solid matrix. Some 
of the examples of peptide ligands include purification of anti-granulocyte macrophage colony 
stimulating factor monoclonal antibody using tetrapeptide Ala-Pro-Ala-Arg (Camperi, et al., 
2003). A hexapeptide Tyr-Ala-Asn-Lys-Gly-Tyr was used for the purification of the serine 
protease coagulation Factor IX from blood plasma (Buettner, et al., 1996). Trypsin was also 
purified from bovine pancreas using tripeptide Thr-Pro-Arg (Makriyannis & Clonis, 1997). 
Cyclic peptides such as somatostatin and CL analogs have also be used in the affinity 
purification of rat liver cell proteins (Kemmer, et al., 1997; Wenzel, et al., 1995). 
Protein-protein and protein-small solute interactions are important in many biological 
processes. Some of the examples include hormone binding with receptors, enzymes with 
substrates and binding of drugs and other compounds with serum proteins (Hage, 2002). Affinity 
chromatography plays important role in bioseparation of biomolecules from complex mixtures.  
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Figure 2.10 Affinity matrices 
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Figure 2.11 Affinity ligands 
  
 
 
 
35 
Table 2.4 Covalent Immobilization techniques (Kim & Hage, 2005). 
   
Group Covalent Immobilization techniques 
Amine CNBr method, Schiff base (reductive amination), N-hydroxysuccinimide, CDI, 
cyanuric chloride, azalactone method, divinyl sulfone, EDC 
Sulfhydryl azalactone method, divinyl sulfone, epoxy method, iodoacetyl/bromoacetyl, 
maleiimide method, pyridyl sulfide, TNB-thiol  
Hydroxyl cyanuric chloride, divinyl sulfone, epoxy 
Aldehyde Hydrazide 
Carboxyl EDC  
 
 
Figure 2.12 Coupling of ligand with amine and sulfhydryl containing support 
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It was reported that analogue of CL 1 bound to proteins in the cytosol and plasma 
membranes of rat hepatocytes. The structural features important for binding with proteins were 
hydrophobic surfaces and cyclic conformational structure of CL (Kemmer, et al., 1997). 
2.5.3 Haptens for Antibody Production 
Antibodies or immunoglobulins belong to special class of proteins found in extracellular 
fluids in vertebrates, particularly blood and lymph. They are produced by white blood cells and 
used as the organism's innate system for identifying and neutralizing foreign organisms such as 
bacteria and viruses (Singer & Doolittle, 1966). Each antibody is highly specific towards a 
particular compound or antigen. Antibodies consist of two kinds of polypeptide chains namely 
two heavy and two light chains held together in a complex by a disulfide bridge (Edelman & 
Benacerraf, 1962; Fleischman, et al., 1962). The structure is mostly conserved but a variable 
region at the tip of each antibody has binding site that has high affinity to a specific antigen. B-
cells in a single vertebrate produce around 108 to 1010 unique antibodies each with different 
binding sites (French, et al., 1989). This innate ability of organisms to generate antibodies of 
specific nature has been used by researchers to produce specific antibodies for many applications 
including catalysis and immunodiagnostics. 
It was reported that the molecule should be above 10,000 Da to illicit an immune 
response. Smaller molecules may be bound covalently to larger protein molecules to produce an 
immune response as well. A small organic molecule linked covalently to a protein in order to 
induce an immune response is called a hapten. When the hapten/protein complex is injected into 
an animal, antibodies are produced. Antibodies that specifically bind to a hapten can be studied 
by a number of methods including immunoprecipitation (Landsteiner, 1945). Fluorescent probes 
are also used to study chemical and binding properties of antibodies (Kabat, 1968; Northrup & 
Erickson, 1992). Examples of use of these antibodies are the detection of dioxin and pesticides 
using antibodies generated in response to synthetic halogenated haptens such as dibenzop-dioxin 
and aldicarb oxime succinic ester respectively. These haptens were conjugated with proteins 
such as BSA, LPH and OVA to produce polyclonal antibodies. (Figure 2.13) (Sanborn, et al., 
1998; Zhang, et al., 2006).  
2.5.3.1 Peptide Antibodies 
Peptide antibodies are used as tools in purification, identification of proteins, diagnostics, 
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therapeutic purpose in biology. The advancement in peptide synthesis helps to generate varied 
sequence of amino acids and generating application specific antibodies. Peptides are conjugated 
with carrier proteins like ovalbumin, BSA and keyhole limpet hemocyanin to elicit antibodies 
(Houen, et al., 2003; Schaaper, et al., 1989; Strynadka, et al., 1988). Commonly, ε-amino group 
of lysine or the thiol group of cysteine are involved in conjugation and it was carried out by one 
pot and two step method (Reichlin, 1980). In the one pot method, carrier protein, cross-linking 
reagent and peptide are mixed together and peptide conjugate was dialyzed to remove unreacted 
reactants. Glutaraldehyde and carbodiimide may be used as cross-linking reagents (Goodfriend, 
et al., 1964; Reichlin, 1980). However, in two-step method process, carrier protein was activated 
with cross-linking agent and then the product reacts with the peptide. The reagents used are m-
maleimidobenzoyl-N-hydroxysuccinimide ester (MBS), iodoacetic acid N-hydroxysuccinimide 
ester (IAAOSu) and N-succinimidyl 3-(2-pyridylthio)-propionate (SPDP) (Carlsson, et al., 1978; 
Houen, et al., 2003; Kitagawa & Aikawa, 1976). These peptide conjugates were used to 
immuninize various species depending on the amount of peptide and antibody required, time 
period response and presence of homologous protein (Trier, et al., 2012).  
Peptide-based polyclonal antibodies may be used to detect a sexually transmitted 
pathogen, Mycoplasma genitalium using immunofluorescence staining (Zarei, et al., 2011). 
Polyclonal antibodies are also used as analytical tool as immunoblots to determine the native or 
denatured calreticulin in solution (Houen, et al., 1997). However, monoclonal antibodies are 
more specific in nature and able to detect single amino acid substitution in the peptide chain. For 
example, deamidated gliadin peptide (QPFPQELPYPQPQ) antibody distinguishes between the 
amidate and deamidate peptides (Skovbjerg, et al., 2004). Another example includes p53 
monoclonal peptide antibody which shows specificity towards dephosphorylated peptide over 
mono or non-phosphorylated peptide (Otvos, et al., 1998). 
CLs are bioactive molecules with molecular weight about 1 kDa and hence they can act 
as haptens. There are no reports on the generation of antibodies using CLs. Hydrophobic amino 
acids in CLs makes these CLs insoluble in water. However, CLs can be coupled to proteins such 
as BSA in organic solvents such as DMSO or THF to form an immunogen. The antibodies 
produced using these CL-BSA conjugates may be used to detect of CLs in flax and flaxseed 
products and for localization of CLs in living tissues.   
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Figure 2.13 Structure of haptens linked to protein 
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2.6 Brief Introduction to Chapter 3 
As described in Chapter 2, flax CLs are present in very small quantity (0.2%; 200 mg/100 
g) in flaxseed and flaxseed products. Previously described extraction protocols were not 
sufficient to obtain these CLs in amounts adequate for isolation in gram quantities. The previous 
methods used for the recovery of CLs involve the extraction of oil from significant quantities of 
plant material, which do not result in large yields of CLs. The present process relates to methods 
for extraction, isolation and purification of individual CLs (1, 3, 5, 10 and 11) from oil adsorbed 
silica. Additionally, oxidation of the enriched CL extracts was performed to simplify 
chromatography for recovery of specific CLs (1, 10 and 11). Recovery of individual hydrophobic 
CLs is vital because each CL may possess different biological activity and availability of 
sufficient quantities will also allow for chemical modification of naturally isolated CLs.  
We have found that CLs 10 and 11 are absent in commercial flax products, but they are 
products of ageing flax. These CLs have been fully characterized using NMR and MS methods 
and can be used as analytical standards. Both these CLs have shown chemical and thermal 
stability at high temperatures. CL 11 has been crystallized in butanol-water solvate. Table 2.3 
describes the old and new nomenclatures of CLs and CLs were represented as numbers instead 
of names in the thesis for simplicity. 
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CHAPTER 3 
DETECTION, ISOLATION AND CHARACTERIZATION OF 
CYCLOLINOPEPTIDES J AND K IN AGEING FLAX 
 
3.1 Abstract 
Methionine sulfone containing CLs 10 and 11 may be produced from their reduced forms 
by oxidation but it is not known if these compounds occur in food that contains flax. These 
compounds have been reported to possess greater immunosuppressive activity than their reduced 
methionine sulfoxide CLs from 3 and 5, respectively. Since 10 and 11 have not been detected in 
commercial flax oil and milled flaxseed, we tested for their presence in flax food products. Here 
we report that 10 and 11 accumulate in ground flaxseed that is exposed to air and heat (100 °C) 
for more than 4 h. Standards of 10 and 11 were prepared, isolated and extensively characterized 
using HPLC-MS/MS, 1D and 2D NMR methods. We also report the excellent thermal and 
oxidative stability of these CLs. Due to the harsh conditions required to produce 10 and 11, it is 
expected that their levels in flax based foods would be low and therefore their presence could 
serve as an indicative measure of severe oxidation of a food product. 
Keywords- Cyclolinopeptides, Isolation, Characterization, Flax, Ageing 
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3.2 Introduction 
Flax, a member of the family Linaceae, is cultivated for production of oil seeds and fibre, 
and is one of the oldest crops (Jhala & Hall, 2010). The edible oil, linseed oil or flaxseed oil is 
obtained by extraction of flaxseed. Polyunsaturated fatty acids, lignan, mucilage and CLs are 
major functional classes of compounds present in flax. Consumption of flaxseed oil increases 
concentration of α-linolenic acid (ALA) in blood plasma (Barceló-Coblijn, et al., 2008; Kaul, et 
al., 2008). ALA is a precursor of the polyunsaturated fatty acids (PUFA) like eicosapentaenoic 
acid (EPA) and docosahexaenoic acid (DHA) that reduce the risk of cardiovascular diseases 
(Gebauer, et al., 2006). Secoisolariciresinol diglucoside (SDG) is a principal lignan in flaxseed, a 
phytochemical antioxidant that acts as a precursor of mammalian lignans and a phytoestrogen 
(Adolphe, et al., 2010; Prasad, 2004; Saggar, et al., 2010). Investigative studies on animals have 
shown that SDG can prevent the development of atherosclerosis and diabetes (Fukumitsu, et al., 
2008; Prasad, 1999, 2009), and additional benefits include modification effects on blood lipids 
and cholesterol levels (Fukumitsu, et al., 2010).  
Flaxseed oil contains natural hydrophobic CLs comprising eight or nine amino acid 
residues (Figure 2.6 and Table 2.3, Chapter 2). The first discovered linseed CL 1, was isolated in 
1959 (Kaufmann & Tobschirbel, 1959) and since then, eight other CLs 2–9 have been isolated 
from flaxseed oil and characterized by NMR and MS methods (Brühl, et al., 2007; Matsumoto, 
et al., 2001; Morita, et al., 1999; Morita, et al., 1997). Reduced CLs 12–15 (originally from 4–7, 
respectively) have also been detected in flax oil and characterized using tandem MS 
fragmentation patterns (Stefanowicz, 2001). CLs 1, 2 and 5 exhibit immunosuppressive activity 
(Gorski, et al., 2001; Morita, et al., 1999; Wieczorek, et al., 1991). In addition, CLs 1, 3 and 5 
induce apoptosis in human lung epithelial cancer cell lines (Reaney, et al., 2013) indicating that 
these compounds have potential applications as pharmaceuticals. CLs could be utilized as drugs 
or drug delivery agents as they have biological activity, hydrophobicity and may form inclusion 
complexes.  For example, the hydrophobicity of CLs plays a significant role in transport across 
cell membranes in addition to distribution in tissues and organs (Kemmer, et al., 1997) and helps 
in binding with human serum albumin (Rempel, et al., 2010). CLs also form inclusion complexes 
with metal ions such as Tb (Chatterji, et al., 1987) and forms crystalline solvates with alcohols 
(Jadhav, et al., 2011; Quail, et al., 2009; Schatte, et al., 2012). CLs were previously numbered 
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from prolyl residue as the first amino acid in the sequence. Recently published flaxseed DNA 
sequences have revealed that isoleucine (Ile) is the first amino acid residue in 1, whereas 
methionine (Met) is the first amino acid residue in sequences of the remaining CLs (Covello, et 
al., 2012; Gui, et al., 2012). 
Cyclic peptides containing methionine sulfone (Msn), a product of Met and methionine 
sulfoxide (Mso) oxidation, are more rare and are not observed as natural products in higher 
plants (Morita & Takeya, 2010; Pomilio, et al., 2006; Tan & Zhou, 2006). These Msn containing 
peptides have higher thermal, acid and base stability than Met and Mso parents. Thermally stable 
peptides have been used in various applications such as biomedical, nanotube technologies, 
microporous solids and photoswitches (Afonso, et al., 2012; Cordes, et al., 2006; Ryu & Park, 
2010).  
A recent review described two new potent immunosuppressant CLs 10 and 11 (Figure 2.6 
and Table 2.3, Chapter 2) (Morita & Takeya, 2010). Of all the eleven known CLs, 1 showed the 
best immunosuppressive activity, followed by 10 and 11, which were previously synthesized in 
75% isolated yield via oxone oxidation of 5 and 3, respectively (Matsumoto, et al., 2001). This 
chapter describes detection of 10 and 11 in flax meal after accelerated ageing and preparation 
and isolation of 10 and 11 from a mixture of 1, 3, 5, 10 and 11. A comprehensive structure 
elucidation of 10 and 11 was performed using tandem mass spectrometry and, NMR (1H, 13C and 
2D) methods. We also investigated the stability of these CLs when exposed to acid and base at 
temperature above 200 °C. 
3.3 Materials and Methods 
3.3.1 Materials 
All chemicals were purchased from Sigma-Aldrich Canada Ltd., Oakville, ON, Canada 
All solvents were HPLC grade and were used as such. Ground flaxseed was obtained from 
Bioriginal Food and Science (Saskatoon, Canada) Inc. The samples had been ground and 
packaged for commercial sale 1 week before the analysis was conducted. Packages were opened 
on the day samples were subjected to accelerated ageing at elevated heat (100 °C) under a stream 
of air. 
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3.3.2 Structural Analysis of Cyclolinopeptides 
3.3.2.1 Nuclear Magnetic Resonance Methods 
Proton NMR spectra were recorded on a 500 MHz Bruker Avance spectrometer (Inverse 
triple resonance probe, TXI, 5 mm; XWIN-NMR 3.5 software). The 1H NMR spectra (500 MHz) 
chemical shifts (δ) values are reported in parts per million (ppm) relative to the internal standard 
TMS. The δ values are referenced to CHCl3 in CDCl3 at 7.27 ppm, and multiplicities are 
indicated by the following symbols: s = singlet, d = doublet, dd = doublet of doublets, m = 
multiplet, and br = broad. For 13C NMR (125.8 MHz), the chemical shift (δ) values were 
referenced to CDCl3 (77.4 ppm). NMR experiments were conducted at 320 K to obtain well-
resolved spectra. Fourier transform infrared (FT-IR) spectra were recorded on a Bio-Rad FTS-40 
spectrometer using the diffuse reflectance method on samples dispersed in KBr (DRIFT); only 
diagnostic and/or intense peaks are reported. Unless otherwise noted, specific rotation [α]D 
(methanol) was determined at ambient temperature on a Perkin-Elmer 141 polarimeter 
employing a 1 mL, 10 cm length; units are 10-1 deg·cm2·g-1 and the concentrations (c) are 
reported in g/100 mL. 
3.3.2.2 Liquid Chromatography Methods 
HPLC-DAD analysis was performed with an Agilent 1200 series HPLC system equipped 
with a quaternary pump, autosampler, degasser and diode array detector (Agilent G1315C/D) 
(wavelength range 190–300 nm). The peaks were detected at wavelengths of 214 nm with a 10 
nm bandwidth and against a reference signal at 300 nm. A ZORBAX Eclipse XDB-C18 (reverse 
phase) column (5 µm particle size silica, 4.6 × 150 mm), equipped with an online filter was used 
for isolation of CLs from flax oil laden silica. The mobile phase consisted of a linear gradient of 
H2O: acetonitrile (55:45 to 90:10 in 25 min) and a flow rate of 0.5 mL/min. Further 
chromatographic analyses were performed on SpeedRod Chromolith RP-18e column (2 µm 
particle size, 50 × 4.6 mm i.d.) equipped with an online filter for detection of CLs from ground 
flaxseed. The mobile phase consisted of H2O-acetonitrile (70:30 to 30:70 in 4 min, 10:90 in 0.5 
min, 70:30 in 0.5 min and equilibrated to 70:30 for 1 min) at a flow rate of 2 mL/min. 
Preparative reverse phase chromatography was performed on a BioCAD SPRINT 
Perfusion Chromatography Workstation (Perspective Biosystems Inc., MA, USA) equipped with 
GL Sciences Inc. Inertsil Prep - octadecylsilane (ODS, 10 µm particle size silica gel, 250 × 30 
 
 
 
44 
mm) column with injection volume of 1.9 mL, and a UV/VIS detector operating at a wavelength 
of 214 nm. The mobile phase consisted of H2O-acetonitrile (35:65 to 30:70 in 10 min, to 0:100 in 
20 min) at a flow rate of 7.0 mL/min. 
3.3.2.3 Mass Spectrometry Method 
 High resolution HPLC-MS was performed on an Agilent HPLC 1100 series directly 
connected to QSTAR XL Systems (Mass Spectrometer Hybrid Quadrupole-TOF LC-MS/MS, 
Applied Biosystems, Toronto, Canada). An electrospray ionisation (ESI) source was used in LC-
MS/MS analysis of 10 and 11. Chromatographic separation was achieved at room temperature 
using a Hypersil ODS C-18 (Hewlett-Packward, Germany, 5 µm particle size silica, 100 × 2.1 
mm) column. The mobile phase consisted of a linear gradient of solvent A, H2O containing 0.1% 
formic acid, and solvent B, acetonitrile containing 0.1% formic acid. The elution was performed 
using a linear gradient from 55% of B to 90% of B within 25 min at a flow rate of 0.25 mL/min. 
Further high resolution HPLC-MS-ESI analyses were performed on an Agilent HPLC 1200 
series directly connected to a MicroTOF-Q II Mass Spectrometer (Bruker Daltonik GmbH, 
Bremen, Germany) equipped with electrospray ionisation (ESI) source for detection of CLs in 
flax meal. Chromatographic separation was achieved at room temperature using a Chromolith 
FastGradient RP-18e column (Merck KGaA, Darmstadt Germany, 50 × 2 mm). The mobile 
phase consisted of solvent A, H2O containing 0.1% formic acid, and solvent B, acetonitrile 
containing 0.1% formic acid. The gradient was 2 min isocratic 40% B, followed by linear 
increase to 90% B in 8 min, the column was reequilibrated with the starting solvent for 6 min 
thereafter. A flow rate of 0.4 mL/min was used throughout each chromatogram. 
3.3.3 Heat Treatment of Ground Flax Meal 
The package of commercial ground flaxseed was shaken thoroughly. Samples of ground 
seed (3 g) were put in sample tubes of an oxidative stability index (OSI) heating block (OSI 
instrument, Omnion Inc., MA, USA,) and held at 100 °C and air pressure of 60 kPa. At regular 
time intervals, sample tubes containing ground flaxseed (120 mg) were removed from the 
heating block and transferred to 2 mL eppendorf tube followed by the addition of 70% (500 µL) 
aqueous methanol. This was then ground in a Retsch mixer mill (MM 300, Retsch GmbH, Haan, 
Germany) for 3 min at a vibrational frequency of 25 Hz using steel beads (5/32” SPEX cat 
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2150). This mixer mill offers processing of samples in 96 collection microtube racks. The tube 
was incubated at 60 °C for 2 h with agitation and filtered using a 0.45-µm filter. 
3.4 Results and Discussion 
Fresh flaxseed samples are rich in Met containing CLs 2, 12–15 (Stefanowicz, 2001). 
After a period of time, Met moieties of these CLs are oxidised to Mso containing CLs 3, 4, 5, 6 
and 7 (Matsumoto, et al., 2001; Morita, et al., 1999). However, Msn containing CLs 10 and 11 
do not occur in either fresh flaxseed extracts or in freshly pressed flaxseed oil (Section 3.4.1). 
These CLs were previously prepared by chemical oxidation of CLs 5 and 3 respectively 
(Matsumoto, et al., 2001). We therefore heated fresh ground flax to accelerate ageing and to 
determine if CLs 3 and 5 are produced under these circumstances. Heating and airflow led to the 
production of significant amounts of 10 and 11. Thus, these CLs could serve as potential 
indicators of oxidative changes occurring in flaxseed products. In order to obtain sufficient CLs 
quantities for further biological studies, we pursued simple CL modification approaches to 
improve CL recovery from oil. The total concentration of CLs in flaxseed is only 0.2% making 
isolation of sufficient individual CLs to utilize as a standard or for analysis a laborious task 
(Brühl, et al., 2007; Matsumoto, et al., 2001; Morita, et al., 1999; Morita, et al., 1997). We 
previously reported the treatment of 2000 L of flax oil with 40 kg of silica to recover large 
quantities of CLs (Reaney, et al., 2013). We report here that long term adsorption of flax CLs on 
silica significantly alters CL composition. Tryptophan containing CLs (4, 6–9) could not be 
recovered from silica that had been stored for 6–12 months before extraction while 3 and 5 
undergo further oxidation yielding new 11 and 10, respectively, each having Msn moieties. Since 
HPLC-DAD analyses of oil-laden silica extract showed presence of CLs 1, 3, 5, 10 and 11, 
purification of this mixture to individual constituent CLs could be time consuming due to the 
large number of fractions and the lower yield of each fraction. We concluded that a chemical 
reduction or oxidation of the crude extract would transform the CLs to similar chemical forms, 
that is, convert Mso CLs to corresponding Met or Msn derivatives. Reduction of the crude 
extract however yields CLs 1, 3, 5, 10 and 11, in which case CLs 1 and 13 co-elute (data not 
shown) making chromatographic separation difficult. We, therefore, resorted to oxidising the 
crude extract of CLs 1, 3, 5, 10 and 11 to yield chromatographically well-resolved mixture of 
CLs 1, 10 and 11 quantitatively. This conversion simplified the preparative chromatographic 
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separation from five to three CLs. Unlike previous methods (Matsumoto, et al., 2001) this also 
reduced the purification step of first obtaining pure CLs 3 and 5 before oxidation to access 11 
and 10. 
3.4.1 Detection of CLs in Freshly Ground Flax Meal 
Fresh ground flax meal was ground and extracted with 70% aqueous methanol. The 
samples were incubated and agitated for 2 h at 60 °C and filtered. HPLC chromatograms of the 
extract showed the presence of CL 1 and reduced CLs 2 and 12–15 (Stefanowicz, 2001). The 
structures of these CLs were confirmed using HPLC and LC-DAD trace (Figures 3.10 and 3.11). 
The molecular masses and retention times (parenthesis) of CLs 1, 2 and 12–15 were determined 
to be 1040.6900 (4.33), 1058.6461 (4.00), 1048.6048 (4.69), 961.5904 (4.33), 1052.5132 (4.33) 
and 1066.5627 (4.44) respectively. CLs 1, 13 and 14 were coeluted. 
3.4.2 Detection of 10 and 11 in Accelerated Ageing  
Ground flax meal samples (3 g) were heated at 100 °C with constant air pressure of 60 
kPa in the heating block of an OSI instrument. The levels of CLs were determined in triplicate 
samples obtained after treatment for 0, 2, 4, 8 and 16 h. CLs were extracted by the above 
procedure and analysed using HPLC and LC-DAD trace (Figures 3.10 and 3.12). CLs 2, 3 and 
11 are homologues of each other containing Met, Mso and Msn residues respectively. A similar 
pattern was also observed for CLs 13, 5 and 10. To display this transformation, the parent ion 
chromatograms were extracted from total ion mass chromatograms comparing the parent ions of 
2, 3 and 11 and separately comparing the parent ions of 13, 5 and 10. This extracted ion 
chromatographic analysis clearly showed the accumulation of 11 and 10 in the flax meal (Figures 
3.1 and 3.2). The extracted ion chromatogram also shows that CLs 3 and 5 were accumulated as 
CLs 2 and 13 decreased in the flaxseed. Finally, after 16 h CLs 10 and 11 were also detected and 
their structures were confirmed by MS/MS fragmentation (Figures 3.3 and 3.4). These results 
show that 10 and 11 are not present in flax meal, but indicators of flax CL oxidation. We have 
also conducted control experiments under constant air pressure of 60 kPa at room temperature 
for 16 h, but formation of 10 and 11 did not occur. 
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Figure 3.1 Extracted ion chromatogram analysis of CLs (2, 3 and 11) showing the 
accumulation of 11 after 16 h 
 
 
Figure 3.2 Extracted ion chromatogram analysis of CLs (13, 5 and 10) showing the 
accumulation of 10 after 16 h 
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Figure 3.3 CID MS/MS spectra of 11 showing fragmentation pattern 
 
    
Figure 3.4 CID MS/MS spectra of 10 showing fragmentation pattern 
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3.4.3 Isolation of CLs from Flaxseed Oil 
Oil-laden silica (Reaney, et al., 2013) (500 g) was mixed with hexane (1.5 L) and the 
slurry was filtered through a sintered glass funnel. The recovered silica was sequentially 
extracted with (a) 20% ethyl acetate in hexane (1.5 L × 2), (b) ethyl acetate (1 L × 3), and (c) 
10% CH3OH in CH2Cl2 (1 L × 3). The filtrate from each fraction was concentrated in vacuo and 
subsequently subjected to HPLC-DAD analyses (214 nm). CLs 1, 3, 5, 10 and 11 were detected 
in fractions b and c with retention times at 8.07, 12.12, 12.45, 16.05 and 21.27 min, respectively 
(Figure 3.5). Combined residues from fractions b and c were dissolved in methanol (250 mL), 
and then cooled to –20 °C for 3 h to allow a less soluble residue to settle. The methanolic 
solution was decanted and the residue was rinsed with methanol (150 mL × 2) with cooling to -
20 °C. The combined methanolic extracts were concentrated to produce a gummy residue that 
was sequentially extracted with hexane (150 mL × 2) and diethyl ether (250 mL × 2) at room 
temperature and at 0 °C, respectively. Finally, the residue was concentrated in vacuo to yield 
37.5 g of crude CLs extract. 
3.4.4 Synthesis of CLs 10 and 11 
A stirred solution of the crude CLs extract (5.2 g) in CH2Cl2 (120 mL) was treated with 
mCPBA (3.75 g, 3 equivalents) at room temperature. After 1 h the reaction mixture was 
sequentially washed with 10% Na2S2O3 (50 mL), saturated aq. NaHCO3, and H2O. The organic 
layer was concentrated to obtain a crude reaction mixture (4.2 g). The HPLC and HPLC-MS 
analyses indicated that the reaction mixture comprised CLs 1, 10 and 11 with retention times at 
12.32, 15.90 and 21.18 min, respectively (Figure 3.6). The crude reaction mixture was then 
subjected to preparative chromatography using BioCad Perfusion Chromatography Workstation 
to obtain CLs 1 (0.215 g), 10 (1.037 g), and 11 (0.997 g). All CLs were solvates. The solvent was 
removed by heating at 200 °C for overnight prior to elemental analysis. The experimental values 
of carbon, hydrogen, nitrogen and sulphur were: 1 (Anal calcd for C57H85N9O9: C- 65.27%, H- 
8.28%, N- 11.89%; Found C- 65.81%, H- 8.24%, N- 12.12%); 10 (Anal calcd for C51H76N8O10S: 
C- 61.26%, H- 7.89%, N- 11.06%, S- 3.10%; Found C- 61.67%, H- 7.71%, N- 11.28%, S- 
3.23%); 11 (Anal calcd for C56H83N9O11S: C- 61.32%, H- 7.75%, N- 11.37%, S- 2.80%; Found 
C- 61.69%, H- 7.67%, N- 11.56%, S- 2.94%). 
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Figure 3.5 HPLC-DAD profile of CL mixture from silica gel extract 
 
 
 
Figure 3.6 HPLC-DAD profile of CL mixtures following m-CPBA oxidation 
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3.4.5 Characterization of 11 
The molecular formula of 11 (C56H84N9O11S, quasimolecular ion signal at m/z 1090.5943 
[M+H]+) obtained by high-resolution HPLC-MS analysis was 15.9898 Da higher than that of 3 
(C56H84N9O10S, m/z 1074.6045 [M+H]+) thus suggesting presence of an additional oxygen atom. 
The IR absorption peaks at 3329 and 1667 cm-1, characteristic of all known CLs, confirmed the 
presence of amide linkages in 11 whereas those at 1305 and 1133 cm-1 were attributed to the 
presence of a Msn residue in 11. These absorption peaks are not diagnostic vibrations in the 
spectra of 2 or 3. The structure analysis was further corroborated by tandem mass spectrometry 
(MS/MS) and NMR spectroscopic data. The MS/MS (Figure 3.3) and NMR spectral data of 11 
showed remarkable similarities to that of 3 (Morita, et al., 1999). MS/MS fragmentation patterns 
revealed the presence of amino acid residues leucine (or isoleucine), valine, and two residues 
phenylalanine and proline. MS/MS doesn’t distinguish between leucine and isoleucine. But 1H 
NMR data of 11 displayed most resonances present in 3. 13C NMR data showed nine amide 
carbonyl signals (δ 170.68, 171.27 (2), 175.46, 171.98, 173.08, 173.73 (2), 175.46) indicating a 
nonapeptide (Table 3.1). However, a fragment loss of m/z 163 in the MS/MS data of 11 (Figure 
3.3) in place of the loss of m/z 147 (Mso in 3) suggested the presence of an Msn residue in 11. 
The sharp singlet at δ 2.85 ppm (signal at δ 2.45 ppm for 3 in DMSO) in the 1H NMR and 
carbon signal at δ 40.1 ppm (signal at δ 37.6 ppm for 3 in DMSO) in 13C NMR data of 11 was 
thus attributed to the three protons and a carbon of a Msn moiety (Morita, et al., 1999). This 
singlet indicated that 11 existed as a single conformer under the NMR experimental conditions. 
The 1H NMR spectrum also showed six amide proton signals that were observed at δ 6.57, 6.80, 
7.37, 7.57, 7.76, and 8.06 ppm (Table 3.1). The protons attached to the heteroatoms were 
assigned from 1H NMR, and their coupling to amide protons and carbonyl carbons employed 
NOE and HMBC correlations. These provided the amino acid sequence of the CL. Sequential 
assignment of β, γ and δ protons were done using 1H-1H COSY and elucidation of the 
attachments of these protons to carbon atoms were performed by HMQC. The amino acid 
sequence of 11 was further established using tandem MS/MS profile (Figure 3.3) and was 
corroborated by 1H-1H COSY. As shown in Figure 3.7, strong NOE correlations observed 
between Hα protons of the two-prolyl groups confirmed cis geometry, defining rigidity within 
the molecule maintaining 11 in one stable conformation.  
 
 
 
52 
The structure of 11 was elucidated as cyclo-(Msn-Leu-Ile-Pro-Pro-Phe-Phe-Val-Ile-). The 
optical rotation [α]D22 of 11 was –85.7° (c 0.20, CH3OH), compared to that of 3 at –109.7° (c 
0.21, CH3OH) that had similar amino acid sequence (Morita, et al., 1999). 
3.4.6 Characterization of 10 
10 was subjected to similar spectroscopic characterization as 11. 10 (C51H77N8O10S, m/z 
993.5303 [M+H]+) also showed a mass 15.9899 Da higher than 5 (C51H77N8O9S, m/z 977.5404 
[M+H]+) thus suggesting presence of an additional oxygen atom. The IR absorption maxima at 
3329, 1667, 1305 and 1133 cm-1 were similar to those of 11. However, the 1H NMR spectrum of 
10, unlike 11, displayed two sharp singlets at δ 2.86 and 3.00 ppm that corresponded to Msn 
moieties in different environments. These observations suggested that 10 existed in two stable 
conformers under the NMR experimental conditions. However 5 showed only one Mso singlet at 
δ 2.56 ppm in DMSO (Morita, et al., 1999). The 1H NMR revealed seven amide proton signals (δ 
6.14, 6.86, 6.96, 6.98, 7.67, 7.71, and 7.72 ppm) (Table 3.2). The 13C NMR spectrum showed 
two sets of signals for each carbon atom corresponding to the two conformers, signals from the 
major conformer are shown in Table 3.2. Thus, eight amide carbonyl signals (δ 170.71, 171.06, 
171.40, 171.80 (2), 172.72, 173.60, 174.90 ppm) were observed in 13C NMR, and MS/MS 
(Figure 3.4) fragmentation pattern suggested 10 to be an octapeptide. The NOE experiments 
(Figure 3.8) showed that the CL present as the major isomer is the trans prolyl isomer and the 
structure of 10 was confirmed to be cyclo-(Msn-Leu-Val-Phe-Pro-Leu-Phe-Ile).  
The optical rotation [α]D22 of 10 was –79.3° (c 0.20, CH3OH) compared to that of 5 at -
75.5° (c 0.20, CH3OH), both having similar amino acid sequences (Morita, et al., 1999). 
3.4.7 Crystal Structure of 11 
We recently published the crystal structure of 11 as a butanol-water solvate that indicated 
eight trans amide bonds and one cis bond between two prolyl residues (Figure 3.9) (Jadhav, et 
al., 2011). It must be noted that butanol-water mixture provided hydrogen bond anchors for 11 
that facilitated crystal formation. NOE shows strong coupling of Hα of Pro4 with Hα of Pro5 and 
coupling of N-H and Hα of adjacent amino acids. Hence NOE results show cis bond between 
two proline residues and trans amide bonds among other residues. NMR data was collected in 
CDCl3 at 320 K.  
 
 
 
53 
 
 
Figure 3.7 Structure of 11 (Double arrows show selected NOE correlations. Half arrows show 
selected HMBC correlations) 
 
Figure 3.8 Structure of 10 (Double arrows show selected NOE correlations. Half arrows show 
selected HMBC correlations)  
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The 2D NMR investigative studies show that the solution structure of 11 is similar to that 
of its crystal structure. However, all attempts at crystallising 10 including the use of solvents 
such as butanol-water, methanol-hexane and butanol-hexane failed. This may be due to the 
existence of two conformers of 10 discovered in NMR experiments. 
3.4.8 Thermal Stability of 10 and 11 
Additionally, we examined the acid and base stability of 10 and 11 at different 
temperatures in neat or in anhydrous organic solutions in a Kugelrohr apparatus. Some of the 
conditions were a) Neat at 200 °C for 2.5 h or 270 °C for 2 and 4 h; b) DMSO at 240 °C for 16 h; 
c) in tBuOK/THF at 100 °C for 4 h; and d) in trifluoroacetic acid at 200 °C for 4 h. Both CLs 
were stable under all the experimental conditions with no decomposition products detected. 
However, 5 and 3, the parent CLs from which 10 and 11 are derived, decomposed to respective 
olefin isomers of 2-amino but-2-enoic acid and 2-amino but-3-enoic acid (data not shown). The 
result of these experiments showed that thermal stability of these CLs was significantly higher 
than their parent counterparts. Hence sulfone side chain and cyclic structural motif stabilizes 
these CLs at temperatures above 200 °C.  
3.5 Conclusion 
In summary, CLs 10 and 11 were detected in ground flaxseed during accelerated ageing. 
CLs (1, 3, 5, 10 and 11) were isolated from flaxseed oil and derivatized to obtain gram quantities 
of 10 and 11. The structures of 10 (trans prolyl isomer) and 11 were fully elucidated using high-
resolution HPLC-MS-ESI, tandem MS, 1D (1H and 13C) and 2D (NOE, COSY, and HMBC) 
NMR spectroscopic methods. This is the first report describing the complete characterization of 
10 and 11. It was established that 11 existed as a single conformer; perhaps by virtue of having 
two proline residues, whereas, 10 existed in two conformations. These pure compounds can be 
used as standards in food industry for detection of ageing of flaxseed and flaxseed products. 
Because of their chemical and oxidative stability 10 and 11 are good candidates in nanotubes and 
biomedical applications. 
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Figure 3.9 Crystal structure of 11 butanol-water solvate 
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3.6 Experimental Data 
Table 3.1 1H and 13C NMR assignments for 11. 
 
Assignment δH δC  δH δC 
Msn1   γ 1.50 (1H, m) 21.90 
α 4.81 (1H, m) 52.11  1.04 (1H, m)  
β 2.49 (1H, m) 26.13 δ 3.46 (1H, m) 47.35 
 2.32 (1H, m)   3.31 (1H, m)  
γ 3.42 (1H, m) 51.09 C=O  173.73 
 3.26 (1H, m)     
εMe 2.85 (3H, s) 40.19 Phe6   
NH 7.37 (1H, d, 8)  α 4.11 (1H, d, 8.4) 57.61 
C=O  171.27 β 3.30 (1H, m) 36.72 
   γ  135.95 
Leu2   δ 7.17 (2H, m) 129.21 
α 4.07 (1H, m) 61.16 ε 7.27 (1H, m) 128.98 
β 2.19 (1H, m) 38.39 ζ 7.33 (2H, m) 127.36 
γ 2.05 (2H, m) 25.61 NH   
δMe 0.94 (6H, d, 6.6) 23.17 C=O  173.73 
  22.05    
NH 7.76 (1H, d, 6.8)  Phe7   
C=O  171.27 α 4.96 (1H, m) 53.83 
   β 3.06 (1H, br.s) 35.59 
IIe3   γ  136.53 
α 4.52 (1H, m) 56.49 δ 7.20 (2H, m) 129.88 
β 1.96 (1H, m) 36.57 ε 7.27 (1H, m) 129.17 
γ 1.52 (2H, m) 24.48 ζ 7.33 (2H, m) 127.50 
γMe 1.09 (3H, d, 6.6) 16.02 NH 7.57 (1H, br.s)  
δMe 0.97 (3H, t, 6.6) 11.35 C=O  175.46 
NH 8.06 (1H, br.s)     
C=O  171.37 Val8   
   α 3.90 (1H, m) 59.07 
Pro4        β 2.14 (1H, m) 29.53 
α 3.90 (1H, m) 62.02 γMe 0.86 (6H, m) 19.82 
β 2.01 (1H, m) 28.63   18.43 
 1.71 (1H, m)  NH 6.57 (1H, br.s)  
γ 2.05 (1H, m) 25.55 C=O  173.08 
 1.95 (1H, m)     
δ 3.90 (1H, m) 48.11 IIe9   
 3.67 (1H, m)  α 4.60 (1H, m) 58.54 
C=O  170.68 β 1.99 (1H, m) 36.95 
   γ 2.17 (2H, m) 25.27 
Pro5   γMe 0.95 (3H, d, 6.6) 16.24 
α 4.07 (1H, m) 61.16 δMe 0.91 (3H, t, 7) 11.76 
β 1.94 (1H, m) 32.21 NH 6.80 (1H, d, 8.4)  
 1.54 (1H, m)  C=O  171.98 
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Table 3.2 1H and 13C NMR assignments for trans prolyl isomer of 10. 
 
Assignment δH δC  δH δC 
Msn1   Pro5   
α 4.76 (1H, m) 51.65 α 4.09 (1H, m) 54.46 
β 2.45 (1H, m) 25.65 β 1.72 (1H, m) 30.32 
 2.20 (1H, m)   1.43 (1H, m)  
γ 3.28 (2H, m) 52.45 γ 1.67 (1H, m) 25.47 
 3.00 (1H, m)   1.49 (1H, m)  
εMe 2.86 (3H, s) 40.68 δ 3.38 (2H, m) 46.72 
εMe(minor) 3.00 (3H, s) 41.73 C=O  170.71 
NH 7.72 (1H, br.s)     
C=O  171.06    
   Leu6   
Leu2   α 3.81 (1H, m) 55.39 
α 4.36 (1H, m) 51.38 β 2.20 (1H, m) 37.19 
β 2.33 (1H, m) 25.56  1.86 (1H,m)  
 1.79 (1H, m)  γ 1.56 (1H,m) 25.38 
γ 1.95 (1H, m) 32.38 δMe 0.96 (3H,m) 22.84 
δMe 0.90 (3H, d, 6.2) 23.20  0.90 (3H,m) 22.13 
 0.84 (3H, d, 6.2) 22.29 NH  7.67 (1H, d, 7)  
NH 6.96 (1H, d, 9)  C=O  173.60 
C=O  171.80    
   Phe7   
Val3   α 4.32 (1H, m) 58.79 
α 4.50 (1H, dd, 6.7, 
6.7) 
57.70 β 3.14 (1H, m) 37.49 
β 2.05 (1H, m) 31.16  3.06 (1H, m)  
γMe 0.96 (3H, d, 6.6) 19.57 γ  135.66 
 0.90 (3H, d, 6.6) 18.50 δ 7.24 (2H, m) 129.40 
NH 6.98 (1H,d)  ε 7.27 (1H, m) 129.33 
C=O  171.80 ζ 7.38 (2H, m) 128.83 
   NH 7.71 (1H, br.s)  
Phe4   C=O  174.90 
α 4.34 (1H,m) 53.37    
β 3.03 (2H,m) 39.02 IIe8   
γ  135.76 α 4.13 (1H, m) 60.41 
δ 7.20 (2H, m) 129.85 β 1.88 (1H, m) 35.93 
ε 7.27 (1H, m) 129.69 γ 1.57 (2H, m) 25.59 
ζ 7.33 (2H, m) 128.88 γMe 0.84 (3H, d, 6.2) 16.51 
NH 6.86 (1H, d, 8.4)  δMe 0.99 (3H, t, 6.2) 11.87 
C=O  171.40 NH 6.14 (1H, br.s)  
   C=O  172.72 
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Figure 3.10 HPLC chromatograms of CLs during accelerated ageing of flax 
  	  
Table 3.3 Data extracted from HPLC chromatograms of CLs during accelerated aging flax. 
Time Retention times (CL)- 
0 h 2.94 (3), 3.39 (5), 3.69 (4), 4.00 (2), 4.33 (14,1,13), 4.40 (15), 4.69 (12) 
2 h 2.76 (7), 2.93 (3), 3.34 (5), 3.71 (4), 4.00 (2), 4.35 (14,1,13), 4.40 (15), 4.70 (12) 
4 h 2.77 (7), 2.93 (3), 3.34 (5), 3.70 (4), 4.05 (2), 4.36 (14,1,13), 4.49 (15), 4.72 (12) 
8 h 2.58 (6), 2.77 (7), 2.91 (3), 3.34 (5), 3.72 (4), 4.03 (2), 4.36 (14,1,13), 4.49 (15), 4.72 (12) 
16 h 2.58 (6), 2.78 (7), 2.91 (3), 3.34 (5,11), 3.71 (4,10), 4.05 (2), 4.34 (1,13) 	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Figure 3.11 LC-DAD trace of CLs in freshly ground flax meal 	  	  	  
	  
     
Figure 3.12 LC-DAD trace of CLs in ground flax meal during accelerated ageing after 16 h 
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3.7 Brief Introduction to Chapter 4 
As described in Chapter 3, individual CLs (1, 10 and 11) are extracted, isolated and 
purified in multigram quantities from flax oil. CLs (10 and 11) containing Msn were also 
detected in ageing flaxseed. The main aim of this chapter is to develop synthetic protocols to 
chemically modify CLs from flax. It is likely that modification of the CLs will be necessary in 
order to increase their utility before they can be effectively used in any application. It was found 
that CLs 10 and 11 are stable to acid and base at temperatures above 100 °C (Chapter 3). Hence 
the chemical modification of 10 and 11 is tedious. They are oxidized products of CLs (5 and 3) 
containing Mso and CLs (13 and 2) containing Met. A new branch of peptide modification 
through sulfur chemistry has been developed. Met side chain of CLs (13 and 2) readily reacts 
with organo halides to form novel substituted Met analogs. It was found that Met and Mso 
derivatives of these analogs were not stable at higher temperatures. In addition, Mso derivatives 
are chiral in nature and may increase the complexity of the reaction product mixture. Hence the 
modified Met was oxidized to more stable Msn derivative to take advantage of the thermal 
stability and simple structure of Msn. Finally Msn derivative was modified to obtain analogs 
containing modified Msn side chains with –NH2 and –OH groups in a systematic fashion by 
keeping basic core intact. In addition, methods were developed for the separation of CLs from 
reaction mixtures after modification. These novel derivatives were characterized using NMR and 
MS. The delta shifts of α protons of the amino acids were used to compare the peptide backbone 
structures of parent CLs and their derivatives. Analogs of 11 have shown slight shift perturbance 
as 11, while analogs of 10 shows major shift perturbance. These chemically modified CLs will 
allow utilizing them in different applications. 
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CHAPTER 4 
SITE-SPECIFIC MODIFICATION OF CYCLOLINOPEPTIDES 
THROUGH METHIONINE 
 
4.1 Abstract 
Flax CLs 10 and 11 are reported to have immunosuppressant activity. While it is 
desirable to produce analogs of these CLs and link them to other molecules they lack active 
nuclei that are commonly used in peptide modification. The methyl sulfide present in methionine 
of the parent CL may be converted to a sulfonium, which can be used in producing more reactive 
derivatives. We found that this route preserves the integrity of the CL. Analogs of 2, 3, 5, 10, 11 
and 13 with activated groups such as -CN, -COOEt, and -NH2 were synthesized from 2 and 13. 
These compounds were characterized by 1D and 2D NMR spectroscopy. It was observed that 
methionine (SCH3) and methionine sulfoxide (SOCH3) were easily eliminated with heating. 
These compounds were not suitable for production of stable analogs. Hence they are oxidized to 
more stable methionine sulfone analogs. Methionine modified CLs that contain active groups can 
be used for synthesis of CL adduct complexes. Such adducts include fluorescent tagged CLs, 
affinity chromatography media, and haptens suitable for antibody production.  
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4.2 Introduction 
Cyclic peptides belong to important class of naturally occurring biologically active 
compounds. For example, gramicidin S (Kratzschmar, et al., 1989) and tyrocidine A (Mootz & 
Marahiel, 1997) are used as antibiotics whereas cyclosporine A (Emmel, et al., 1989) is used as 
an immunosuppressant drug. Cyclic peptides are more stable than linear peptides and resist 
protease degradation, For example, cyclic Gαi binding peptide [cyclo-(MITWYEFVAGTK)] 
have shown proteolytic stability compared to the parent linear molecule. (Driggers, et al., 2008; 
Kleiner, et al., 2010; Millward, et al., 2007). Selective transformation of functional groups on 
biomolecules such as carbohydrates and peptides is important in biomedical research to prepare 
adducts and study structure-function relationships. In addition, tagged peptides were also used in 
forming fluorescent adducts, affinity media, isotope labeled peptides and haptens for antibody 
production (Bode, et al., 2012; Hamamoto, et al., 2011; Jayaraj, et al., 2003; Tozzi, et al., 2003). 
However, site directed chemical modification without affecting other functional groups is often a 
formidable challenge. Modified cyclic peptides may be produced by several approaches. In a 
classical approach, amino acids are sequentially added to a solid phase support, and then released 
by a reaction that results in cyclization (Merrifield resin) (Merrifield, 1963, 1965, 1969). A 
second approach requires a source of peptide that can be modified through a heteroatom such as 
oxygen, sulfur or nitrogen found in suitable amino acids including serine, threonine, cysteine, 
lysine etc. (Kotha & Lahiri, 2005). The latter approach is particularly efficient in peptides that 
have few heteroatoms and, thus, do not need the addition of protective groups to convert 
carboxylic and amine and active side group functionality of the peptides to less reactive species. 
A further advantage of this strategy is realized with mild reactions that preserve the chirality of 
the peptides. This approach is suited for studies of structure/function activity relationships of 
biologically active peptides to generate families of analogs (Jamonnak, et al., 2010).There are 13 
proteinogenic amino acids containing hetero functional groups in their side chains, which may 
undergo chemical transformations under mild conditions. For examples, alkylation of thiol 
functionality in a cysteine residue of an unprotected tetrapeptide has been reported (Or, et al., 
1991) also the hydroxyl groups of serine have been used as reactive centers in elimination-
addition (Sommerfeld & Seebach, 1993) and metal-crosscoupling reactions (Dunn, et al., 1995). 
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The alkylation of methionine (Met) residues in chymotrypsin and ribonucleaseA were 
previously reported using α-halo acetic acids and derivatives (Gundlach, et al., 1959a; Lawson & 
Schramm, 1962). Iodoacetic acid can alkylate sulfhydryl groups at neutral or slightly acidic pH 
at faster rates compare to other nucleophilic amino acid residues like lysine, tyrosine and 
histidine (Korman & Clarke, 1956). The reaction of Met and iodoacetic acid yields a sulfonium 
salt, and elemental analysis and decomposition products formed during acidic hydrolysis 
confirmed the formation of salt. Depending on the reaction conditions, different hydrolysate 
products were formed from sulfonium salt. Alkylation of L-methionine at 110 °C in 6 N HCl for 
20 h leads to S-carboxymethylhomocysteine. In addition, the sulphonium salt decomposes to 
homoserine at 100 °C for 1 hour in the presence of 0.2 M phosphate buffer (pH 6.5). Similar 
conditions in 0.2 M citrate buffer at pH 2.2, homoserine lactone was formed along with 
homoserine. The decomposition of Met based sulfonium salts depends on bonding of the Met 
through its carboxyl and amino groups. For example, the alkylation of L-methionine is pH 
independent and Met desulfurizes to homoserine and homoserine lactone during acid hydrolysis. 
However, Met residue of ribonuclease A efficiently alkylates at pH 2.8 and 40 °C. After 
hydrolysis, Met, S-carboxymethylhomocysteine and homoserine (and its lactone) products were 
formed (Gundlach, et al., 1959a; Gundlach, et al., 1959b). It was also reported that Met can be 
regenerated from sulfonium salts using β-mercaptoethanol (Naider & Bohak, 1972). This 
approach was used for isolation of Met peptides under acidic conditions (Grunert, et al., 2003).  
Flaxseed oil contains hydrophobic CLs comprising eight or nine amino acids. CLs are 
bioactive compounds with potential for use as therapeutics. To date, nine CLs (1 to 9), having 
molecular weights of approximately 1 kDa have been isolated from flaxseed (Figure 2.6 and 
Table 2.3, Chapter 2) (Kaufmann & Tobschirbel, 1959; Matsumoto, et al., 2001; Morita, et al., 
1999). Reduced CLs 12–15 of CLs 4–7 respectively have also been detected in flax oil and 
characterized using tandem MS fragmentation patterns (Stefanowicz, 2001). The CLs 1, 3, and 5 
induce apoptosis in a human lung epithelial cancer cell line (Reaney, et al., 2013). 1 inhibits both 
cholate uptake into hepatocytes of rat liver (50% inhibition at 3 µm) and the activation and 
proliferation of T-lymphocyte. Other compounds, which are similar in structure, such as 
somatostatin and antanamide have also shown inhibition of cholate uptake into hepatocytes. 
(Gaymes, et al., 1996; Kessler, et al., 1986). The two newly discovered CLs 10 and 11 possess 
immunosuppressive activity (Figure 2.6 and Table 2.3, Chapter 2). Of all the eleven CLs, 1 
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showed the best immunosuppressive activity on concanavalin A induced response of human 
peripheral blood lymphocytes with an IC50 of 2.5 µg/mL followed by 11 (25.2 µg/mL) and 10 
(28.1 µg/mL) (Morita & Takeya, 2010). The CLs 10 and 11 were synthesized in 75% isolated 
yield via oxone oxidation of 5 and 3, respectively (Matsumoto, et al., 2001), but were also 
detected in heat treated flax meal at 100 °C with constant air pressure of 60 kPa in the heating 
block of an OSI instrument for 16 h (Jadhav, et al., 2013). 
Analogs of 1 were produced using an amino acid synthesizer and substituting amino 
acids in the structure (Siemion, et al., 1999). Zabrocki et al. synthesized various analogs of 1 
using β3-Phe, homoPhe, β-Pro amino acid residues and conducted structure activity relationship 
studies of the immunosuppressive activity. Mouse splenocytes and sheep erythrocytes were used 
to measure proliferative response and secondary humoral immune response in vitro (Drygała, et 
al., 2009; Kaczmarek, et al., 2009; Katarzyńska, et al., 2008). However, 1 has shown better 
immunosuppressive activity as compared to its various analogs. It was suggested that the 
biological activity of 1 might reside in the Pro-Phe-Phe tripeptide fragments in the cyclic chain. 
It was also found that the amino acid triad Pro-Xxx1-Xxx2 was also present in other 
immunosuppressant cyclic peptides such as cycloamanide B (Pro-Ser-Phe), antamanide (Pro-
Phe-Phe) and hymenistatin I (Pro-Tyr-Val) where Xxx1 can be a hydrophobic and Xxx2 can be a 
hydrophobic or an aromatic amino acid residue (Kessler, et al., 1986; Siemion, et al., 1999). A 
similar tripeptide fragment also occurs in CLs 10 and 11 where Xxx1 is Phe in 11, but Leu in 10. 
Hence during the chemical modification of 10 and 11, this bioactive tripeptide fragment did not 
retain its activity when modified. 
This chapter describes the site-specific modification of CLs 3 and 5 through the Met 
residue while maintaining the CLs core structure intact. Modification of cyclic peptides through 
Met has not been previously reported and hence various analogs were synthesized and 
characterized. In addition, these modified CLs were completely characterized using 
spectrometric techniques including 1D and 2D NMR.  
4.3 Materials and Methods 
All chemicals were purchased from Sigma-Aldrich and HPLC grade solvents were used. 
3 and 5 were obtained from flax oil (Okinyo-Owiti, et al., 2013). 
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All other reagents were purchased from commercial sources and were used without 
further purification. The NMR spectra were recorded on a 500 MHz Bruker Avance spectrometer 
(Bruker Biospin, Germany, Inverse triple resonance probe, TXI, 5 mm, XWIN-NMR 3.5 
software). Well resolved sharp spectral signals were obtained from NMR spectra acquired at 320 
K. Subsequently, the 2D NMR spectra were also acquired at 320 K. Proton and corresponding 
carbon signals were assigned using 1H-1H COSY and HMQC correlations. The correlations 
between the amide protons, carbonyl carbons and α-CH protons were determined from NOE and 
HMBC experiments. 1H NMR spectra were taken in CDCl3 and referenced to the appropriate 
solvent signal. Chemical shifts are reported in ppm units downfield from tetramethylsilane. 
Fourier transform infrared (FT-IR) spectra were recorded on a Bio-Rad FTS-40 spectrometer 
(Win-IR software, Version-4.14) using the diffuse reflectance method on samples dispersed in 
KBr (DRIFT); only diagnostic and/or intense peaks are reported.  
HPLC-DAD analysis was performed with an Agilent 1200 series HPLC system equipped 
with a quaternary pump, autosampler, degasser and diode array detector (Agilent G1315C/D, 
1024-element photodiode array, wavelength range 190–300 nm). The peaks were detected at 
wavelengths of 214 nm with a 10 nm bandwidth and against a reference signal at 300 nm. 
Chromatography was conducted using a Chromolith® SpeedRod RP-18e column (Sorbent 
lot/column No.-UM8142/034, 2 µm mesoporous size, 50 × 4.6 mm, i.d.) equipped with an online 
filter. The mobile phase consisted of H2O-acetonitrile (70:30 to 30:70 in 4 min, 10:90 in 0.5 min, 
70:30 in 0.5 min and equilibrated to 70:30 for 1 min) at a flow rate of 2 mL/min (Olivia, et al., 
2012). A Chromolith® SemiPrep RP-18e column (Sorbent lot/column No.-UM8707/016, 2 µm 
particle size, 100 × 10 mm i.d.) equipped with an online filter was used for preparative liquid 
chromatographic separations of the CLs. The mobile phase consisted of H2O-acetonitrile (80:20 
for 0.5 min and to 10:90 in 4.5 min, 80:20 in 0.25 min and equilibrated to 80:20 for 0.75 min) at 
a flow rate of 5 mL/min. 
Reverse phase chromatography of crude CLs reaction mixtures were also performed 
using Sep-Pak® vac 20 cc (5 g) tc18 cartridges (37–55 µm particle size, 125 Å, Waters, Ireland). 
The mobile phase consisted of gradient elution of H2O-acetonitrile (100:0 to 0:100). 
Mass spectral analyses were achieved using a MicroTOF-Q II Mass Spectrometer 
(Bruker Daltonik GmbH, Bremen, Germany) equipped with an atmospheric-pressure chemical-
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ionization (APCI) source (Parameters- dry temp- 200 °C; vaporizer temp- 450 °C; dry gas- 8 
L/min; nebulizer 1.6 bar; capillary voltage- 4000 V) and used for MS/MS of modified CLs. 
Further high resolution HPLC-MS was performed on an Agilent HPLC 1100 series directly 
connected to QSTAR XL Systems (Mass Spectrometer Hybrid Quadrupole-TOF LC-MS/MS, 
Applied Biosystems, Toronto, Canada) with electrospray ionization (ESI) source. 
Chromatographic separation was achieved at room temperature using a Hypersil ODS C-18 
(Hewlett-Packward, Germany, 5 µm particle size silica, 100 × 2.1 mm) column. The mobile 
phase consisted of a linear gradient of solvent A, H2O containing 0.1% formic acid, and solvent 
B, acetonitrile containing 0.1% formic acid. The elution was performed using a linear gradient 
from 55% of B to 90% of B within 25 min at a flow rate of 0.25 mL/min. 
4.4 Results and Discussion 
In the current investigation, CLs 10 [cyclo-(Msn-Leu-Val-Phe-Pro-Leu-Phe-Ile)] and 11 
[cyclo-(Msn-Leu-Ile-Pro-Pro-Phe-Phe-Val-Ile)], each containing a methyl sulphone (Msn) 
residues are biologically active (Morita & Takeya, 2010) and thermally stable (Jadhav, et al., 
2013). But the attempts to reduce Msn to Met were unsuccessful (data not shown). The Met 
containing CLs 2 and 13 were, therefore, accessed through reduction of the methionine sulfoxide 
(Mso) precursor CLs 3 and 5, respectively. Mso containing peptides are readily reduced to Met 
containing peptides using (NH4I/TFA/Me2S) and (TiCl4/NaI) (Nicolas, et al., 1995; Pennington 
& Byrnes, 1995) and, thereby, allowing modification of these compounds with reactive 
iodomethylene groups (Gundlach, et al., 1959a). The Met therefore serves as point of attachment 
for the elongation of activated side chain while keeping the basic core of CL structure intact. CLs 
containing reactive groups such as groups–NH2, –COOH and –OH may thus be readily 
incorporated thus enabling selective coupling with other reactive functional groups. 
4.4.1 Optimization of Met Coupling 
CL 3 was reduced to 2 using sodium borohydride in presence of iodine (Figure 4.1). Met 
is reactive and can be reacted with electrophilic haloalkyl or haloacetyl compounds to form 
additional compounds (Kramer & Deming, 2012). The plausible mechanism for the alkylation of 
Met with electrophilic group (R-X) is through the formation of a sulfonium intermediate and 
subsequently release of the MeX leaving group forming a S-R compound (Gundlach, et al., 
1959a). CL 2 was subsequently treated with iodoacetonitrile in presence of dimethylformamide 
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(DMF) and N-methyl pyrrolidinone at 100°C for 20 h to form nitrile 16 (-SCH2CN). Similar 
treatment with iodoacetate yielded ester 21 (-SCH2COOEt). Met compounds can be eliminated 
using Raney Ni to alkane (α-amino butyric acid) (Kiryushkin, et al., 1969) or to produce an 
alkene (S-vinyl glycine) at elevated temperature (Kuechenthal, et al., 2010).  
In our attempts to reduce nitrile 16 to an amine led to elimination of mercaptoacetonitrile 
to form 17 under the experimental conditions. In order to avoid elimination product, 16 was 
oxidized to sulfoxide nitrile (18) (-SOCH2CN). However, the sulfoxide nitrile 18 underwent 
elimination under reducing conditions (H2 at 1 atm, Pd-C and LiOH at 170 °C) to produce 
mixtures of external and internal olefins. It was surmised that oxidation of 16 to a more stable 
sulfone 19 (-SO2CH2CN) will provide access to amine 20 that resists elimination. Thus, mCPBA 
oxidation of 16 yielded 19 that was reduced to amine 20 (-SO2CH2CH2NH2) under 1 atm of H2, 
PtO2 and AcOH at room temperature in low yield. Elimination products were not detected under 
these reaction conditions. 
An alternative and better yielding route to amine 23 and alcohol 24 that does not lead to 
elimination products was sought. 23 and 24 were obtained from ester 21 following its oxidation 
to a comparatively thermally stable 22. Treatment of 22 with ethylene diamine and ethanolamine 
provided access to amine 23 and alcohol 24 respectively. Similarly the amine 27 and alcohol 28 
analog of 10 were also synthesized (Figure 4.2).  
4.4.2 Characterizations of 24 and 28 
The structures of 24 and 28 were confirmed by MS/MS and NMR methods (Figure 4.3). 
HPLC-MS analysis showed a [M+H]+ ion peak at m/z 1177.6730 corresponding to a molecular 
formula, C59H89N10O13S of 24 and m/z 1080.5921 [M+H]+ corresponding to a molecular formula, 
C54H82N9O12S of 28. MS/MS fragmentation pattern shows the amino acid sequence of both these 
derivatives (Figure 4.4) and also confirms the attachment of hydroxyl side chain to the Msn 
residue. The IR absorption peaks at 3329 cm-1 and 1665 cm-1, characteristic of all known CLs 
(Jadhav, et al., 2013; Matsumoto, et al., 2001; Morita, et al., 1999) confirmed the presence of 
amide linkages in 24 and 28 whereas those at 1320 and 1122 cm-1 were attributed to the presence 
of a Msn residue and broad band at 3334 shows presence of hydroxyl groups in 24 and 28. The 
CID MS/MS and NMR spectral data of 24 (Figure 4.4A) showed remarkable similarities to that 
of 11.  
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Figure 4.1 Synthesis of amine and alcohol derivatives of 11. Reagents and conditions: a) 
NaBH4, I2, THF, room temperature (RT); b) ICH2CN, DIPEA, NMP, 100 °C; c) 
mCPBA, DCM, RT; d) H2 (1 atm), PtO2, AcOH, RT; e) H2 (1 atm), Pd-C, LiOH, 
dioxane: water, 140°C; f) NaIO4, THF: H2O; g) ICH2COOEt, DIPEA, NMP, 100 
°C; h) mCPBA, DCM, RT; i) ethylenediamine, MeOH, reflux; j) ethanolamine, 
MeOH, reflux 
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Figure 4.2 Synthesis of amine and alcohol derivatives of 10. Reagents and conditions: a) 
NaBH4, I2, THF, RT; b) ICH2CN, DIPEA, NMP, 100 °C; c) mCPBA, DCM, RT; d) 
H2 (1 atm), PtO2, AcOH, RT; e) H2 (1 atm), Pd-C, LiOH, dioxane: water, 140 °C; 
f) NaIO4, THF: H2O; g) ICH2COOEt, DIPEA, NMP, 100 °C; h) mCPBA, DCM, 
RT; i) ethylenediamine, MeOH, reflux; j) ethanolamine, MeOH, reflux 
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However, a fragment loss of m/z 250 in the MS/MS data of 24 (Figure 4.4A) in place of 
the loss of m/z 163 (Msn in 11) suggested the presence of an alcohol bearing side chain attached 
to the Msn residue in 24. The α protons were assigned from 1H NMR while β, γ and δ protons 
were assigned using 1H-1H COSY. Elucidation of the attachments of these protons to carbon 
atoms as performed by HMQC. In addition, the coupling of amide protons with carbonyl carbons 
was confirmed using NOE and HMBC correlations (Figure 4.3). These data provided the amino 
acid sequence of the CL. The amino acid sequence of 24 was further established using tandem 
MS/MS profile (Figure 4.4A). However 28 shows presence of only one isomer as compared to 
the parent 10, which contains two isomers. The hydroxyl group in the side chain of 28 forms a 
hydrogen bond with the carbonyls to stabilize the molecule and lock it in a single conformation. 
MS/MS profile of 28 also shows attachment of alcohol side chain (Figure 4.4B). 
4.4.3 Structure Prediction using Chemical Shift (αH) Difference 
Following the preparation of CLs analogs 23, 24, 27 and 28, it was important to 
investigate the occurrence of structural changes in the CL core structure. NMR spectroscopy was 
used as a tool to compare the structural similarity of the starting material 11 and 10 to those of 
their analogs (23 and 24) and (27 and 28) respectively (Figure 4.5). It was reported that chemical 
shifts of α protons of amino acids can be used to determine the extent, identity and location of 
secondary structural elements present in proteins (Wishart, et al., 1992).  
Initially, the chemical shift of each amino acid in randomly coiled peptides was studied to 
determine the chemical shift index. The empirically derived chemical shift index can then be 
compared to the experimentally measured value of chemical shift for the Hα of each amino acid 
in the peptide chain. Wishart et al. developed rules that predict protein secondary structure. 
These rules are as follows: “(a) If the α-proton chemical shift is greater than the range given in 
Table 4.1 for that residue, mark a “1” beside it. (b) If the α-proton chemical shift is less than the 
range given in Table 4.1 for that residue, mark a “-1” beside it. (c) If the α-proton chemical shift is 
within the given range in Table 4.1 for that residue, mark a “0” beside it. Any “dense” grouping 
of four or more “-1’s” not interrupted by a “1” is a helix. Any “dense” grouping of three or more 
“1’s” not interrupted by a “-1” is a β-strand. All other regions are designated as coil”(Wishart, et 
al., 1992). 
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Figure 4.3 Structures of 24 and 28. Double arrows show selected NOE correlations. Half 
arrows show selected HMBC correlations 
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Figure 4.4 CID MS/MS spectra of 24 (A) and 28 (B) showing fragmentation pattern 
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Table 4.1 Chemical shift values of αH used in determination of secondary structure. Adapted 
from (Wishart, et al., 1992). 
 
Residue αH range (ppm) Residue αH range (ppm) 
Ala 4.35 ± 0.10 Met 4.52 ± 0.10 
Cys 4.65 ± 0.10 Asn 4.75 ± 0.10 
Asp 4.76 ± 0.10 Pro 4.44 ± 0.10 
Glu 4.29 ± 0.10 Gln 4.37 ± 0.10 
Phe 4.66 ± 0.10 Arg 4.38 ± 0.10 
Gly 3.97 ± 0.10 Ser 4.50 ± 0.10 
His 4.63 ± 0.10 Thr 4.35 ± 0.10 
IIe 3.95 ± 0.10 Val 3.95 ± 0.10 
Lys 4.36 ± 0.10 Trp 4.70 ± 0.10 
Leu 4.17 ± 0.10 Tyr 4.60 ± 0.10 
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Figure 4.5 Chemical shift differences of αH signals for CLs 23 and 24 (A) and CLs 27 and 28 
(B) compared with 11 and 10, respectively 
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However this method is not a substitute for the two- and three-dimensional NMR 
methods, but it can complement them (Williamson & Asakura, 1997; Wishart, et al., 1995; 
Wishart, et al., 1992). Some of the examples to use chemical shifts of α proton of each amino 
acid residue to determine any structural changes in the backbone structure include Kalata B1 and 
α-Conotoxin ImI (Daly, et al., 2003; Dekan, et al., 2011). However, 27 and 28 shift perturbations 
indicated significant structural changes compared with 10. The chemical shift difference of αH 
signals for CLs 23 and 24 compare to 11 for most of the residues (six out of nine for 23 and five 
out of nine amino acid residues for 24) is less than 0.1. This indicates that substitution at the Msn 
side chain have might have effect on the structure of the molecule. But analogs 27 and 28 show 
major difference in Δ Hα values compare to 10, hence there might be structural difference 
between the parent and modified compounds. We have previously reported that 10 is present in 
two isomeric forms (Jadhav, et al., 2013). In contrast, 27 and 28 were present as single isomers. 
The stability of the single isomer may be due to hydrogen bonding of the amine and hydroxyl 
side chains. The chemical shift analysis showed that there might be structural changes induced 
by amine and alcohol side chain in 23 and 24, but there are major structural changes in 27 and 28 
compare to their parent CLs.  
4.4.4 Experimental Procedures 
CLB (2) 
Sodium borohydride (1 eq, 0.07 g) and iodine (1.5 eq, 0.35 g) were added to a 
stirred solution of CL 3 (2 g, 1.9 mmol) in THF (25 mL). The resulting mixture was stirred 
at room temperature for 1h and was subsequently treated with water and was extracted with 
CH2Cl2. The solvent was removed and CL 2 was purified by flash column chromatography 
(1.8 g).  
1HNMR (500 MHz, CDCl3, COSY, NOESY): Met1: δ 4.27 (1H, dd, 8.4, 8.2, α), 
1.99 (2H, m, β), 2.57 (1H, m, γ), 2.49 (1H, m, γ), 2.07 (3H, s, εMe), 6.52 (1H, d, 6.4, NH); 
Leu2: δ 3.65 (1H, m, α), 1.63 (2H, m, β), 1.99 (1H, m, γ), 0.94 (3H, d, 6.6 Hz, δMe), 0.92 
(3H, d, 6.6 Hz, δMe); Ile3: δ 4.44 (1H, m, α), 1.92 (1H, m, β), 1.78 (2H, m, γ), 1.05 (3H, d, 
6.4 Hz, γMe), 0.84 (3H, t, 7.5, δMe), 7.34 (1H, br s, NH); Pro4: δ 4.03 (1H, m, α), 2.24 
(1H, m, β), 1.92 (1H, m, β), 2.10 (1H, m, γ), 1.99 (1H, m, γ), 4.19 (1H, m, δ), 3.72 (1H, m, 
δ); Pro5: δ 3.94 (1H, m, α), 1.92 (2H, m, β), 1.50 (1H, m, γ), 0.74 (1H, m, γ), 3.34 (1H, m, 
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δ), 3.00 (1H, m, δ); Phe6: δ 4.74 (1H, m, α), 3.35 (1H, m, β), 3.00 (1H, m, β), 7.26 (m, 2H, 
δ), 7.18 (1H, m, ε), 7.10 (2H, m, ζ), 7.95 (1H, m, NH); Phe7: δ 3.95 (1H, m, α), 3.21 (1H, 
m, β), 2.79 (1H, m, β), 7.26 (m, 2H, δ), 7.18 (1H, m, ε), 7.10 (2H, m, ζ), 7.45 (1H, d, 6.4, 
NH); Val8: δ 3.89 (1H, m, α), 2.24 (1H, m, β), 1.05 (3H, d, 6.6 Hz, γMe), 1.00 (3H, d, 6.6 
Hz, γMe), 8.09 (1H, br s, NH); Ile9: δ 4.20 (1H, m, α), 1.99 (1H, m, β), 1.50 (2H, m, γ), 
0.95 (3H, d, 6.6 Hz, γMe), 0.89 (3H, t, 7.5 Hz, δMe), 6.82 (1H, br s, NH). 
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Met1: δ 58.6 (α), 25.4 (β), 31.3 (γ), 
15.3 (εMe), 170.7 (C=O); Leu2: δ 58.6 (α), 28.9 (β), 25.2 (γ), 23.4 (δMe), 21.4 (δMe), 
171.4 (C=O); Ile3: δ 56.2 (α), 37.2 (β), 25.4 (γ), 16.1 (γMe), 11.0 (δMe), 171.5 (C=O); 
Pro4: δ 60.9 (α), 31.5 (β), 21.5 (γ), 46.8 (δ), 170.0 (C=O); Pro5: δ 54.8 (α), 37.5 (β), 24.7 
(γ), 48.3 (δ), 174.7 (C=O); Phe6: δ 60.9 (α), 36.0 (β), 137.2 (γ), 129.7 (δ), 129.0 (ε), 127.4 
(ζ), 172.5 (C=O); Phe7: δ 55.6 (α), 37.7 (β), 136.4 (γ), 129.1 (δ), 128.9 (ε), 126.8 (ζ), 175.0 
(C=O); Val8: δ 62.4 (α), 29.6 (β), 19.6 (γMe), 18.3 (γMe), 172.4 (C=O); Ile9: δ 54.0 (α), 
35.0 (β), 25.4 (γ), 15.4 (γMe), 10.8 (δMe), 171.5 (C=O). 
CLE' (13) 
Similarly, CL 5 (2 g, 2.0 mmol) was reduced with sodium borohydride (1eq, 0.08 g) 
and iodine (1.5eq, 0.39 g) to obtain 13 (1.8 g) using the procedure above for CL 2. 
1HNMR (500 MHz, CDCl3, COSY, NOESY): Met1: δ 4.69 (1H, m, α), 2.38 (1H, m, 
β), 1.83 (1H, m, β), 2.47 (2H, m, γ), 2.06 (3H, s, εMe), 2.11 (3H, s, εMe minor), 7.38 (1H, 
m, NH); Leu2: δ 4.25 (1H, m, α), 2.27 (1H, m, β), 1.81 (1H, m, β), 1.92 (1H, m, γ), 0.90 
(3H, m, δMe), 0.87 (3H, m, δMe); Val3: δ 4.45 (1H, m, α), 2.07 (1H, m, β), 0.97 (3H, d, 6.4 
Hz, γMe), 0.94 (3H, d, 6.4 Hz, γMe), 7.04 (1H, d, 7.5, NH); Phe4: δ 4.29 (1H, m, α), 3.00 
(2H, m, β), 7.39-7.17 (m, 5H, δ, ε, ζ), 6.86 (1H, br s, NH); Pro5: δ 4.31 (1H, m, α), 1.65 
(1H, m, β), 1.52 (1H, m, β), 1.66 (1H, m, γ), 1.46 (1H, m, γ), 3.37 (2H, m, δ); Leu6: δ 3.79 
(1H, m, α), 2.21 (1H, m, β), 1.83 (1H, m, β), 1.57 (1H, m, γ), 0.94 (3H, m, δMe), 0.90 (3H, 
m, δMe), 7.59 (1H, m, NH); Phe7: δ 4.32 (1H, m, α), 3.16 (1H, m, β), 3.02 (1H, m, β), 
7.39-7.17 (m, 5H, δ, ε, ζ), 7.57 (1H, m, NH); Ile8: δ 4.09 (1H, m, α), 1.83 (1H, m, β), 1.57 
(2H, m, γ), 0.81 (3H, d, 6.4 Hz, γMe), 0.87 (3H, m, δMe), 6.07 (1H, br s, NH). 
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Met1: δ 52.4 (α), 29.8 (β), 29.9 (γ), 
15.5 (εMe), 15.6 (εMe (minor)), 171.1 (C=O); Leu2: δ 63.1 (α), 36.3 (β), 25.3 (γ), 23.4 
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(δMe), 22.1 (δMe), 172.1 (C=O); Val3: δ 57.5 (α), 31.7 (β), 19.4 (γMe), 18.2 (γMe), 171.7 
(C=O); Phe4: δ 51.3 (α), 38.8 (β), 135.4 (γ), 129.2 (δ), 129.2 (ε), 127.6 (ζ), 171.4 (C=O); 
Pro5: δ 58.5 (α), 37.2 (β), 25.2 (γ), 46.5 (δ), 170.6 (C=O); Leu6: δ 55.3 (α), 30.9 (β), 25.1 
(γ), 23.3 (δMe), 21.4 (δMe), 173.1 (C=O); Phe7: δ 53.4 (α), 37.4 (β), 135.8 (γ), 129.6 (δ), 
129.5 (ε), 127.9 (ζ), 174.1 (C=O); Ile8: δ 60.3 (α), 35.8 (β), 25.2 (γ), 16.3 (γMe), 11.7 
(δMe), 172.3 (C=O). 
S4.1-cyanomethylhomocysteine CLB (16) 
CL 2 (50 mg, 0.05 mmol) was dissolved in N-methylpyrrolildinone (2.5 mL) at 
room temperature. Diisopropylethylamine (20 µL) and iodoacetonitrile (25 µL) were 
sequentially added to the solution and the resulting mixture was heated to 100 °C for 20 h. 
The reaction mixture was extracted with EtOAc and the combined organic extract was 
washed with water and was subsequently concentrated under high vacuum (3 mbar) to yield 
a crude mixture. This crude mixture was purified using Sep-Pak cartridges and analyzed by 
HPLC. CL nitrile 16 was obtained (0.027 g).  
1HNMR (500 MHz, CDCl3, COSY, NOESY): Met1: δ 4.35 (1H, m, α), 2.41 (1H, m, 
β), 2.06 (1H, m, β), 2.86 (1H, m, γ), 2.78 (1H, m, γ), 3.28 (2H, s, SCH2); Leu2: δ 3.81 (1H, 
m, α), 1.62 (2H, m, β), 2.16 (1H, m, γ), 0.95 (3H, d, 6.4 Hz, δMe), 0.93 (3H, d, 6.4 Hz, 
δMe); Ile3: δ 4.53 (1H, m, α), 1.92 (1H, m, β), 2.21 (2H, m, γ), 1.06 (3H, d, 6.8 Hz, γMe), 
0.89 (3H, t, 7.5, δMe); Pro4: δ 3.98 (1H, m, α), 2.22 (1H, m, β), 1.91 (1H, m, β), 2.03 (1H, 
m, γ), 1.89 (1H, m, γ), 4.11 (1H, m, δ), 3.74 (1H, m, δ); Pro5: δ 4.02 (1H, m, α), 1.93 (2H, 
m, β), 1.51 (1H, m, γ), 0.87 (1H, m, γ), 3.34 (1H, m, δ), 3.06 (1H, m, δ); Phe6: δ 4.72 (1H, 
m, α), 3.16 (1H, m, β), 2.77 (1H, m, β), 7.24 (m, 3H, δ, ε), 7.07 (2H, m, ζ); Phe7: δ 4.23 
(1H, m, α), 3.34 (2H, m, β), 7.30 (m, 2H, δ), 7.24 (1H, m, ε), 7.15 (2H, m, ζ), 7.96 (1H, d, 
5, NH); Val8: δ 3.81 (1H, m, α), 2.19 (1H, m, β), 1.01 (3H, d, 7 Hz, γMe), 0.98 (3H, d, 7 
Hz, γMe), 7.67 (1H, br s, NH); Ile9: δ 4.29 (1H, m, α), 2.06 (1H, m, β), 1.65 (2H, m, γ), 
0.95 (3H, d, 6.4 Hz, γMe), 0.87 (3H, t, 7.5 Hz, δMe), 6.51 (1H, br s, NH). 
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Met1: δ 53.4 (α), 25.2 (β), 28.9 (γ), 
17.1 (SCH2), 116.7 (CN), 170.8 (C=O); Leu2: δ 62.7 (α), 29.6 (β), 25.4 (γ), 23.4 (δMe), 
21.4 (δMe), 171.6 (C=O); Ile3: δ 55.8 (α), 37.4 (β), 24.8 (γ), 15.3 (γMe), 11.0 (δMe), 172.0 
(C=O); Pro4: δ 54.9 (α), 37.4 (β), 24.7 (γ), 48.3 (δ), 170.1 (C=O); Pro5: δ 61.0 (α), 31.6 (β), 
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21.7 (γ), 47.0 (δ), 174.6 (C=O); Phe6: δ 55.4 (α), 37.7 (β), 137.0 (γ), 129.6 (δ), 129.0 (ε), 
127.4 (ζ), 172.2 (C=O); Phe7: δ 58.7 (α), 35.8 (β), 136.4 (γ), 129.1 (δ), 128.9 (ε), 127.0 (ζ), 
175.1 (C=O); Val8: δ 58.6 (α), 29.6 (β), 19.5 (γMe), 18.4 (γMe), 172.2 (C=O); Ile9: δ 58.7 
(α), 35.3 (β), 24.8 (γ), 16.2 (γMe), 11.1 (δMe), 172.1 (C=O). 
1-2-aminobutanoic acid CLB (17)  
CL 16 (30 mg, 0.03 mmol) was dissolved in dioxane: H2O (3:1 v/v, 1.2 mL). Pd-C 
and LiOH were added to the reaction mixture that was stirred overnight at 140 °C under H2 
(1 atm). The reaction mixture was filtered and was neutralized with saturated NaHCO3. The 
reaction mixture was extracted with ethyl acetate and was concentrated to obtain the crude 
product (35 mg) (17). HPLC-MS analyses indicated a [M+H]+ ion at m/z 1012.6275, 
corresponds to a molecular formula of C55H81N9O9. 
S4.1-cyanomethylhomocysteine S-dioxide CLC (18)  
CL 16 (30 mg, 0.03 mmol) was dissolved in THF: H2O (5:2 v/v, 1.2 mL) and was 
cooled to 0 °C before addition of aqueous solution of NaIO4 (0.8 mL, excess). The reaction 
mixture was stirred overnight and was filtered. After removal of THF under reduced 
pressure, EtOAc was added to the resulting aqueous solution, which was then washed 
successively with water and brine. The organic layer was evaporated to yield a sulfoxide 
nitrile 18 (25 mg). HPLC-MS analyses indicated a [M+H]+ ion at m/z 1099.5958, 
corresponds to a molecular formula of C57H83N10O10S. The structure was further confirmed 
by LC-MS/MS analyses.  
S4.1-cyanomethylhomocysteine S, S-dioxide CLK (19)  
CL 16 (9.4 mg, 0.009 mmol) was dissolved in dichloromethane (1 mL) to which m-
CPBA (6.4 mg) was added. The reaction mixture was stirred at room temperature for 1 h, 
and was sequentially washed with a solution of 10% Na2S2O3 (5 mL), saturated aq. 
NaHCO3, and H2O to yield the sulfonyl nitrile 19 (10 mg).  
1HNMR (500 MHz, CDCl3, COSY, NOESY): Msn1: δ 4.85 (1H, m, α), 2.69 (1H, m, 
β), 2.35 (1H, m, β), 3.67 (1H, m, γ), 3.53 (1H, m, γ), 4.04 (2H, s, SO2CH2), 7.35 (1H, m, 
NH); Leu2: δ 4.02 (1H, m, α), 2.12 (2H, m, β), 1.65 (1H, m, γ), 0.95 (3H, d, 6.4 Hz, δMe), 
0.93 (3H, d, 6.4 Hz, δMe), 7.78 (1H, br s, NH); Ile3: δ 4.48 (1H, m, α), 1.93 (1H, m, β), 
1.70 (2H, m, γ), 1.11 (3H, d, 6.4 Hz, γMe), 0.87 (3H, m, δMe), 8.13 (1H, br s, NH); Pro4: 
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3.87 (1H, m, α), 2.27 (1H, m, β), 1.70 (1H, m, β), 2.05 (1H, m, γ), 1.96 (1H, m, γ), 3.93 
(1H, m, δ), 3.67 (1H, m, δ); Pro5: δ 4.12 (1H, m, α), 1.99 (2H, m, β), 1.47 (1H, m, γ), 1.24 
(1H, m, γ), 3.35 (2H, m, δ); Phe6: δ 4.89 (1H, m, α), 3.04 (2H, dd, 4.2, 12.5 Hz, β), 7.26 
(m, 3H, δ, ε), 7.16 (2H, m, ζ), 7.19 (1H, m, NH); Phe7: δ 4.07 (1H, m, α), 3.39 (2H, m, β), 
7.34 (m, 2H, δ), 7.26 (1H, m, ε), 7.16 (2H, m, ζ), 7.61 (1H, br s, NH); Val8: δ 3.87 (1H, m, 
α), 2.12 (1H, m, β), 0.95 (3H, m, γMe), 0.94 (3H, m, γMe), 6.47 (1H, br s, NH); Ile9: δ 4.58 
(1H, m, α), 1.99 (1H, m, β), 2.16 (2H, m, γ), 0.97 (3H, m, γMe), 0.84 (3H, m, δMe), 6.73 
(1H, br s, NH). 
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Msn1: δ 51.7 (α), 25.4 (β), 50.8 (γ), 
42.5 (SO2CH2), 110.2 (CN), 171.1 (C=O); Leu2: δ 61.0 (α), 38.4 (β), 25.4 (γ), 22.9 (δMe), 
21.9 (δMe), 171.1 (C=O); Ile3: δ 56.3 (α), 36.6 (β), 24.8 (γ), 15.6 (γMe), 11.2 (δMe), 171.8 
(C=O); Pro4: δ 61.8 (α), 28.5 (β), 25.1 (γ), 48.1 (δ), 170.4 (C=O); Pro5: δ 61.0 (α), 32.1 (β), 
21.9 (γ), 47.4 (δ), 173.8 (C=O); Phe6: δ 53.4 (α), 35.1 (β), 136.1 (γ), 129.7 (δ), 128.9 (ε), 
127.5 (ζ), 173.8 (C=O); Phe7: δ 57.8 (α), 36.7 (β), 135.4 (γ), 129.1 (δ), 128.9 (ε), 127.3 (ζ), 
175.1 (C=O); Val8: δ 59.1 (α), 29.3 (β), 19.6 (γMe), 18.2 (γMe), 173.0 (C=O); Ile9: δ 58.3 
(α), 36.8 (β), 24.8 (γ), 16.1 (γMe), 11.3 (δMe), 171.8 (C=O). 
S4.1-(2-aminoethyl)homocysteine S, S-dioxide CLK (20) 
CL 19 (8 mg, 0.007 mmol) was dissolved in acetic acid (0.5 mL) under argon and 
PtO2 was added. The reaction mixture was stirred at RT under H2 (1 atm) overnight. The 
reaction mixture was filtered and then neutralized with sat. NaHCO3. The reaction mixture 
was extracted with ethyl acetate and was concentrated to obtain the crude product (10 mg) 
(20). HPLC-MS analyses indicated a [M+H]+ ion at m/z 1119.6275, corresponds to a 
molecular formula of C57H83N10O10S. 
S4.1-ethoxycarbonylmethylhomocysteine CLB (21) 
CL 2 (0.3 g, 0.28 mmol) was dissolved in N-methylpyrrolildinone (10 mL) at room 
temperature. Diisopropylethylamine (2.5 eq, 0.12 mL) and iodoacetate (7 eq, 0.23 mL) 
were sequentially added to the solution and the resulting mixture was heated to 100 °C for 
20 h. The reaction mixture was extracted with EtOAc and the combined organic extract was 
washed with water and was subsequently concentrated under high vacuum to yield a crude 
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mixture that was purified using Sep-Pak cartridges and analyzed by HPLC. The ester (-
COOEt) derivative, 21, was obtained in 0.27 g. 
1HNMR (500 MHz, CDCl3, COSY, NOESY): Met1: δ 4.27 (1H, dd, 8, 8.4 Hz, α), 
1.95 (2H, m, β), 2.63 (1H, m, γ), 2.44 (1H, m, γ), 3.19 (2H, s, SCH2), 4.16 (2H, q, 7Hz, 
SCH2COOCH2), 1.26 (3H, t, 7 Hz, S-CH2COOCH2CH3), 6.44 (1H, br s, NH); Leu2: δ 3.61 
(1H, m, α), 2.17 (2H, m, β), 1.98 (1H, m, γ), 0.93 (3H, d, 7 Hz, δMe), 0.91 (3H, d, 7 Hz, 
δMe); Ile3: δ 4.42 (1H, m, α), 1.91 (1H, m, β), 2.22 (2H, m, γ), 1.00 (3H, d, 6.6 Hz, γMe), 
0.83 (3H, t, 7 Hz, δMe), 7.44 (1H, br s, NH); Pro4: δ 4.03 (1H, br s, α), 2.22 (1H, m, β), 
1.91 (1H, m, β), 2.02 (1H, m, γ), 1.87 (1H, m, γ), 4.16 (1H, br s, δ), 3.71 (1H, m, δ); Pro5: δ 
3.95 (1H, m, α), 1.95 (2H, m, β), 1.52 (1H, m, γ), 0.85 (1H, m, γ), 3.33 (1H, m, δ), 2.98 
(1H, m, δ); Phe6: δ 4.71 (1H, m, α), 3.21 (1H, m, β), 2.77 (1H, m, β), 7.25 (m, 2H, δ), 7.19 
(1H, m, ε), 7.09 (2H, m, ζ) 7.45 (1H, br s, NH); Phe7: δ 4.03 (1H, m, α), 3.36 (2H, m, β), 
7.25 (m, 2H, δ), 7.19 (1H, m, ε), 7.09 (2H, m, ζ);; Val8: δ 3.87 (1H, m, α), 2.22 (1H, m, β), 
1.05 (3H, d, 7.3 Hz, γMe), 1.03 (3H, d, 7.3 Hz, γMe), 8.09 (1H, br s, NH); Ile9: δ 4.16 (1H, 
m, α), 2.10 (1H, m, β), 1.61 (2H, m, γ), 0.94 (3H, d, 7 Hz, γMe), 0.87 (3H, t, 7 Hz, δMe), 
6.79 (1H, br s, NH). 
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Met1: δ 58.1 (α), 25.4 (β), 29.8 (γ), 
33.7 (SCH2), 60.9 (SCH2COOCH2), 14.3 (SCH2COOCH2CH3), 169.8 (COOCH2CH3), 
170.7 (C=O); Leu2: δ 58.5 (α), 28.8 (β), 25.1 (γ), 23.5 (δMe), 21.3 (δMe), 171.2 (C=O); 
Ile3: δ 56.1 (α), 37.1 (β), 25.3 (γ), 16.1 (γMe), 11.1 (δMe), 171.5 (C=O); Pro4: δ 54.6 (α), 
37.4 (β), 24.7 (γ), 48.3 (δ), 170.6 (C=O); Pro5: δ 61.5 (α), 31.5 (β), 21.5 (γ), 46.8 (δ), 174.8 
(C=O); Phe6: δ 55.7 (α), 37.7 (β), 137.2 (γ), 129.6 (δ), 128.9 (ε), 127.4 (ζ), 172.4 (C=O); 
Phe7: δ 61.5 (α), 35.7 (β), 136.4 (γ), 129.0 (δ), 128.8 (ε), 126.7 (ζ), 175.1 (C=O); Val8: δ 
62.4 (α), 29.5 (β), 19.6 (γMe), 18.3 (γMe), 172.4 (C=O); Ile9: δ 53.7 (α), 34.9 (β), 25.3 (γ), 
15.2 (γMe), 10.7 (δMe), 172.0 (C=O). 
S4.1-ethoxycarbonylmethylhomocysteine CLE' (25)  
Similarly, CL 13 (1 g, 1.0 mmol) was activated with iodoacetate (7 eq, 1.55g, 0.21 
mL) and diisopropylethylamine (2.5 eq, 0.36 g, 0.45 mL) in N-methylpyrrolildinone (8 mL) 
using above procedure to obtain 25 (1.1g) 
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1HNMR (500 MHz, CDCl3, COSY, NOESY): Met1: δ 4.69 (1H, m, α), 2.45 (1H, m, 
β), 1.84 (1H, m, β), 2.62 (2H, m, γ), 3.19 (2H, s, SCH2), 4.14 (2H, q, 7Hz, 
SCH2COOCH2), 1.25 (3H, t, 7 Hz, SCH2COOCH2CH3), 7.42 (1H, d, 9, NH); Leu2: δ 4.31 
(1H, m, α), 2.30 (1H, m, β), 1.75 (1H, m, β), 1.95 (1H, m, γ), 0.86 (6H, d, 6.6 Hz, δMe); 
Val3: δ 4.46 (1H, m, α), 2.06 (1H, m, β), 0.96 (3H, d, 6.4 Hz, γMe), 0.94 (3H, d, 6.4 Hz, 
γMe), 7.03 (1H, d, 8.6, NH); Phe4: δ 4.32 (1H, m, α), 3.01 (2H, m, β), 7.38-7.15 (m, 5H, δ, 
ε, ζ), 6.72 (1H, br s, NH); Pro5: δ 4.31 (1H, m, α), 1.57 (1H, m, β), 1.45 (1H, m, β), 1.64 
(1H, m, γ), 1.50 (1H, m, γ), 3.37 (2H, m, δ); Leu6: δ 3.79 (1H, m, α), 2.22 (1H, m, β), 1.84 
(1H, m, β), 1.57 (1H, m, γ), 0.87 (6H, m, δMe), 7.53 (1H, d, 7 Hz, NH); Phe7: δ 4.30 (1H, 
m, α), 3.16 (1H, m, β), 3.04 (1H, m, β), 7.38-7.15 (m, 5H, δ, ε, ζ), 7.59 (1H, br s, NH); Ile8: 
δ 4.11 (1H, m, α), 1.84 (1H, m, β), 1.57 (2H, m, γ), 0.80 (3H, d, 6.4 Hz, γMe), 0.87 (3H, m, 
δMe), 6.08 (1H, br s, NH). 
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Met1: δ 52.2 (α), 31.1 (β), 29.6 (γ), 
33.8 (SCH2), 61.4 (SCH2COOCH2), 14.3 (SCH2COOCH2CH3), 170.5 (S-
CH2COOCH2CH3), 171.1 (C=O); Leu2: δ 51.3 (α), 29.9 (β), 30.8 (γ), 23.2 (δMe), 22.1 
(δMe), 173.1 (C=O); Val3: δ 57.4 (α), 31.6 (β), 19.4 (γMe), 18.1 (γMe), 171.7 (C=O); Phe4: 
δ 53.3 (α), 38.8 (β), 135.4 (γ), 129.2 (δ), 129.1 (ε), 127.6 (ζ), 171.3 (C=O); Pro5: δ 63.2 (α), 
38.2 (β), 25.3 (γ), 46.5 (δ), 170.8 (C=O); Leu6: δ 55.3 (α), 37.2 (β), 25.1 (γ), 22.8 (δMe), 
21.9 (δMe), 173.1 (C=O); Phe7: δ 58.4 (α), 37.4 (β), 135.9 (γ), 129.6 (δ), 129.5 (ε), 127.9 
(ζ), 174.1 (C=O); Ile8: δ 60.2 (α), 35.8 (β), 25.3 (γ), 16.3 (γMe), 11.7 (δMe), 172.3 (C=O). 
S4.1-ethoxycarbonylmethylhomocysteine S, S-dioxide CLK (22) 
CL 21 (0.15 g, 0.13 mmol) was dissolved in dichloromethane (5 mL) to which m-
CPBA (3eq, 0.1 g) was added. The reaction mixture was stirred at room temperature for 1 
h, and was sequentially washed with a solution of 10% Na2S2O3 (5 mL), saturated aq. 
NaHCO3, and H2O to yield Msn 22 (0.16 g). 
1HNMR (500 MHz, CDCl3, COSY, NOESY): Msn1: δ 4.61 (1H, m, α), 2.46 (2H, m, 
β), 3.46 (2H, m, γ), 3.95 (2H, s, SO2CH2), 4.23 (2H, q, 7Hz, SO2CH2COOCH2), 1.29 (3H, 
t, 7 Hz, SO2CH2COOCH2CH3), 7.20 (1H, d, 7, NH); Leu2: δ 4.06 (1H, d, 7.9 Hz, α), 2.16 
(2H, m, β), 1.63 (1H, m, γ), 0.95 (3H, d, 6.4 Hz, δMe), 0.93 (3H, d, 6.4 Hz, δMe), 7.63 
(1H, d, 6 Hz, NH); Ile3: δ 4.48 (1H, m, α), 1.93 (1H, m, β), 1.50 (2H, m, γ), 1.07 (3H, d, 
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6.8 Hz, γMe), 0.84 (3H, t, 6.8 Hz, δMe), 6.60 (1H, br s, NH); Pro4: δ 3.81 (1H, m, α), 2.16 
(1H, m, β), 1.67 (1H, m, β), 2.17 (1H, m, γ), 1.95 (1H, m, γ), 4.01 (1H, m, δ), 3.46 (1H, m, 
δ); Pro5: δ 4.06 (1H, m, α), 2.16 (1H, m, β), 1.94 (1H, m, β), 1.49 (1H, m, γ), 0.96 (1H, m, 
γ), 3.29 (2H, m, δ); Phe6: δ 4.85 (1H, m, α), 3.09 (2H, dd, 4.2, 12.5 Hz, β), 7.24 (m, 2H, δ), 
7.20 (1H, m, ε), 7.12 (2H, m, ζ); Phe7: δ 3.99 (1H, m, α), 3.67 (2H, m, β), 7.30 (m, 3H, δ, 
ε), 7.12 (2H, m, ζ) 7.72 (1H, br s, NH); Val8: δ 3.87 (1H, m, α), 2.16 (1H, m, β), 0.95 (3H, 
d, 6.4 Hz, γMe), 0.93 (3H, d, 6.4 Hz, γMe); Ile9: δ 4.48 (1H, m, α), 1.95 (1H, m, β), 2.16 
(2H, m, γ), 0.92 (3H, d, 6.4 Hz, γMe), 0.90 (3H, t, 6.4 Hz, δMe). 
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Msn1: δ 52.4 (α), 25.3 (β), 51.2 (γ), 
57.6 (SO2CH2), 62.7 (SO2CH2COOCH2), 14.1 (SO2CH2COOCH2CH3), 162.8 
(COOCH2CH3), 170.6 (C=O); Leu2: δ 61.0 (α), 37.9 (β), 25.4 (γ), 23.2 (δMe), 21.7 (δMe), 
171.4 (C=O); Ile3: δ 56.3 (α), 36.2 (β), 24.8 (γ), 15.6 (γMe), 11.1 (δMe), 171.7 (C=O); 
Pro4: δ 62.0 (α), 28.6 (β), 25.1 (γ), 48.1 (δ), 170.5 (C=O); Pro5: δ 56.6 (α), 31.9 (β), 21.7 
(γ), 47.1 (δ), 174.1 (C=O); Phe6: δ 54.2 (α), 36.1 (β), 136.4 (γ), 129.8 (δ), 129.0 (ε), 127.4 
(ζ), 173.0 (C=O); Phe7: δ 58.3 (α), 36.2 (β), 136.3 (γ), 128.9 (δ), 127.3 (ε), 127.3 (ζ), 175.2 
(C=O); Val8: δ 58.8 (α), 29.4 (β), 19.6 (γMe), 18.3 (γMe), 172.8 (C=O); Ile9: δ 58.3 (α), 
36.7 (β), 25.0 (γ), 16.1 (γMe), 11.3 (δMe), 171.8 (C=O). 
S4.1-ethoxycarbonylmethylhomocysteine S, S-dioxide CLJ (26) 
Similarly, CL 25 (0.7 g, 0.68 mmol) was oxidized with m-CPBA (3eq, 0.35 g) in 
dichloromethane (15 mL) using the procedure above to obtain 26 (0.74 g). 
1HNMR (500 MHz, CDCl3, COSY, NOESY): Msn1: δ 4.71 (1H, m, α), 2.58 (1H, m, 
β), 2.18 (1H, m, β), 3.52 (1H, m, γ), 3.17 (1H, m, γ), 3.92 (2H, dd, 14.6, 14.6, SO2CH2), 
4.23 (2H, q, 7Hz, SO2CH2COOCH2), 1.29 (3H, t, 7 Hz, SO2CH2COOCH2CH3), 7.69 (1H, 
br s, NH); Leu2: δ 4.33 (1H, m, α), 2.32 (1H, m, β), 1.72 (1H, m, β), 1.95 (1H, m, γ), 0.88 
(3H, m, δMe), 0.81 (3H, m, δMe), 6.83 (1H, br s, NH); Val3: δ 4.47 (1H, m, α), 2.05 (1H, 
m, β), 0.97 (3H, d, 6.8 Hz, γMe), 0.94 (3H, d, 6.8 Hz, γMe), 6.97 (1H, br s, NH); Phe4: δ 
4.34 (1H, m, α), 3.02 (2H, m, β), 7.39-7.18 (m, 5H, δ, ε, ζ), 6.66 (1H, br s, NH); Pro5: δ 
4.12 (1H, m, α), 1.72 (1H, m, β), 1.42 (1H, m, β), 1.65 (1H, m, γ), 1.47 (1H, m, γ), 3.36 
(2H, m, δ); Leu6: δ 3.79 (1H, m, α), 2.18 (1H, m, β), 1.86 (1H, m, β), 1.54 (1H, m, γ), 0.94 
(3H, d, 6.8 Hz, δMe), 0.88 (3H, m, δMe), 7.61 (1H, d, 7 Hz, NH); Phe7: δ 4.31 (1H, m, α), 
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3.17 (1H, m, β), 3.07 (1H, m, β), 7.39-7.18 (m, 5H, δ, ε, ζ), 7.69 (1H, br s, NH); Ile8: δ 4.07 
(1H, m, α), 1.86 (1H, m, β), 1.54 (2H, m, γ), 0.79 (3H, m, γMe), 0.86 (3H, m, δMe), 6.12 
(1H, br s, NH). 
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Msn1: δ 51.3 (α), 24.8 (β), 51.4 (γ), 
57.5 (SO2CH2), 62.7 (SO2CH2COOCH2), 14.1 (SO2CH2COOCH2CH3), 162.9 (S 
O2CH2COOCH2CH3), 170.9 (C=O); Leu2: δ 51.2 (α), 37.0 (β), 25.4 (γ), 23.3 (δMe), 21.8 
(δMe), 171.6 (C=O); Val3: δ 57.5 (α), 32.0 (β), 19.4 (γMe), 18.2 (γMe), 171.6 (C=O); Phe4: 
δ 53.1 (α), 38.9 (β), 135.5 (γ), 129.2 (δ), 129.1 (ε), 127.6 (ζ), 171.2 (C=O); Pro5: δ 54.2 (α), 
31.0 (β), 25.2 (γ), 46.5 (δ), 170.4 (C=O); Leu6: δ 55.3 (α), 29.9 (β), 29.3 (γ), 23.0 (δMe), 
21.4 (δMe), 173.4 (C=O); Phe7: δ 58.4 (α), 37.3 (β), 135.6 (γ), 129.6 (δ), 129.5 (ε), 127.9 
(ζ), 174.6 (C=O); Ile8: δ 60.2 (α), 35.7 (β), 25.0 (γ), 16.3 (γMe), 11.7 (δMe), 172.5 (C=O). 
S4.1-[2-(2-aminoethylamino)-2-oxo-ethyl]homocysteine S, S-dioxide CLK (23) 
CL 22 (0.1 g, 0.09 mmol) was dissolved in methanol and ethylene diamine (excess) 
was added. The resulting reaction mixture was refluxed overnight. The organic solvents 
were evaporated and the resulting crude product was purified using Sep-Pak cartridges and 
was analyzed by HPLC. CL 23 was obtained in 0.09 g.  
1HNMR (500 MHz, CDCl3, COSY, NOESY): Msn1: δ 4.72 (1H, m, α), 2.50 (1H, m, 
β), 2.40 (1H, m, β), 3.48 (1H, m, γ), 3.41 (1H, m, γ), 3.90 (2H, s, SO2CH2), 2.87 (4H, m, 
NHCH2CH2NH2), 7.41 (1H, br s, NH); Leu2: δ 3.88 (1H, br s, α), 2.17 (2H, br s, β), 1.64 
(1H, m, γ), 0.92 (6H, d, 6.6 Hz, δMe), 7.75 (1H, br s, NH); Ile3: δ 4.47 (1H, m, α), 1.92 
(1H, m, β), 1.50 (2H, m, γ), 1.08 (3H, d, 6.6 Hz, γMe), 0.86 (3H, t, 7 Hz, δMe), 8.03 (1H, 
br s, NH); Pro4: δ 3.79 (1H, br s, α), 2.17 (1H, m, β), 1.64 (1H, m, β), 2.04 (1H, m, γ), 1.94 
(1H, m, γ), 3.97 (1H, br s, δ), 3.65 (1H, m, δ); Pro5: δ 4.11 (1H, m, α), 2.12 (1H, m, β), 
1.95 (1H, m, β), 1.50 (1H, m, γ), 0.96 (1H, m, γ), 3.31 (2H, m, δ); Phe6: δ 4.86 (1H, m, α), 
3.10 (1H, m, β), 3.00 (1H, m, β),7.24 (m, 3H, δ, ε), 7.15 (2H, m, ζ); Phe7: δ 3.97 (1H, m, 
α), 3.31 (2H, m, β), 7.32 (m, 2H, δ), 7.24 (1H, m, ε), 7.15 (2H, m, ζ) 7.67 (1H, br s, NH); 
Val8: δ 3.88 (1H, m, α), 2.17 (1H, m, β), 0.92 (6H, d, 6.6 Hz, γMe); Ile9: δ 4.53 (1H, m, α), 
1.98 (1H, m, β), 1.64 (2H, m, γ), 0.96 (3H, d, 6.4 Hz, γMe), 0.84 (3H, t, 6.4 Hz, δMe), 6.78 
(1H, br s, NH). 
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13CNMR (125 MHz, CDCl3, HMQC, HMBC): Msn1: δ 57.2 (α), 25.1 (β), 50.7 (γ), 
58.6 (SO2CH2), 42.9 (NHCH2CH2NH2), 41.2 (NHCH2CH2NH2), 171.9 (C=O); Leu2: δ 61.8 
(α), 29.9 (β), 25.5 (γ), 23.1 (δMe), 21.9 (δMe), 171.9 (C=O); Ile3: δ 56.3 (α), 36.7 (β), 25.4 
(γ), 15.6 (γMe), 11.2 (δMe), 171.9 (C=O); Pro4: δ 59.1 (α), 28.7 (β), 25.1 (γ), 48.2 (δ), 
170.9 (C=O); Pro5: δ 61.2 (α), 32.0 (β), 21.7 (γ), 47.3 (δ), 173.6 (C=O); Phe6: δ 54.2 (α), 
35.6 (β), 136.4 (γ), 129.8 (δ), 129.0 (ε), 127.4 (ζ), 173.6 (C=O); Phe7: δ 61.2 (α), 38.4 (β), 
135.9 (γ), 129.1 (δ), 128.9 (ε), 127.3 (ζ), 175.2 (C=O); Val8: δ 59.1 (α), 29.4 (β), 19.7 
(γMe), 18.3 (γMe), 173.2 (C=O); Ile9: δ 58.3 (α), 36.7 (β), 25.4 (γ), 16.1 (γMe), 11.3 
(δMe), 173.0 (C=O). 
S4.1-[2-(2-aminoethylamino)-2-oxo-ethyl]homocysteine S, S-dioxide CLJ (27)  
Similarly, CL 26 (0.3 g, 0.29 mmol) was coupled with ethylene diamine (excess) in 
methanol (6 mL) to obtain 27 (0.27 g) using the procedure described above. 
1H NMR (500 MHz, CDCl3, COSY, NOESY) Msn1: δ 4.92 (1H, m, α), 2.58 (1H, m, 
β), 2.20 (1H, m, β), 3.43 (2H, m, γ), 3.41 (2H, m, SO2CH2), 3.06 (2H, m, 
NHCH2CH2NH2), 3.43 (2H, m, NHCH2CH2 NH2), 4.36 (2H, br s, NHCH2CH2NH2), 6.81 
(1H, m, NH); Leu2: δ 4.01 (1H, m, α), 1.74 (1H, m, β), 1.65 (1H, m, β), 2.38 (1H, m, γ), 
0.84 (3H, d, 6.6 Hz, δMe), 0.78 (3H, d, 6.6 Hz, δMe), 8.97 (1H, br s, NH); Val3: δ 4.19 
(1H, m, α), 2.38 (1H, m, β), 0.95 (6H, m, γMe), 6.49 (1H, br s, NH); Phe4: δ 4.81 (1H, m, 
α), 3.22 (1H, m, β), 3.12 (1H, m, β), 7.25-7.06 (m, 5H, δ, ε, ζ), 7.02 (1H, m, NH); Pro5: δ 
4.47 (1H, m, α), 2.38 (1H, m, β), 1.75 (1H, m, β), 2.04 (1H, m, γ), 1.95 (1H, m, γ), 3.73 
(1H, m, δ), 3.52 (1H, m, δ); Leu6: δ 3.45 (1H, m, α), 2.05 (1H, m, β), 1.95 (1H, m, β), 1.75 
(1H, m, γ), 0.92 (6H, m, δMe), 8.11 (1H, m, NH); Phe7: δ 5.24 (1H, m, α), 3.07 (2H, m, β), 
7.25–7.06 (m, 5H, δ, ε, ζ), 7.52 (1H, br s, NH); Ile8: δ 4.08 (1H, m, α), 1.28 (1H, m, β), 
1.46 (1H, m, γ), 1.41 (1H, m, γ), 1.04 (3H, m, γMe), 0.91 (3H, m, δMe). 
13C NMR (125 MHz, CDCl3, HMQC, HMBC): Msn1: δ 50.3 (α), 25.0 (β), 50.8 (γ), 
60.4 (SO2CH2), 40.4 (NHCH2CH2NH2), 40.7 (NHCH2CH2NH2), 163.1 
(CONHCH2CH2NH2), 170.5 (C=O); Leu2: δ 56.4 (α), 39.8 (β), 29.6 (γ), 23.0 (δMe), 22.3 
(δMe), 172.9 (C=O); Val3: δ 59.7 (α), 30.5 (β), 19.6 (γMe), 17.6 (γMe), 171.8 (C=O); Phe4: 
δ 54.5 (α), 36.7 (β), 138.0 (γ), 129.0 (δ), 128.7 (ε), 126.7 (ζ), 172.9 (C=O); Pro5: δ 63.7 (α), 
29.8 (β), 25.0 (γ), 48.4 (δ), 173.9 (C=O); Leu6: δ 59.7 (α), 25.6 (β), 25.0 (γ), 22.5 (δMe), 
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22.0 (δMe), 173.4 (C=O); Phe7: δ 50.8 (α), 35.9 (β), 137.3 (γ), 128.8 (δ), 128.3 (ε), 126.6 
(ζ), 172.3 (C=O); Ile8: δ 54.5 (α), 25.3 (β), 39.8 (γ), 17.6 (γMe), 10.2 (δMe), 172.3 (C=O). 
S4.1-[2-(2-hydroxyethylamino)-2-oxo-ethyl]homocysteine S, S-dioxide CLK (24) 
CL 22 (90 mg, 0.08 mM) was dissolved in methanol (5 mL) and ethanolamine (100 µL, 
excess) was added. The resulting reaction mixture was refluxed overnight. The organic solvents 
were evaporated and the resulting crude product was analyzed by reversed-phase HPLC and 
purified using preparative HPLC. CL 24 was obtained in 55 mg yield.  
1HNMR (500 MHz, CDCl3, COSY, NOESY) Msn1: δ 4.68 (1H, m, α), 2.45 (2H, m, β), 
3.45 (2H, m, γ), 3.94 (2H, s, SO2CH2), 3.71 (2H, m, NHCH2CH2OH), 3.54 (1H, m, 
NHCH2CH2OH), 3.31 (1H, m, NHCH2CH2OH), 7.41 (1H, br s, NH); Leu2: δ 4.08 (1H, br s, α), 
2.14 (2H, m, β), 1.63 (1H, m, γ), 0.91 (6H, d, 6.4 Hz, δMe), 7.74 (1H, br s, NH); Ile3: δ 4.45 (1H, 
m, α), 1.93 (1H, m, β), 1.48 (2H, m, γ), 1.07 (3H, d, 6.6 Hz, γMe), 0.85 (3H, m, δMe), 7.99 (1H, 
br s, NH); Pro4: δ 3.71 (1H, m, α), 2.14 (1H, m, β), 1.62 (1H, m, β), 2.05 (1H, m, γ), 1.92 (1H, m, 
γ), 3.94 (1H, m, δ), 3.67 (1H, m, δ); Pro5: δ 4.08 (1H, m, α), 1.92 (2H, m, β), 1.48 (1H, m, γ), 
0.96 (1H, m, γ), 3.31 (2H, m, δ); Phe6: δ 4.84 (1H, m, α), 3.1 (1H, m, β), 2.98 (1H, m, β),7.25 
(m, 3H, δ, ε), 7.14 (2H, m, ζ); Phe7: δ 3.98 (1H, m, α), 3.67 (2H, m, β), 7.30 (m, 2H, δ), 7.25 
(1H, m,), 7.14 (2H, m, ζ) 7.64 (1H, m, NH); Val8: δ 3.86 (1H, m, α), 1.92 (1H, m, β), 0.91 (6H, 
d, 7 Hz, γMe); Ile9: δ 4.51 (1H, m, α), 1.93 (1H, m, β), 1.63 (2H, m, γ), 0.96 (3H, d, 6.6 Hz, 
γMe), 0.85 (3H, m, δMe), 6.77 (1H, br s, NH). 
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Msn1: δ 52.4 (α), 24.8 (β), 50.6 (γ), 58.5 
(SO2CH2), 61.6 (NHCH2CH2OH), 43.2 (NHCH2CH2OH), 161.6 (CONHCH2CH2OH), 171.1 
(C=O); Leu2: δ 58.8 (α), 38.4 (β), 25.4 (γ), 23.1 (δMe), 21.9 (δMe), 171.1 (C=O); Ile3: δ 56.3 (α), 
36.6 (β), 25.2 (γ), 15.5 (γMe), 11.1 (δMe), 172.0 (C=O); Pro4: δ 56.8 (α), 28.7 (β), 25.1 (γ), 48.2 
(δ), 170.8 (C=O); Pro5: δ 61.2 (α), 31.9 (β), 21.7 (γ), 47.3 (δ), 173.7 (C=O); Phe6: δ 54.4 (α), 
35.7 (β), 136.4 (γ), 129.8 (δ), 129.0 (ε), 127.3 (ζ), 170.8 (C=O); Phe7: δ 59.0 (α), 38.4 (β), 136.0 
(γ), 129.1 (δ), 129.0 (ε), 127.3 (ζ), 175.2 (C=O); Val8: δ 62.0 (α), 29.4 (β), 19.7 (γMe), 18.3 
(γMe), 172.9 (C=O); Ile9: δ 58.1 (α), 36.6 (β), 25.4 (γ), 16.0 (γMe), 11.2 (δMe), 171.4 (C=O). 
S4.1-[2-(2-hydroxyethylamino)-2-oxo-ethyl]homocysteine S, S-dioxide CLJ (28) 
Using the procedure described above CL 26 (50 mg, 0.05 mM) was reacted with 
ethanolamine (100 µL, excess) in methanol (3 mL) to obtain 28 (33 mg). 
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1H NMR (500 MHz, CDCl3, COSY, NOESY) Msn1: δ 4.88 (1H, m, α), 2.57 (1H, m, β), 
2.19 (1H, m, β), 3.45 (2H, m, γ), 4.00 (1H, m, SO2CH2), 3.89 (1H, m, SO2CH2), 4.48 (1H, m, 
NHCH2CH2OH), 3.51 (1H, m, NHCH2CH2OH), 3.89 (1H, m, NHCH2CH2OH), 3.20 (1H, m, 
NHCH2CH2OH), 7.75 (1H, br s, NHCH2CH2OH), 6.83 (1H, m, NH); Leu2: δ 4.00 (1H, m, α), 
1.62 (2H, m, β), 2.35 (1H, m, γ), 0.85 (3H, d, 6.6 Hz, δMe), 0.78 (3H, d, 6.6 Hz, δMe), 9.17 (1H, 
br s, NH); Val3: δ 4.20 (1H, m, α), 2.48 (1H, m, β), 0.94 (6H, m, γMe), 6.24 (1H, br s, NH); 
Phe4: δ 4.79 (1H, m, α), 3.34 (1H, m, β), 3.09 (1H, m, β), 7.25-7.06 (m, 5H, δ, ε, ζ), 7.02 (1H, m, 
NH); Pro5: δ 4.48 (1H, m, α), 2.38 (1H, m, β), 1.78 (1H, m, β), 2.07 (1H, m, γ), 1.97 (1H, m, γ), 
3.75 (1H, m, δ), 3.51 (1H, m, δ); Leu6: δ 3.45 (1H, m, α), 2.38 (2H, m, β), 1.68 (1H, m, γ), 0.92 
(6H, m, δMe), 8.13 (1H, d, 7.5, NH); Phe7: δ 5.33 (1H, m, α), 3.75 (1H, m, β), 3.09 (1H, m, β), 
7.25–7.06 (m, 5H, δ, ε, ζ), 7.49 (1H, d, 9.9, NH); Ile8: δ 4.07 (1H, m, α), 1.26 (1H, m, β), 1.49 
(1H, m, γ), 1.39 (1H, m, γ), 1.09 (3H, d, 6.4 Hz, γMe), 0.91 (3H, m, δMe). 
13C NMR (125 MHz, CDCl3, HMQC, HMBC): Msn1: δ 50.2 (α), 25.0 (β), 50.3 (γ), 60.9 
(SO2CH2), 61.2 (NHCH2CH2OH), 43.7 (NHCH2CH2OH), 163.0 (CONHCH2CH2OH), 170.8 
(C=O); Leu2: δ 56.5 (α), 40.6 (β), 29.5 (γ), 22.9 (δMe), 22.4 (δMe), 173.1 (C=O); Val3: δ 59.3 
(α), 32.4 (β), 19.6 (γMe), 17.4 (γMe), 171.8 (C=O); Phe4: δ 54.6 (α), 36.3 (β), 138.4 (γ), 129.0 
(δ), 128.8 (ε), 126.6 (ζ), 173.2 (C=O); Pro5: δ 63.8 (α), 30.5 (β), 25.1 (γ), 48.4 (δ), 174.0 (C=O); 
Leu6: δ 59.7 (α), 25.7 (β), 24.9 (γ), 22.4 (δMe), 22.1 (δMe), 173.6 (C=O); Phe7: δ 50.8 (α), 35.8 
(β), 137.2 (γ), 128.7 (δ), 128.4 (ε), 126.6 (ζ), 172.3 (C=O); Ile8: δ 54.7 (α), 25.2 (β), 39.8 (γ), 
17.7 (γMe), 10.0 (δMe), 172.2 (C=O). 
4.5 Conclusion 
In summary, we have described methods to modify CLs (3 and 5) using methionine as 
point of attachment to produce 23, 24, 27 and 28. The simplicity and the operational ease make 
these methods suitable for producing CL analogs to be used for different applications. The 
structures of all derivatives (ester, nitrile, amine and alcohol) were elucidated using high-
resolution HPLC-MS-ESI, tandem MS, 1D (1H and 13C) and 2D (NOE, COSY, and HMBC) 
NMR spectroscopic methods. This is the first report on their complete characterization. The 
similarity of NMR chemical shifts of 23 and 24 with parent CL 11 for most of the amino acid 
residues shows that that the modified CLs may have similar overall structure as the parent CL. 
However, 27 and 28 shows major shift perturbations when compared to the starting material 10. 
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4.6 Brief Introduction to Chapter 5 
Biochemical and biophysical studies of molecules and their interactions often requires 
covalent coupling where such coupling enables the elucidation of specific molecular processes. 
Flax CLs 2 and 13, as described in Chapter 4, were modified to form stable Msn analogs of 10 
and 11 containing amino and hydroxyl side chain. The introduced reactive side chains are now 
readily covalently coupled with the functional groups of molecules (e.g. fluorescence labels), 
macromolecules (BSA) and affinity chromatography media for further studies. In Chapter 5, for 
example, these modified CLs were covalently linked to fluorescent molecules yielding novel 
fluorescent CLs. As a prerequisite of utilizing the CL-coumarin fluorescent label the absorption 
and fluorescence spectra of CL-coumarin complexes in solvents were studied. CLs could be used 
in charge transfer devices and also in electro optical devices. CLs were also coupled with solid 
affinity matrix and resulting CL matrix was used to purify apolipoprotein A1 from chicken 
serum. CLs were covalently coupled to BSA and these were used to induce the production of 
polyclonal antibodies in rabbits. The resulting polyclonal antibodies (pAbs) were used to develop 
a competitive indirect enzyme-linked immunosorbent assay (CI-ELISA).  
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CHAPTER 5 
APPLICATIONS OF FLAX CYCLOLINOPEPTIDES 
 
5.1 Abstract 
Synthetic analogs of flax CLs 10 and 11, containing reactive –NH2 and –OH groups, 
were selectively coupled with complementary functional groups present in fluorescent labels, 
affinity resin and protein (BSA). Amino analogs were coupled with the N-hydroxysuccinimide 
ester of coumarin dye and affinity matrix to form a covalent linkage. We have developed a 
general synthetic protocol that may be used to prepare various fluorescent CL derivatives from 
commercially available dyes. In this study N-hydroxysuccinimide coumarin dye was covalently 
coupled with amine CLs. The spectroscopic analysis was performed in different solvents such as 
methanol, ethanol, acetonitrile and DMF. The alcoholic solvents have shown better quantum 
yields compare to other solvents. CLs were also used as affinity tag to capture high-density 
lipoprotein (HDL) from the chicken serum. The agarose gel matrix containing activating group 
such as N-hydroxysuccinimide was coupled with amine CL and this CL-matrix was used to 
isolate protein from serum. The sequence of the isolated protein with MW of 28 kDa is identical 
to apolipoprotein A1 (Apo A1). In addition, CLs containing hydroxyl side chain were used as 
haptens. The haptens were conjugated to BSA through carbonyldiimidazole coupling and the 
incorporation of haptens was compared by MALDI, LC-ESI-MS, and SDS-PAGE and 
polyclonal antibodies were produced in rabbits. The polyclonal antibodies can be used both for 
the therapeutic purpose and detection of CLs in flax and flaxseed samples. Competitive indirect 
enzyme-linked immunosorbent assay (CI-ELISA) was developed by the use of specific 
polyclonal antibodies (pAbs).  
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5.2 Introduction 
Cyclic peptides are important class of structurally diverse complex molecules that 
exhibits a wide range of biological activity. Peptides have been identified that are antimicrobial, 
antiviral, insecticidal, anti-inflammatory and immunosuppressant. Cyclic peptides are typically 
much more stable when compared to linear peptides. They resist proteolytic degradation, due to 
their conformational restriction, and lack both C and N-terminus, making them stable to 
exopeptidease. The increase in rigidity of these structurally constrained peptides makes them 
suitable for selective binding and ligands for macromolecular receptors. Selective transformation 
of functional groups on biomolecules such as carbohydrates and peptides is important in 
biomedical research to prepare analogues and study structure-function relationships. In addition, 
tagged peptides were also used in forming fluorescent adducts, affinity media, isotope labeled 
peptides and haptens for antibody production (Bode, et al., 2012; Hamamoto, et al., 2011; 
Jayaraj, et al., 2003; Tozzi, et al., 2003). 
CLA (1) a natural nonapeptide isolated from linseed oil in 1959 by Kaufmann and 
coworker (Kaufmann & Tobschirbel, 1959). Another eight cyclic nona- and octapeptides, CLs 
(2–9) were also isolated from the seeds of L. usitatissimum L. and their structures were 
determined by extensive 2D nuclear magnetic resonance (NMR) methods and chemical 
degradation (Matsumoto, et al., 2001; Morita, et al., 1999) (Figure 2.6 and Table 2.3, Chapter 2). 
In addition 11 and 10 were chemically synthesized from their parent CLs 3 and 5, respectively 
and they were also be obtained from ageing flaxseed (Jadhav, et al., 2013; Matsumoto, et al., 
2001). 1 was found to possess the immunosuppressive activity comparable to that of CsA 
(Wieczorek, et al., 1991). The strong immunosuppressive activity of 1 makes the CL interesting 
from the point of view of its possible utilization in medicine (Wieczorek, et al., 1991). Of all the 
eleven CLs, 1 showed the best immunosuppressive activity on human peripheral blood 
lymphocytes. It showed the inhibitory effects on concanavalin A with an IC50 of 2.5 µg/mL 
followed by 11 (25.2 µg/mL) and 10 (28.1 µg/mL) (Morita & Takeya, 2010). The molecular 
mechanism of 1 and CsA is similar, i.e. first they bind with cyclophilin, and then inhibits the 
phosphatase calcineurin (Siemion, et al., 1999). The biological activity and presence of 
hydrophobic amino acid residues makes them good candidates in the fields of fluorescence 
labeling, affinity purification and antibody production. The attachment of fluorescence tag and 
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production of antibodies against these CLs will help in monitoring these bioactive CLs in vitro 
and in vivo. 
In this study, the CLs were systematically linked to molecules or materials of interest 
such as fluorescence tags, affinity resin and proteins. In addition, these CL conjugates were 
characterized using spectrometric techniques including NMR, MS/MS, MALDI, ESI, and SDS-
PAGE. This study helps to generate novel CL conjugates coupled to different set of molecules 
such as big molecule (protein), small molecule (fluorescent dye) and surface (matrix). The use of 
hydrophobic CL in different applications will help to increase its utility in addition to its 
biological activity. 
5.3 Materials and Methods 
5.3.1 Materials  
Affinity gel (Affi-Gel 10), iodoacetamide (IAA) and dithiothreitol (DTT) were purchased 
from Bio-Rad (Hercules, CA, USA); Sequencing grade-modified trypsin (Trypsin Gold) was 
purchased from Promega (Madison, WI, USA). TRIZMA® PRE-SET CRYSTALS 
[tris(hydroxymethyl)aminomethane], 50 mM, pH 9.0] as a coating buffer, phosphate buffered 
saline with Tween 20 [PBST; 0.01 M phosphate buffer with 138 mM NaCl, 2.7 mM KCl, 0.05% 
(w/v) Tween 20, pH 7.4], phosphate-citrate buffer tablets (50 mM phosphate-citrate buffer, pH 
5.0, 1 tablet/100 mL), hydrogen peroxide, 3,3',5,5'-tetramethyl-benzidine (TMB), BSA, N,N'-
carbonyldiimidazole (CDI), Tween 20, horseradish peroxidase (HRP) conjugate of goat anti-
rabbit IgG, sinapic acid, and Coomassie Brilliant Blue G-250 were purchased from Sigma 
Chemical Co. (St. Louis, MO, USA). All chemicals were of analytical grade. A Milli-Q system 
(Millipore, Bedford, MA) equipped with a 0.2 µm filter was used to prepare deionized water for 
all mobile phases. Amicon Ultra-4 centrifugal filters having 3 K regenerated cellulose 
membranes were obtained from Millipore (Carrigtwohill, Ireland). Chicken serum was obtained 
from 10 weeks old commercial broiler chickens. Chickens were fed on basal diet, which was un-
medicated diet formulated to fulfill the nutritional requirements. A T-Gel absorbent column (T-
Gel Purification kit, Pierce Co., Rockford, IL, USA) was used to purify polyclonal antibody 
(pAb). Micro Reaction vessels (2 mL with cap & septa, amber) obtained from Supelco analytical 
(Bellefonte, PA, USA). Microtiter plates, Maxisorp from Nunc Co. (Roskilde, Denmark) and a 
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microplate reader, THERMOmax from Molecular Devices Co. (Sunnyvale, CA, USA) were used 
for colorimetric assays.  
5.3.2 Instrumentation 
All proton and carbon NMR spectra were acquired on a Bruker Avance 500 MHz NMR 
spectrometer (Bruker BioSpin, Germany) applying a 5 mm TXI (1H/13C) triple-resonance inverse 
probe, equipped with a Z-gradient coil, and analyzed using Bruker XWIN-NMR 3.5 software. 
Well-resolved sharp spectral signals were obtained from NMR acquisitions at 320 K. Fourier-
transform infrared (FTIR) spectra were recorded using a FTS-40 Bio-Rad spectrometer 
(Digilab/BioRad, Cambrige, MA, USA) operating in diffuse reflectance mode on samples 
dispersed in KBr (DRIFT); only diagnostic and/or intense peaks are reported. The spectra were 
analyzed with Bio-Rad Win-IR software (Version 4.14). Fluorescence measurements were 
performed on a π*-180 PiStar stopped-flow apparatus (Applied Photophysics, Surrey, U.K.), 
both of the slit widths were set at 4 nm. The relative quantum yield of the standard coumarin 120 
(7-amino-4-methyl-1, 2-benzopyrone) in ethanol (0.98 in EtOH) was used to calculate compound 
quantum yield. Absorbance of all solutions between 200 and 700 nm was below 0.7 AU. 
Fluorescence spectra details: - Intensity- 3 sec, Scan time- 1, Boxcar width- 0, Range- 200–1000 
nm. All the solutions were excited at 354 nm. 
HPLC-diode array detector (DAD) analysis was performed on an Agilent 1200 series 
HPLC system (Agilent Technologies Canada Inc., Mississauga, ON, Canada) equipped with a 
quaternary pump, an autosampler, degasser, and DAD (1024-element photodiode array, 190–300 
nm). The peaks were detected at wavelengths of 214 nm with a 10 nm bandwidth corrected 
against a reference signal at 300 nm. Chromatography was conducted according to Olivia et al. 
using a Chromolith® SpeedRod RP-18e column (2 µm macropore size, 50 × 4.6 mm i.d.) 
equipped with an online filter. The mobile phase consisted of H2O-acetonitrile (70:30 to 30:70 in 
4 min, 10:90 in 0.5 min, 70:30 in 0.5 min and equilibrated to 70:30 for 1 min) at a flow rate of 2 
mL/min (Olivia, et al., 2012). A Chromolith® SemiPrep RP-18e column (2 µm particle size, 100 
× 10 mm i.d.) equipped with an online filter was used for preparative liquid chromatographic 
separations of the CLs. The mobile phase consisted of H2O-acetonitrile (80:20 for 0.5 min and to 
10:90 in 4.5 min, 80:20 in 0.25 min and equilibrated to 80:20 for 0.75 min) at a flow rate of 5 
mL/min. 
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MS/MS of CLs was performed using a MicrOTOF-Q II Mass Spectrometer (Bruker 
Daltonik GmbH, Bremen, Germany) equipped with an APCI source (Parameters- dry temp- 200 
°C; vaporizer temp- 450 °C; drying gas- 8 L/min; nebulizer 1.6 bar; capillary voltage- 4000 V).  
MALDI-TOF-Mass spectra were acquired by matrix-assisted laser desorption ionization–
time-of-flight MS using a 4800 MALDI TOF-TOF Proteomics Analyzer (Applied Biosystems, 
LLC. Frederick, MD, USA) equipped with a diode-pumped 355 nm Nd:YAG laser, and a laser 
intensity of 5500. The ion extraction delay time was set to 2000 ns and positive ion linear mode 
was used. Protein mass spectra were recorded as sums of 1000 laser shots. For MALDI matrix 
deposition, 10 mg/mL of sinapic acid was prepared in acetonitrile/water/TFA (50:50:0.1, v/v/v). 
The matrix (0.8 µL) was deposited on the 384-well plate (Opti-TOF insert, Applied Biosystems), 
followed by the application of 1.0 µL of the protein sample, then a 0.5 µL of matrix solution was 
spotted on top of the protein solution. After allowing the plate to dry under ambient conditions, 
the plate was loaded into the MS for data acquisition. 
LC-ESI-QTOF-High resolution HPLC-electrospray ionization (ESI)-MS analyses were 
performed on an Agilent HPLC 1200 series directly connected to a MicrOTOF-Q II Mass 
Spectrometer (Bruker Daltonik GmbH, Bremen, Germany) equipped with an ESI source 
operating in positive ion mode. Protein conjugate samples were introduced onto the ESI-MS by 
HPLC employing a Poros R1 20 column (4.6 × 100 mm, Applied Biosystems, 20 µm) using the 
following linear gradient: 90:10, 0.1% formic acid/water to 10% formic acid/acetonitrile over 25 
min at a flow of 1 mL/min. Ionization conditions of ESI analysis were as follows: dry gas 
temperature 220 °C, drying gas flow 10 L/min; nebulizer pressure 6 bar, capillary temperature 
4500 V, scan range 50–20000 m/z. Molecular weights of the conjugates were determined from 
the high m/z scans after converting the complex spectra of multicharged protein species to the 
mass domain using Bruker’s deconvolution software (Compass data analysis). 
5.3.3 Preparations of Affinity CLs 30 and 32 
CL 30 was prepared using the procedure as described by Hering et al, (Hering, et al., 
2005). CL 23 (0.16 g, 0.14 mmol) was dissolved in MeOH (5 mL) and triethylamine (0.5 mL) 
was added to the solution. A slurry of Affi-Gel 10 resin in MeOH (20 mL total volume with 8.30 
mL settled resin volume, 0.125 mmol,) added to above solution and agitated on a shaker at 4 °C 
for 16 h. The gel was filtered and washed with cold MeOH and cold water sequentially, and the 
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combined filtrates were concentrated. The gel was added to a solution of ethanolamine (6.25 mL, 
0.1 M solution in water, 0.625 mmol) in cold water (25 mL) and agitated on a shaker at 4 °C for 
4 h. The gel was then filtered and washed with cold water (6 column volumes) and cold 0.2% 
aqueous NaN3 (3 column volumes) and stored at 0 °C in a solution of 0.2% aqueous NaN3 to 
form coupled gel 30.  
Similarly, CL 32 was synthesized from 27 using the above procedure. 27 (0.16 g, 0.15 
mmol) was dissolved in MeOH (5 mL) and triethylamine (0.5 mL) was added to the solution. 
Affi gel coupled CL 30 was slurry packed into a preparative column (POROS® PI 20 µm 
column (4.6 × 100 mm, 1.7 mL), Applied Biosystems®) and connected to Agilent 1200 series 
HPLC system equipped with a quaternary pump, an autosampler, degasser and diode array 
detector (1024-element photodiode array, 190–300 nm). The peaks were detected at wavelengths 
of 280 nm with a 10 nm bandwidth and against a reference signal at 360 nm. The column was 
first incubated with serum for 3 min and then eluted with a buffer of 0.02 M Tris-HCl pH-7.5 
(Solvent A) to remove non-bound protein for 12 min and finally, eluted with (1 mg/mL of 11 in 
35% MeOH/0.02 M Tris-HCl pH-7.5, Solvent B) to remove bound proteins for 15 min and the 
column is again equilibrated for 10 min with solvent A at a flow rate of 0.5 mL/min. The 
fractions were concentrated by ultrafiltration in an Amicon Ultra-4 centrifugal filter with a 3K-
regenerated cellulose membrane and finally, concentrated sample was centrifuged at 10000 × g 
for 3 min and the resulting clear retentate solution was used for SDS-PAGE.  
5.3.4 SDS-PAGE 
Presence of protein was confirmed by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) as described previously (Bollag, et al., 1996) using a Mini protean 
II system (Bio-Rad, Richmond, CA). Protein concentration was determined using a Bio-Rad 
protein assay dye reagent (protein solution was added to acidic dye and absorbance was 
measured at 595 nm, Bio-Rad, Richmond, CA). A standard curve was prepared with a BSA 
solution. Protein concentrations of 20–30 µg were used during gel electrophoresis. The 8% 
stacking gel buffer (5.28 mL sterile water; 2.03 mL 40% acrylamide; 2.5 mL 0.5 M Tris-HCl pH 
6.8; 100 µL 10% SDS; 50 µL 10% APS; 8 µL TEMED) and 5% resolving gel buffer (3.01 mL 
sterile water; 0.64 mL 40% acrylamide; 1.25 mL 1.5 M Tris-HCl pH 8.8; 50 µL 10% SDS; 100 
µL 10% APS; 8 µL TEMED) were used. The samples were diluted with sample buffer (0.6 mL 
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pH 6.8; 1 M Tris-HCl; 2 mL 10% (w/v), SDS; 5 mL 50% (w/v) glycerol; 0.8 mL, bromophenol 
blue), boiled at 95 °C for 5 min, and then applied onto a polyacrylamide gel. Electrophoresis was 
conducted for 75 min at a constant voltage of 100 V and then the gels were stained with 
Coomassie brilliant blue for 1 h. Subsequently, gels were destained using 10% acetic acid in 
MeOH: H2O (40:60) and the gel image was scanned using a scanner. 
5.3.5 Trypsin Digest 
Proteins were digested in-gel with the MassPrep II Proteomics Workstation (Micromass, 
UK) following the previously described procedure (Sheoran, et al., 2005). Briefly, Coomassie-
blue-stained protein gel bands are cut into pieces of ~1 mm3 and placed into 96-well plates. 
Protein bands were destained twice (10 minute incubations) with 100 µL of 1:1(v/v) ammonium 
bicarbonate: acetonitrile. Protein reduction was performed with the addition of 10 mM DTT 
prepared in 0.1 M ammonium bicarbonate, for 30 min at 37 ºC. This step was followed by 
alkylation, achieved by adding 50 µL of 55 mM IAA prepared in 0.1M ammonium bicarbonate. 
The alkylation reaction was carried out for 20 minutes also at 37 ºC. Gels are washed and 
dehydrated before being saturated with 25 µL of 6 ng/µL trypsin prepared in 50 mM ammonium 
bicarbonate; digestion was carried out at 37 ºC for 5 h. CLs were extracted with 30 µL 0.1% 
trifluoroacetic acid/3% acetonitrile for 30 min, and then twice with 24 µL, 0.1% trifluoroacetic 
acid/50% acetonitrile for 30 min. The combined extracts were dried in a SpeedVac System 
(Model DNA 120, Thermo Savant DNA SpeedVac System, San Diego, CA). Samples were 
reconstituted in 40 µL of 0.1% trifluoroacetic acid/3.0% acetonitrile for LC-ESI MS analysis (or 
in 10 µL of the same solvent for MALDI TOF/TOF analysis). 
5.3.6 Production of Antisera  
Preparation of Immunogen (33 and 34) 
The immunogen was prepared by conjugating CLs (24, MW 1177.6 Da; 28, MW 1080.6 
Da) with BSA (MW 66462.2 Da), according to the method of Lee et al. (Lee, et al., 2000). 33 
conjugate was prepared as follows: 24 (10 mg, 8.5 × 10-3 mM) and CDI (5.4 mg, 3.3 × 10-2 mM) 
were added to a 2-mL micro reaction vessel containing a triangular stir bar. Tetrahydrofuran 
(THF, 0.6 mL) was added and the reaction mixture stirred continuously at room temperature and 
0.15 mL (×4) of reaction mixture was added slowly to a continuously stirred solution of BSA 
(2.0 mg, 3.0 × 10-5 mM) dissolved in 1 mM sodium borate (1 mL, pH 8.5) for different time 
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intervals (4, 12, 16, and 24 h). The reaction was stirred for 48 h at room temperature and the 
solutions was then filtered and centrifuged (×6) against a 30000-MW cutoff filter with deionized 
distilled water (50 mL), until pH was neutral. The filtrate was then rinsed from the filter, diluted 
to a concentration of 1 mg/mL in deionized distilled water, and stored at –20 °C. The 34 
conjugate was also obtained using the method described above, except that the 28 (10 mg, 9.2 × 
10-3 mM) was used instead of the 24 (10 mg, 8.5 × 10-3 mM). 
Rabbits were immunized with emulsions prepared from conjugates of 33 and 34 at the 
Animal Care Unit, College of Veterinary Medicine using approved animal care protocols 
(Animal and Ethics Committee, University of Saskatchewan, Saskatoon, SK, Canada). First, 
immunogen concentration was 1.0 mg protein/mL in 10 mM PBS containing 138 mM NaCl and 
2.7 mM KCl at pH 7.4. An aliquot of the protein solution, containing approximately 150 µg of 
protein, was then mixed with TiterMax® Gold (CytRx, Norcross, GA, USA) in a 1:1 ratio (v/v). 
The selected animal (~3 kg) received the prepared immunogen through subcutaneous 
administration. Test bleeds were taken 3 weeks after the 1st immunization and 1 week after each 
boost. Immunization boost was given after third week and continued until fifth week. The 
antisera titre was determined by a non-competitive indirect enzyme linked immunosorbent assay 
(NCI-ELISA) as described in section 5.2.8. Blood (80 mL/animal) was collected 1-week after the 
last booster injection, which gave the highest antiserum titre. The antisera were isolated from the 
blood by centrifuging at 3000 g for 20 min with NaN3 (0.02%, w/v), and stored at −70 °C until 
use. 
5.3.7 Purification of Polyclonal Antibodies 
The purification of immunoglobulin G (IgG) type antibodies was performed using a T-
Gel purification kit and gel filtration chromatography (Sephadex G-25). Briefly, antisera (1 mL) 
was mixed with K2SO4 to a 0.5 M solution, centrifuged at 10000 g for 20 min, and then filtered 
through a 0.45-µm syringe filter (Polytetrafluoroethylene membrane, Sartorius Co., Göttingen, 
Germany). The filtrate was loaded onto a T-Gel column (thiophilic adsorption, column contains 
a sulfone group in proximity to thioether group which helps in binding with proteins) 
equilibrated with a pH 8.0 binding buffer (provided by the manufacturer) containing 0.5 M 
potassium sulfate and then washed with 50 mM sodium phosphate buffer at pH 8.0. The eluted 
IgG protein fractions (280 nm absorbing fractions) were pooled. Fractions (1.5 mL) were 
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desalted using a Sephadex G-25 column (15 × 170 mm) then equilibrated with PBS. UV 
absorbance (280 nm) was determined for each fraction. The fraction showing the highest 
absorbance was assumed to contain IgG Ab. IgG concentration of 8 mg protein/mL was 
recovered from 10 mL of antiserum through this purification. 
5.3.8 ELISA Protocol 
In the NCI-ELISA with 33, each well of polystyrene microtiter plate was coated with 100 
µL of 33 conjugate (2 µg/mL) in a coating buffer (0.05 M Tris, 0.15 M NaCl buffer, pH 9.0). 
Antigen-treated plates were stored overnight at 4 °C, and each well was washed three times with 
buffer (150 µL, 0.02 M Tris, 0.15 M NaCl buffer, pH 7.4, with 0.02% Tween 20). The anti-33 
antiserum (100 µL) diluted with the PBS buffer (dilution 1/10000, v/v) containing 1% BSA as a 
blocking reagent, was added to each well and left for 1 h. After washing three times, goat anti-
rabbit IgG-HRP conjugate (100 µL), as secondary Abs diluted to 1/5000, 1/7000, and 1/10000 
(v/v) in the PBS buffer, was added to each well and left for 1 h. After washing three times, 
substrate solution (100 µL, 0.01% TMB, 0.05 M phosphate citrate buffer, pH 5.0, 0.002% H2O2, 
v/v) was added, developed for 30 min at room temperature, and the reaction was stopped with 2 
M H2SO4 (50 µL). Absorbance was measured at 450 nm with a microplate reader. The protocol 
for the NCI-ELISA coating with CL antigen was similar to that previously described (Otvos & 
Szendrei, 1997). Briefly, 50 µL of 24 or 28 (10 µg/mL in 80% isopropyl alcohol/water) was 
added to wells of a microtiter plate. The plate was kept at 37 °C for 2 h to dry the antigen on the 
plate. After washing 3 times with PBST, 100 µL of 1% BSA-PBS as a blocking solution was 
added and allowed to incubate at 37 °C for 1 h. The plate was washed as described above, and 50 
µL of diluted anti-33 antiserum or anti-34 antiserum was added. After incubation at 37 °C for 1 h 
and washing the plate, 100 µL of goat anti-rabbit IgG-HRP conjugates (1/3000 dilution in 1% 
BSA-PBS) was added. The plate was incubated at 37 °C for 1 h and then washed. After washing 
three times, the coloring reaction was the same as described for the NCI-ELISA.  
In the Competitive Indirect Enzyme Linked Immunosorbent assay (CI-ELISA), the 
procedure was the same as in the NCI-ELISA, except that 100 µL of 24 solution and anti-33 
antiserum, diluted to 1/10000 in the washing buffer containing 1% BSA (1:1 mixture), were 
added to each well of the 33 conjugate-coated plate in place of the antiserum used in the 
experiment of the NCI-ELISA.  
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5.4 Results and Discussion 
In this study, we have selected two types of CLs, 11 and 10 containing nine and eight 
amino acid residues. However, 11 and 10 contain Msn moieties and are oxidised products of CLs 
(2 and 3) and CLs (13 and 5) with the same basic core. We have already devised a method to 
systematically modify the Met in the parent CLs (2 and 13) without changing other amino acids 
(Chapter 4). CLs were produced that contain reactive –NH2 and –OH groups that can be used to 
selectively couple intact CLs with other reactive functional groups present in fluorescent 
compounds, affinity media and protein (BSA) designed for binding these reactive groups. In this 
study, amino analogs of 10 and 11 were reacted with a succinimidyl ester of coumarin dye and 
affinity gel to form a covalent bond. We have developed a general synthetic protocol and could 
be used to prepare various fluorescent CL derivatives from commercially available dyes with 
reactive groups. The florescence spectra of these compounds were obtained in different polarity 
of solvents to understand the photophysical behaviour of CL/coumarin complexes. The 
hydrophobic surfaces and cyclic conformational structure makes these CLs good candidates to 
bind proteins. CLs consist of two different surfaces, hydrophobic surface formed by aromatic 
side chains and the other hydrophilic, formed by CL backbone that helps in binding with protein. 
The analogue of 1 has shown binding to proteins from cytosol and plasma membranes of rat 
hepatocytes (Kemmer, et al., 1997). However, there was no study on the binding of chicken 
serum proteins with CLs. Hence CL affinity matrix was used to study the binding of chicken 
serum proteins with CLs. In addition, alcohol analogs (24 and 28) were coupled with the lysine 
of BSA through CDI activation so that the CLs might act as hapten to induce antibody 
production when injected into rabbits. pAbs recovered from the rabbit serum can be used in two 
ways: for localization of CLs when they are introduced to a medium or biological material or 
detection of CLs in flax and flaxseed products. The total concentration of CLs is only 0.2% of 
flaxseed and various groups have isolated CLs (Brühl, et al., 2007; Matsumoto, et al., 2001; 
Morita, et al., 1999; Morita, et al., 1997). NMR and HPLC-MS were utilized to identify and 
characterize the CLs. However, they are not satisfactory for the detection of CLs in multi-
component mixtures such as oil, fat, wax and grease. In contrast, an enzyme-linked 
immunosorbent assay (ELISA) provides highly sensitive, rapid, and precise means to analyze a 
large number of samples. ELISA uses enzyme and antibody. Antigen quantification of 
nanograms is possible. 11 and 10 are the oxidized products of their parent CLs 3 and 5 and are 
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not present in freshly ground flaxseed but may be indicators of ageing and oxidation flaxseed 
(Jadhav, et al., 2013) (Chapter 3). 
5.4.1 Synthesis of CL Conjugates  
The analogs of CLs (11 and 10) containing amine (23 and 27) and hydroxyl side chain 
(24 and 28) were synthesized previously (Chapter 4). Amine reactive groups of 23 and 27 were 
coupled with coumarin succinimidyl ester dye to form fluorescent derivatives 29 and 31 
respectively. Similarly 23 and 27 were also coupled with the succinimidyl ester of affinity matrix 
to form CL-matrix 30 and 32, respectively (Figure 5.1). These reactions form a stable covalent 
amide bond between CL and dye, matrix with a loss of N-hydroxysuccinimide. Alcohol reactive 
groups of 24 and 28 were used to couple with the BSA. Initially, hydroxyl group of CLs (24 and 
28) was activated with CDI and then reacted with the lysine of BSA to produce CL-BSA 
conjugates 33 and 34, respectively (Figure 5.2). 
5.4.2 Characterization of CL Conjugates 
5.4.2.1 Characterization of Fluorescent Derivatives 29 and 31 
The protons attached to the heteroatoms were assigned from 1H-NMR, and their coupling 
to amide protons and carbonyl carbons employed NOE and HMBC correlations (Figure 5.3). 
These elucidated the amino acid sequence of the CL. 1H-1H COSY was used for assignment of β, 
γ and δ protons while elucidation of the attachments of these protons to carbon atoms was 
determined by HMQC. The MS/MS and NMR spectral data of 29 (Figure 5.4 and experimental 
section) showed similarities to that of 11 (Jadhav, et al., 2013). However, a fragment loss of m/z 
451 in the MS/MS data of 29 (Figure 5.4) in place of the loss of m/z 163 (Msn in 11) suggested 
the presence of an attachment of coumarin molecule to Msn1 residue in 29. The amino acid 
sequence of 29 was verified using tandem MS/MS fragmentation (Figure 5.4). MS/MS profile of 
31 reveals the amino acid sequence (Figure 5.5). However, the 13C NMR spectrum showed two 
sets of signals for each carbon atom corresponding to two CL conformers of 31 similar to 10 
(Jadhav, et al., 2013). Signals from the major conformer are shown in the experimental section. 
The structures of 29 and 31 were confirmed by MS/MS and NMR methods. HPLC-MS analysis 
showed a [M+H]+ ion peak at m/z 1378.6751 corresponding to a molecular formula, 
C70H96N11O16S of 29 and m/z 1281.6317 corresponding to C65H89N10O15S of 31.  
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Figure 5.1 Synthesis of fluorescent derivatives (29, 31) and CL affinity matrices (30, 32) 
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Figure 5.2 Synthesis of CL-BSA conjugates 33 and 34 
 
 
Figure 5.3 Structures of 29 and 31. Double arrows show selected NOE correlations. Half 
arrows show selected HMBC correlations 
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Following the preparation of fluorescent CLs 29 and 31 it was important to investigate 
the occurrence of structural changes in the CL core structure. NMR spectroscopy was therefore 
used as a tool to compare the structural signals of the starting material 11 and 10 to those of the 
conjugate products 29 and 31, respectively. The α protons of each amino acid residue were used 
to determine if measurable structural changes took place (Dekan, et al., 2011). Our observation 
from chemical shift analyses showed that most of the amino acid residues (six out of nine and 
five out of eight amino acid residues for 29 and 31 respectively) shows no significant 
perturbations in the NMR signals of 29 and 31 compared to mother compounds 11 and 10, 
respectively (Table 5.1). We therefore concluded that the CLs 29 and 31 might have structural 
similarity to their parent CLs.  
5.4.2.2 Characterization (Coupling efficiency) of Bound Ligand and Matrix 
The coupling efficiency of stationary phase containing coupled modified CLs and matrix 
can be determined by performing elemental analysis (C, N and S) on the blank gel and CL-
coupled matrix 30 and 32 (Table 5.2). In this analysis, samples were first fully combusted and 
then the products of its combustion such as carbon dioxide, water, nitric oxide and sulfur dioxide 
were analyzed. The difference in % of S between blank and modified gel was used to determine 
the coupling efficiency. The analysis shows almost 70% coupling of CLs to the gel in 30 and 
about 38% in 32. 
5.4.2.3 Characterization of BSA Conjugate 
The CL-BSA conjugates (33 and 34) were characterized using SDS-PAGE, MALDI and 
ESI-QTOF. These analyses indicate binding of haptens (CLs) to BSA. 
SDS-PAGE. This technique determines protein molecular weight. Incorporation of 
haptens covalently bound to the protein would increase their molecular mass and possibly 
decrease their mobility in the SDS gel. After conjugation, bands attributed to the conjugate of CL 
with BSA were broader and less mobile than unreacted BSA (66 kDa) (Figure 5.7). This result is 
consistent with the formation of BSA covalently bound to CL. However, The CL-BSA 
conjugates have shown smeared bands in gel electrophoresis. This prevents the determination of 
the exact molecular mass (es) of the CL-BSA conjugates as compare to BSA (Adamczyk, et al., 
1994). As SDS-PAGE has lower sensitivity in mass discrimination (<5%) than MS techniques, it 
can’t determine exact number of haptens incorporated into the protein (Barinaga, 1989).
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MALDI. MALDI has been used to determine the molecular weights of proteins (Figure 
5.7) (Adamczyk, et al., 1994). The average number of haptens incorporated into immunogen was 
determined from the difference in the measured molecular weights of the conjugate from non-
modified BSA. The reported molecular mass of BSA is 66430.3 Da (Hirayama, et al., 1990) and 
CLs 24 and 28 were 1176.6 Da and 1079.6 Da with loss of hydrogen during conjugation, 
respectively. However 33 conjugate shows molecular masses of 44587.7 (M + 2H)2+ = 89175.4 
Da and 77761.2 Da implying incorporation of haptens. 34 conjugate also shows hapten addition 
with a molecular mass of 44928.4 (M + 2H)2+ = 89856.8 Da, 78918.0 Da and 68074.5 Da. 
LC-ESI-QTOF Mass Spectrometry. Molecular weights of 33 and 34 conjugates were 
recorded after deconvolution of mass spectra. Addition of one molecule of 24 to BSA increased 
molecular mass of the CL-BSA conjugate by 1204.6 Da [1176.6 + 28 (CO)] while addition of 28 
would increase mass by 1107.6 Da [1079.6 + 28 (CO)]. A molar mass of 93591.9 for 33 
conjugate (93591.9 – 66430.3 = 27161.6), as observed by MALDI, indicates that 22.5 haptens 
(24) were attached to BSA. There were different numbers of incorporation of haptens based on 
various molecular masses (Table 5.3). 
5.4.3 Applications of CL Conjugates 
5.4.3.1 Fluorescence Studies of 29 and 31 
The absorption and fluorescence studies were conducted in four different solvents 
(methanol, ethanol, acetonitrile and dimethylformamide) at a concentration of 3 × 10-5 M. The 
samples were excited at 354 nm, and the emission spectrum was recorded. Coumarin 120 (7-
amino-4-methyl-1, 2-benzopyrone) was used as reference (Bryantseva, et al., 2008). 7-methoxy 
coumarin in which methoxy group acts as electron donor and carbonyl as acceptor was used as 
tag. The fluorescence intensity of this coumarin dyes is solvent dependent and it increases with 
solvent polarity with negligible emission shift (Heldt, et al., 1995; Muthuramu & Ramamurthy, 
1984). It has been postulated that, nπ* and ππ* singlet states are close to each other in the non-
polar solvent, where intersystem crossing takes place and hence the fluorescence yield is lower. 
However in polar solvent the difference between these two states is larger, making intersystem 
crossing inefficient (Muthuramu & Ramamurthy, 1984). 29 and 31 absorb light at 347 nm and 
emit light at 406 nm. Both show the same trend having higher quantum yields in methanol and 
ethanol than in either acetonitrile or DMF (Table 5.4 and 5.5).   
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Figure 5.4 CID MS/MS spectrum of 29 showing fragmentation pattern 
 
 
 
Figure 5.5 CID MS/MS spectrum of 31 showing fragmentation pattern  
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Table 5.1 Chemical shift differences of αH signals for 29 and 31 compared with the 11 and 
10, respectively. 
 
 
Table 5.2 Elemental analysis of blank and CL gels (30 and 32). 
 
 C N S 
Blank gel 43.10 4.692 0.000 
30 46.42 4.201 0.581 
32 44.68 3.879 0.293 
 
  
αH assignment 11 29 
Msn1 4.81  4.76 
Leu2 4.07  3.83 
IIe3 4.52  4.47 
Pro4 3.90  3.78 
Pro5 4.07 4.11 
Phe6 4.11 3.82 
Phe7 4.96  4.86 
Val8 3.90  3.86 
IIe9 4.60  4.55 
αH assignment 10 31 
Msn1 4.76 4.63 
Leu2 4.36  4.33 
Val3 4.50  4.42 
Phe4 4.34  4.42 
Pro5 4.09 4.12 
Leu6 3.81 3.60 
Phe7 4.96  4.97 
Ile8 4.13 3.90 
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Figure 5.6 SDS-PAGE patterns of 33 (A) and 34 (B) conjugates 
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Figure 5.7 MALDI-TOF mass spectra of 33 (A) and 34 (B) conjugates 
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Table 5.3 Molecular masses of 33 and 34 conjugates. 
 
33 conjugate 34 conjugate 
  93591.9 (MBSA + 22.5 HAP, 100) 
81290.4 (MBSA + 12.3 HAP, 84) 
84522.5 (MBSA + 15.0 HAP, 82) 
84637.2 (MBSA + 15.1 HAP, 81) 
84598.2 (MBSA + 15.0 HAP, 79) 
81485.6 (MBSA + 12.5 HAP, 71) 
81462.4 (MBSA + 12.5 HAP, 56) 
       93612.7 (MBSA + 24.5 HAP, 100) 
66746.4 (MBSA + 0 HAP, 90) 
     90085.1 (MBSA + 21.4 HAP, 80) 
   76398.7 (MBSA + 9.0 HAP, 78) 
Mconjugate (MBSA + average number of haptens, relative intensity) 
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The hydrogen bonding of hydroxyl group of alcohols have extra effect as compare to 
both aprotic acetonitrile and DMF. However, fluorescence in DMF occurs with very low 
quantum yield as compare to fluorescence in other solvents. Potentially non-radiative decay or 
conformational changes occur in the dye that arises from interaction with the CL in DMF 
lowering the quantum yield. 
Fluorescent tags have been successfully used for imaging proteins inside cells and are 
valuable in establishing the fate of a given protein or chemical compound in biochemical 
processes. (Ferro-Flores, et al., 2010). Some of the examples of fluorescent-labeled peptide 
include peptide-dye conjugate [arginine-glycine-aspartic acid (RGD)-Cy5.5] has shown affinity 
to integrin receptor as contrast agent in vitro, in vivo, and ex vivo. The ε-amino group of lysine 
residue present in RGDyK peptide was coupled with N-hydroxysuccinimide ester of cyanine 5.5 
dye to use as a fluorescent probe to detect U87MG glioblastoma xenograft with high contrast 
(Chen, et al., 2004). The biological activity of CLs makes them good candidates to be used them 
as fluorescent tag. However there was no report on the attachment of fluorescent dye to CLs. In 
this study we are attaching a coumarin dye to CLs through a covalent linkage. NMR studies 
shows that the CL dye conjugate molecule might have structural similarity with the parent 
molecule CLs 10 and 11. Hence they can be used for fluorescent imaging and active side chain 
chain to link any type of dye. The polar protic solvent have shown higher quantum yield as 
compare to aprotic solvent. The hydrogen bonding has extra effect and makes intersystem 
crossing between nπ* and ππ* singlet states inefficient. 
5.4.3.2 Affinity Purification using CL Affinity Matrix 30 
Amine reacting side chain of 30 was used to couple with the succinimidyl ester of Affi-
gel 10 matrix. This forms a stable amide bond between CL and matrix with a loss of N-
hydroxysuccinimide. The affinity column was directly attached to an HPLC solvent delivery 
system and compounds eluting from the column were monitored at 280 nm. The chromatogram 
shows two peaks where the first peak represents the bound protein and the second unbound 
protein (Figure 5.8). Initially the column was eluted with Tris buffer to remove unbound protein. 
Subsequently, 11 was incorporated in the elution solvent to enable the removal of bound 
compounds. As 11 has low solubility in Tris buffer, a mixture of methanol and Tris buffer was 
used to dissolve this CL.   
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Table 5.4 Spectroscopic analysis of 29 in different solvents. 
 
Solvent λmax  λemission ϕ Quantum yield 
Ethanol 348 407 0.69 
Methanol 348 404 0.71 
Acetonitrile 345 402 0.57 
Dimethylformamide 347 408 0.44 
 
 
Table 5.5 Spectroscopic analysis of 31 in different solvents.  
 
Solvent λmax λemission ϕ Quantum yield 
Ethanol 348 403 0.62 
Methanol 347 403 0.68 
Acetonitrile 345 405 0.59 
Dimethylformamide 347 406 0.42 
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The column was also eluted with Tris buffer-methanol before 11 was added to confirm 
that methanol addition was not eluting the protein. This solvent without 11 did not elute 
additional protein from the column. The columns were regenerated by elution with methanol. 
SDS-PAGE 
Bound protein fractions released by elution with 11 were added to a SDS-PAGE 
electrophoresis gel. Coomassie blue shows a single band at 28 kDa (Figure 5.9 lane 4). The 
affinity-purified fraction (bounded protein) was compare to crude serum (Figure 5.9 lanes 2 and 
3). This band was excised and the protein digested with trypsin as described in the Materials and 
Methods. The resulting CL was sequenced and amino acid sequences thus obtained (Table 5.6) 
was identical to that of a chicken apolipoprotein A1. The matched amino acids were shown in 
red and it shows 58% protein coverage and it consists of 246 amino acids.  
Hydrophobicity of CLs plays a significant role in transport across cell membranes in 
addition to distribution in tissues and organs (Kemmer, et al., 1997). Hydrophobic peptides such 
as the somatostatin analogue 008, linear hydrophobic peptide EMD 55068 and 1 analogue CDP 
[c(-Ala-Lys-Pro-Phe-Phe-Ala-Lys-Pro-Phe-Phe-)] have shown binding to proteins in the plasma 
membranes and cytosol of rat hepatocytes. The specific binding proteins in the plasma 
membranes are cytochrome P450 II Cl3, cytochrome P450 II C22 and 3-hydroxyandrogen-UDP-
glucuronosyltransferase. In the cytosol, the glutathione-S-transferase is the binding protein. 1 and 
its analogues have shown two surfaces, aromatic side chain forms hydrophobic and the peptide 
backbone forms a hydrophilic surface. These hydrophobic surfaces and cyclic conformational 
structure helps these compounds to bind proteins (Kemmer, et al., 1997). Hence it was 
interesting to study the binding of chicken serum proteins with analog 11 via affinity 
chromatography. Amino side chain of 23 and 27 is accessible for covalent linkage with affinity 
matrix. In our study we have identified a specific binding of protein Apo A1 with 23. The main 
function of Apo A1 is to reverse cholesterol transport and cholesterol efflux. It was reported that 
CsA inversely affects the Apo A1 uptake, degradation and resecretion. If CLs binds with Apo 
A1, then it might act as inhibitor and may interfere in cholesterol homeostasis. This study will 
help to understand the effect of binding on the biological activity of CLs. 
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Figure 5.8 Elution profile of crude serum 
 
 
 
Figure 5.9 Coomassie blue stained gel-showing electrophoresis of Apo A1 purification 
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 5.4.3.3 ELISA Study using Polyclonal Antibodies against 33 and 34  
When the properties of two polyclonal antibodies (pAbs) produced in this study were 
compared, the recognizing pattern of the anti-33 pAb toward antigens was similar to that of the 
anti-34 pAb. In this study, the CI-ELISA was developed, and the feasible test of optimized 
immunoassay was performed. The standard curves showed the detection limit and the ranges of 
the competitive indirect method using the anti-33/34 pAbs (Figures 5.10 and 5.11). In the CI-
ELISAs (Figure 5.11), the detection limit of 28 by the anti-34 pAb with the blocking buffer (1% 
BSA in PBS) was 0.01 µg/mL, whereas without the blocking buffer it was 0.1 µg/mL, indicating 
that with blocking buffer was 10 fold more sensitive than without the blocking buffer. However, 
in the CI-ELISA using the anti-33 pAb, the detection limit of 24 was approximately 0.01 µg/mL 
(ppm) and almost the same results were obtained with and without the blocking buffer. 
Therapeutic peptides have gain importance as drug candidates in different applications 
including anti-microbial therapy, anticancer vaccines, Alzheimer’s therapy, and anti-malarial 
(Ganz & Lehrer, 1998; Ghosh, et al., 2001; Soto, et al., 1998; Zwaveling, et al., 2002). Hence it 
is important to monitor the stability of the drug inside the body and antibodies play an important 
role (Ohara, et al., 2011). Some of the examples include cyclic hydrophobic peptides such as 
immunosuppressant cyclosporine A (CsA) and growth inhibiting hormone somatostatin have 
been used to produce polyclonal antibodies. The pAbs of CsA were used to monitor the 
cyclosporine levels using radioimmunoassay and somatostatin pAbs were used to detect the 
presence of somastotatin receptor in carcinoid tumors (Cacalano, et al., 1989; Janson, et al., 
1998). However there were no reports on the generation of pAbs against flax CLs. In this study 
CLs were conjugated to BSA and the CL-BSA conjugates were used to generate pAbs in rabbits. 
Hence pAbs generated against CLs can be used to develop competitive indirect ELISA (CI-
ELISA) for the detection of CLs in complex matrices. It was reported that CL 5 is responsible for 
the bitter flavor of flaxseed oil (Brühl, et al., 2007). Since these generated pAbs will have affinity 
to CL 5 and might be able to detect CL 5 (bitter flavor) in oil. They can be use for both 
therapeutic drug monitoring and detection in flaxseed samples.	  Affinity between molecules and 
other molecules or solids depends on three dimensional structures (Segura, et al., 2007). In this 
study the effect of modifying CLs with an activating group has the potential to change the 
backbone conformation of CL molecule and thus change the affinity with other molecule. 
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Table 5.6 Apo A1 peptide sequence. 
 
1 RSFWQHDEPQ TPLDRIRDMV DVYLETVKAS GKDAIAQFES SAVGKQLDLK 
51 LADNLDTLSA AAAKLREDMA PYYKEVREMW LKDTEALRAE LTKDLEEVKE 
101 KIRPFLDQFS AKWTEELEQY RQRLTPVAQE LKELTKQKVE LMQAKLTPVA 
151 EEARDRLRGH VEELRKNLAP YSDELRQKLS QKLEEIREKG IPQASEYQAK 
201 VMEQLSNIRE KMTPLVQEFR ERLTPYAENL KNRLISFLDE LQKSVA 
 
 
 
 
Figure 5.10 Binding of 10 µg of 24 or 28 to anti-33 pAb or anti-34 pAb 
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CLs covalently attached to coumarin dye, affinity matrix and BSA through a sulfone side 
chain may not have the same conformation as the native unmodified CL. For example, 
glycopeptides binding to major histocompatibility complex (MHC) can elicit a T-cell response if 
the glycan moiety is attached at suitable position to the peptide. The substitution of the linkage of 
the glycosyl peptide with serine for threonine did not affect binding. Also in this model system 
there is no effect of configuration of the glycan moiety (α or β linkage). Thus the atoms involved 
in the covalent linkage between glycan and peptide were hypothesized to be inaccessible to 
MHC and have negligible effect on binding affinity (Galli-Stampino, et al., 1997). These studies 
have shown that if the glycan is situated outside the MHC affinity region of the peptide, it may 
not be recognized (Harding, et al., 1993). This effect may be caused by an indirect effect where 
the glycan changes the conformation of the peptide. However if glycan is situated at the region 
of the molecule involved in affinity it will typically affect binding (Ishioka, et al., 1992). If the 
glycan protruds away from binding site then the binding is typically maintained (Deck, et al., 
1995). CL 1 has shown immunosuppressive activity by complexing with cyclophilin and it was 
reported that sequence of the binding region is Val-Pro-Pro-Phe (Gallo, et al., 1995). However, 
this binding region is opposite to the sulfone side chain and, thus, may not be affected by 
covalent attachment of the linking moiety. The conformation of the peptide backbone can be 
determined by studying the 1H-NMR shift of the alpha protons of amino acids. Therefore, the 
peptide backbone of parent and modified CLs were compared to determine if modification led to 
structural changes. Here we report that the chemical shifts of alpha proton for most of the amino 
acid residues of parent and modified CLs were similar and hence the conformational structure 
may have been intact. However to confirm the affinity fragment responsible for binding, 
chemical modification at the binding region should be performed.  
5.5 Experimental Procedures 
Fluorescent Derivatives (29 and 31) 
A mixture of CL 23 (0.2 g, 0.05 mmol) and 7-methoxycoumarin-3-carboxylic 
succinimidyl ester (1.5 eq, 0.08 g) was dissolved in a solution of 30% methanol/acetonitrile and 
triethylamine (1 eq, 0.02 g) was added. The reaction mixture was stirred at room temperature for 
2h. The organic solvents were evaporated and crude product was purified using preparative-
HPLC to obtain 29 in 0.24 g.   
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Figure 5.11 Standard curve of CI-ELISA’s for 24 or 28 using anti-33 pAb or anti-34 pAb	   	  
24 or 28 conc (µg/ mL) 
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HPLC-MS analysis showed a [M+H]+ ion peak at m/z 1378.6751 corresponding to a 
molecular formula, C70H96N11O16S of 29. 
1HNMR (500 MHz, CDCl3, COSY, NOESY): Msn1: δ 4.76 (1H, m, α), 2.51 (1H, m, β), 
2.39 (1H, m, β), 3.40 (2H, m, γ), 3.87 (2H, s, SO2CH2), 2.87 (4H, m, NHCH2CH2NH), 7.79 
(1H, br s, NHCH2CH2NHCoumarin), 8.90 (1H, m, NHCH2CH2NHCoumarin), 3.91 (3H, s, 
OCH3), 8.79 (1H, s), 7.57 (1 H, d, 8.6 Hz), 6.92 (1H, d, 8.6 Hz), 6.85 (1H, s), 7.31 (1H, m, NH); 
Leu2: δ 3.83 (1H, m, α), 1.93 (2H, m, β), 1.62 (1H, m, γ), 0.92 (6H, d, 7 Hz, δMe); Ile3: δ 4.47 
(1H, m, α), 1.90 (1H, m, β), 1.49 (2H, m, γ), 1.07 (3H, d, 6.8 Hz, γMe), 0.82 (3H, t, 6.8 Hz, 
δMe); Pro4: δ 3.78 (1H, br s, α), 2.15 (1H, m, β), 1.64 (1H, m, β), 1.98 (1H, m, γ), 1.94 (1H, m, 
γ), 3.86 (1H, br s, δ), 3.61 (1H, m, δ); Pro5: δ 4.11 (1H, m, α), 1.93 (2H, m, β), 1.49 (1H, m, γ), 
0.95 (1H, m, γ), 3.31 (2H, m, δ); Phe6: δ 4.86 (1H, m, α), 3.08 (1H, m, β), 2.98 (1H, m, β),7.25 
(m, 3H, δ, ε), 7.14 (2H, m, ζ); Phe7: δ 3.92 (1H, m, α), 3.31 (2H, m, β), 7.30 (m, 2H, δ), 7.25 
(1H, m, ε), 7.14 (2H, m, ζ) 7.71 (1H, br s, NH); Val8: δ 3.86 (1H, m, α), 2.16 (1H, m, β), 0.90 
(6H, d, 7 Hz, γMe); Ile9: δ 4.55 (1H, m, α), 1.98 (1H, m, β), 1.51 (2H, m, γ), 0.95 (3H, d, 6.4 Hz, 
γMe), 0.84 (3H, t, 6.4 Hz, δMe), 6.78 (1H, br s, NH). 
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Msn1: δ 52.1 (α), 25. 5 (β), 50.6 (γ), 58.4 
(SO2CH2), 40.5 (NHCH2CH2NHCoumarin), 39.5 (NHCH2CH2NH2), 56.2 (OCH3), 165.3, 
163.2, 161.8, 161.2, 157.0, 148.6, 131.3, 114.9, 114.2, 112.6, 100.6, 171.0 (C=O); Leu2: δ 61.8 
(α), 38.4 (β), 25.8 (γ), 23.1 (δMe), 21.9 (δMe), 171.7 (C=O); Ile3: δ 56.3 (α), 36.6 (β), 25.1 (γ), 
15.6 (γMe), 11.1 (δMe), 171.9 (C=O); Pro4: δ 56.2 (α), 28.6 (β), 25.5 (γ), 48.1 (δ), 170.9 (C=O); 
Pro5: δ 61.1 (α), 32.0 (β), 21.7 (γ), 47.3 (δ), 173.7 (C=O); Phe6: δ 54.1 (α), 35.5 (β), 136.3 (γ), 
129.7 (δ), 129.0 (ε), 127.3 (ζ), 173.2 (C=O); Phe7: δ 57.3 (α), 36.9 (β), 135.9 (γ), 129.1 (δ), 128.9 
(ε), 127.3 (ζ), 175.4 (C=O); Val8: δ 56.2 (α), 29.4 (β), 19.7 (γMe), 18.3 (γMe), 173.2 (C=O); Ile9: 
δ 59.1 (α), 36.8 (β), 25.1 (γ), 16.1 (γMe), 11.3 (δMe), 173.0 (C=O). 
Similarly, 27 (0.2 g, 0.18 mmol) was coupled with 7-methoxy coumarin-3-carboxylic 
succinimidyl ester (1.5 eq, 0.09 g) in presence of triethylamine (1eq, 0.19 mg, 0.025mL) in 30% 
methanol/acetonitrile solution to obtain 31 (0.25 g) using above procedure. 
1HNMR (500 MHz, CDCl3, COSY, NOESY): Msn1: δ 4.63 (1H, m, α), 2.52 (1H, m, β), 2.17 
(1H, m, β), 3.29 (1H, m, γ), 3.13 (1H, m, γ), 3.72 (2H, s, SO2CH2), 3.60 (2H, m, 
NHCH2CH2NHCoumarin), 3.49 (2H, m, NHCH2CH2NHCoumarin), 8.76 (1H, br s, 
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NHCH2CH2NHCoumarin), 8.96 (1H, m, NHCH2CH2NHCoumarin), 3.87 (3H, s, OCH3), 8.81 
(1H, s), 7.63 (1 H, d, 9 Hz), 6.86 (1H, d, 9 Hz), 6.80 (1H, s), 7.74 (1H, m, NH); Leu2: δ 4.33 (1H, 
m, α), 2.33 (1H, m, β), 1.54 (1H, m, β), 1.84 (1H, m, γ), 0.83 (6H, m, δMe); Val3: δ 4.42 (1H, m, 
α), 2.17 (1H, m, β), 1.02 (6H, m, γMe), 7.56 (1H, br s, NH); Phe4: δ 4.42 (1H, m, α), 3.13 (1H, 
m, β), 3.06 (1H, m, β), 7.30-7.10 (m, 5H, δ, ε, ζ); Pro5: δ 4.12 (1H, m, α), 1.46 (2H, m, β), 1.59 
(1H, m, γ), 1.46 (1H, m, γ), 3.29 (2H, m, δ); Leu6: δ 3.60 (1H, m, α), 1.70 (2H, m, β), 1.39 (1H, 
m, γ), 0.93 (6H, m, δMe), 7.95 (1H, d, 7.5, NH); Phe7: δ 4.97 (1H, m, α), 3.02 (2H, m, β), 7.30-
7.10 (m, 5H, δ, ε, ζ); Ile8: δ 3.90 (1H, m, α), 1.76 (1H, m, β), 1.60 (2H, m, γ), 0.83 (3H, m, γMe), 
0.93 (3H, m, δMe), 7.67 (1H, br s, NH).  
13CNMR (125 MHz, CDCl3, HMQC, HMBC): Msn1: δ 52.0 (α), 25.4 (β), 50.7 (γ), 48.2 
(SO2CH2), 40.3 (NHCH2CH2NHCoumarin), 38.7 (NHCH2CH2NH2), 56.1 (OCH3), 165.1, 
162.9, 162.9, 161.9, 156.8, 148.8, 131.7, 114.7, 114.0, 112.8, 100.4, 172.8 (C=O); Leu2: δ 63.5 
(α), 30.1 (β), 28.9 (γ), 22.9 (δMe), 21.7 (δMe), 172.8 (C=O); Val3: δ 57.7 (α), 30.9 (β), 19.5 
(γMe), 18.4 (γMe), 171.9 (C=O); Phe4: δ 53.5 (α), 36.0 (β), 138.1 (γ), 129.1 (δ), 128.9 (ε), 127.0 
(ζ), 173.2 (C=O); Pro5: δ 60.2 (α), 30.6 (β), 25.2 (γ), 46.4 (δ), 173.9 (C=O); Leu6: δ 61.2 (α), 
40.2 (β), 25.0 (γ), 22.7 (δMe), 21.6 (δMe), 171.3 (C=O); Phe7: δ 53.5 (α), 37.6 (β), 137.7 (γ), 
129.0 (δ), 128.4 (ε), 126.5 (ζ), 171.9 (C=O); Ile8: δ 58.7 (α), 35.9 (β), 25.2 (γ), 16.1 (γMe), 11.5 
(δMe), 171.3 (C=O). 
5.6 Conclusion 
The analogs of CLs 10 and 11 containing amine and alcohol derivatives were 
successfully coupled to fluorescent dye, affinity matrix and protein. All the CL conjugates were 
characterized using different spectrometric techniques. CL dye conjugate was formed by 
covalent linkage of amino analogs with N-hydroxysuccinimide ester of coumarin dye. It shows 
that coumarin derivative of 11 exists as single isomer and 10 exist in two isomers. The 
fluorescence studies of CL dye conjugates were done in various solvents to determine the solvent 
effect. Spectroscopic analysis shows higher quantum yields for CL coumarin conjugates in 
methanol and ethanol as compare to acetonitrile and DMF. Amino analogs were coupled with N-
hydroxysuccinimide ester of agarose gel to form CL affinity matrix. The coupling efficiency of 
affinity matrix to 11 analog was about 70% compare to 10 (38%). CL affinity matrix has shown 
binding to apolipoprotein A1 in chicken serum Apo A1 was characterized by the molecular mass 
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of 28 kDa obtained from the trypsin digest band. Hydroxyl analogs were coupled to BSA to elicit 
immune response and produce polyclonal antibodies in rabbits. The incorporation of CLs 
(haptens) was monitored by SDS-PAGE, MALDI and ESI-QTOF. Both MALDI and ESI-QTOF 
shows the attachment of haptens to BSA. In addition more than 25 haptens were incorporated to 
BSA in both CLs. Based on these results, the CI-ELISAs using the pAbs produced in this study 
could be applied to detect CLs in complex matrices. ELISA provides highly sensitive, rapid, and 
precise means to analyze a large number of samples. These purified antibodies can be potentially 
utilize in localizing CLs in cell lines and also can be used in detection of CLs in ageing flax. The 
use of tagged CLs will help to increase their utility before they can be effectively used in any 
application.  
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CHAPTER 6 
GENERAL DISCUSSION 
 
Plant cyclic peptides belong to the important class of biological active compounds. They 
possess various biological activities such as antimalarial, immunomodulating, 
immunosuppressive, antiplatelet and antifungal. However these peptides are found in very small 
quantity and the distribution varies between 10–2 to 10–5% of plant dry material (Tan & Zhou, 
2006). This limits the utilization of peptides in various applications. The highest quantity of 
cyclic peptides is present in the seeds of Annona glabra (1.0 × 10–2%), while Phytolacca 
polyandra (1.4 × 10–5%) shows the lowest (Li, et al., 1999; Xiong, et al., 2002). Similarly CLs 
are also present in small quantity in flax for example, 30 kg of dry roots of flax have produced (1 
- 0.28 g; 2 - 0.016 g; 3 - 0.12 g; 4 - 0.048 g; 5 - 0.008 g) (Morita, et al., 1999). Another 
promising method to obtain peptides is by performing successive chemical reactions where 
single amino acids are added to the carboxylic end of a peptide or amino acid (Merrifield, 1963). 
However, the cost of synthesizing peptides using solid and solution phase chemistry is also high. 
For example, the cost of small-scale peptide synthesis (10 mg) ranges from roughly $20–$60 
depending on the number of amino acids. As the number of amino acid residues increases, the 
cost also increases. Larger scale production of grams of peptide can lower the cost of production. 
A gram of a 40 amino acid peptide can cost just $1600. (Latham, 1999). CLs could be utilized as 
drugs or drug delivery agents as they have biological activity, hydrophobicity and may form 
inclusion complexes. For example, the hydrophobicity of CLs plays a significant role in transport 
across cell membranes in addition to distribution in tissues and organs (Kemmer, et al., 1997) 
and helps in binding with human serum albumin (Rempel, et al., 2010). CLs also form inclusion 
complexes with metal ions such as Tb (Chatterji, et al., 1987) and forms crystalline solvates with 
alcohols (Jadhav, et al., 2011; Quail, et al., 2009; Schatte, et al., 2012). In this study we have 
taken advantage of the polarity of CLs by adsorbing on silica gel and solvent-solvent extraction 
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protocol was used to remove CLs from the silica column. However, tryptophan containing CLs 
such as CLs 4, 6–9 were decomposed and HPLC-DAD showed presence of CLs 1, 3, 5, 10 and 
11. We have oxidized the crude mixture to simplify the preparative chromatographic separation 
from five to three CLs 1, 10 and 11 and obtain gram quantities. Previous process includes first 
obtaining pure CLs 3 and 5 and then oxidation to access 10 and 11, which increases the number 
of purification steps (Matsumoto, et al., 2001). 
The novel CLs 10 and 11 were completely characterized using NMR (1D and 2D) and 
LCMS. NMR experiments were done at different temperatures and well resolved sharp spectral 
signals were obtained from NMR acquisitions at 320 K. The results show that 11 exists as single 
isomer and 10 as two isomers. The temperature has effect on the NMR chemical shifts of CLs. In 
flax CLs, Pro residue plays a major role in the conformational flexibility and it can produce 
cis/trans isomers. These isomers convert at slower rate into each other to give separate signals 
that can complicate the spectra. Hence temperature variability is necessary to obtain well-
resolved spectra without presence of minor conformers (Morita, et al., 1999). The variation in 
temperature can also be used to monitor the intramolecular hydrogen bonding of NH with the 
carbonyl oxygen. As the temperature increases the hydrogen bond is weakened and NH proton 
shifts to up field. It has been proposed that hydrogen bonded NH is found at downfield because 
of the interaction with carbonyl oxygen. However, this assumption is not always true. The proton 
exchange method can also be used to determine the hydrogen bonding (Baxter & Williamson, 
1997).  
These CLs 10 and 11 have shown thermal stability over 200 °C and there structures were 
confirmed by taking the NMR before and after the treatment. Normally, biological molecules 
such as proteins are only stable at physiological temp of around 40–45 °C (Vogt, et al., 1997) 
and there are also thermophiles proteins having stability above 100 °C (Scandurra, et al., 1998). 
But this thermal stability over 200 °C makes these CLs good candidates in the fields of 
biomedical, nanotubes technologies, microporous solids and photoswitches. For example, cyclic 
D, L peptides cyclo[-(Trp-D-Leu)3-Gln-D-Leu-], shown to spontaneously self assemble in a 
columnar manner to be used in nanotubes and microporous solids. A small model cyclic 
phosphopeptides was tagged with hemithioindigo chromophore as photoswitch to study complex 
folding processes. (Afonso, et al., 2012; Cordes, et al., 2006; Ryu & Park, 2010). It was observed 
that 10 and 11 were not present in flaxseed oil and result of flax ageing. These pure compounds 
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can be used as standards in food industry for detection of ageing of flaxseed and flaxseed 
products. 
The second aim was to utilize these gram quantities of CLs. Site directed chemical 
modification is often a formidable challenge and applicable to peptides that have few 
heteroatoms. (Kotha & Lahiri, 2005). This has advantage over linear peptide synthesis 
(Merrifield resin) as described above to perform SAR studies (Jamonnak, et al., 2010). We have 
described the chemical modification at Met side chain to synthesize active analogs, which are 
away from the bioactive tripeptide, Phe-Phe-Pro fragment (Kessler, et al., 1986). The chemical 
shifts of alpha proton of modified peptides relative to the parent gave important structural 
information about the conformation. (Dekan, et al., 2011). The analogs of 11 have no significant 
perturbations for most of amino acid residues in chemical shift, while analogs of 10 show little 
similarity. The reason might be hydrogen bonding of amino and hydroxyl analogs with the amide 
carbonyl. Met derivatives were oxidized to more stable Msn counterparts. Hence versatile active 
group at side chain can be used to attach different molecules and increase utility of CLs.  
The final aim was to synthesis of CL adduct complexes such as fluorescent tagged CLs, 
affinity chromatography media, and haptens suitable for antibody production. The biological 
activity of CLs makes them good candidates to be used them as fluorescent tag. Fluorescent tags 
have been successfully used for imaging proteins inside cells and are valuable in establishing the 
fate of a given protein or chemical compound in biochemical processes (Ferro-Flores, et al., 
2010). However there was no report on the attachment of fluorescent dye to CLs. In this study 
we are attaching a coumarin dye to CLs through a covalent linkage. NMR studies shows that CL 
dye conjugate molecules might have structural similarity with the parent molecule 10 and 11. 
Hence they can be used for fluorescent imaging. We have developed a general synthetic protocol 
and could be used to prepare various fluorescent CL derivatives from commercial available dyes. 
The fluorescent CL compounds have shown similar structures as compare to parent CLs. This 
result shows that after coupling with the dye, CL conformation has not been altered and can be 
used for fluorescent imaging. 
Protein-protein and protein-small solute interactions are important in many biological 
processes. Some of the examples include hormone binding with receptors, enzymes with 
substrates and binding of drugs and other compounds with serum proteins (Hage, 2002). Affinity 
chromatography plays important role in bioseparation of biomolecules from complex mixture. It 
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was reported that analogue of CL 1 have shown binding to proteins in the cytosol and plasma 
membranes of rat hepatocytes. The structural features important for binding with proteins were 
hydrophobic surfaces and cyclic conformational structure of CL (Kemmer, et al., 1997). We 
have made CL affinity matrix to study the binding of chicken serum proteins. In our study we 
have identified a specific binding of CL with protein which main function is to cholesterol efflux 
and reverse cholesterol transport. It was reported that CsA inhibits Apo A1 (Le, et al., 2004) and 
CLs binding with Apo A1 suggest that it may interfere in cholesterol homeostasis. Hence this 
study will help to understand the effect of binding on the biological activity of CLs.  
Antibodies are generally produced from native or recombinant proteins. However 
peptides have also provided better platform to produce antibodies. They have added advantage 
such as manufacturing cost; easily produced with high purity and mimic the epitope of protein 
(Trier, et al., 2012). Peptide polyclonal antibodies are used as analytical tool as immunoblots to 
determine the native or denatured calreticulin in solution (Houen, et al., 1997). There are no 
reports on the generation of antibodies using CLs. Hydrophobic amino acids in CLs makes these 
CLs insoluble in water. But CLs were coupled with BSA in THF to form immunogen. The 
incorporation of haptens has successfully shown by MALDI and ESI-TOF. The generated pAbs 
in this study can be used in two ways: detection of CLs in flax and flaxseed products and 
therapeutic purpose for localization of CLs. Previous procedures for identification and 
characterization of these CLs were done using NMR, HPLC-MS methods (Matsumoto, et al., 
2001; Morita, et al., 1999; Stefanowicz, 2001). However, they are not satisfactory for the 
detection of CLs in multi-component mixtures. In contrast, an enzyme-linked immunosorbent 
assay (ELISA) provides highly sensitive, rapid, and precise means to estimate biological 
parameters, with the added advantage that it can rapidly analyze a large number of samples. 
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CHAPTER 7 
SUMMARY AND CONCLUSIONS 
 
Flax CLs are known to exhibit various biological activities such as immunosuppression 
and apoptopic induction in human epithelial cancer cell lines. CLs are thus bioactive compounds 
with potential for use as therapeutics. The current research investigated: 1) isolation of CLs from 
flax oil in multigram quantities, 2) the isolated CLs containing Mso were chemically modified by 
making specific changes to the Met or Mso group in a systematic fashion, without changing 
other amino acids, and 3) the modified CLs were linked to molecules or materials of interest 
including fluorescence tags, affinity chromatography media and BSA (for production of 
polyclonal antibodies). In addition, these CLs derivatives were completely characterized using 
spectrometric techniques including 1D and 2D NMR spectrometry, as well as mass spectrometry.  
Methods have been developed to isolate and purify five CLs namely 1, 3, 5, 10 and 11 
from flax oil in multigram quantities. We have developed an oxidation protocol to simplify the 
purification step by reducing the number of CLs from five to three (1, 10 and 11). CLs 10 and 11 
have been fully characterized using NMR methods and their thermal stability has been reported. 
In addition the solution state structure of 11 is similar to its solid state and shows presence of 
single conformer. These solid and solution state studies will lead us to determine the binding 
region of the CLs. However, crystals could not be grown for 10 and NMR also shows presence 
of two isomers. Prior to this study, there were not sufficient CLs available to perform chemical 
modification and structure activity relationship studies. These CLs have to be synthesized using 
solid phase resin method that leads to increase in the overall cost of the material.  
A synthetic strategy has been developed to chemically modify the Met side chains of the 
parent CLs. These Met CLs can be obtained by reduction of Mso group. The modification 
through Met is not known and mostly reactive amino acids such as lysine, aspartic acid, glutamic 
acid serine and threonine have been used as point of attachment to other functional group. The 
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synthetic reactive analogs containing active amine and hydroxyl have been synthesized and 
completely characterized using 1D and 2D NMR techniques. The thermal stability of Msn CLs 
has been utilized by oxidizing the modified Met.  
These reactive analogs have been successfully coupled with fluorescent moieties for use 
as fluorescent tags. A coumarin dye was added to the CL side chain and their spectroscopic 
analyses have shown high quantum yields. In addition, the CLs have been fused to affinity 
chromatography media to purify CL-binding proteins from complex mixtures. For example, they 
have shown affinity to the apolipoprotein A1 present in the chicken serum and finally, CLs were 
also coupled with protein to act as hapten to produce antibodies. These antibodies were used to 
develop competitive indirect ELISA. 
Key findings and highlights of this research include the following: 
 The present research relates to methods for isolating CLs from flaxseed by simplifying 
the CL extracts to increase the efficiency of chromatography for recovery of specific 
CL(s). 
 CLs 10 and 11 were found to be ageing products of flax oil and solution structures were 
determined. Hence they can act as standards in the food industry as markers of oxidation.  
 The CLs 10 and 11 have been shown to have suitable heat and oxidative stability for use 
in harsh environments. This makes them good candidates in the fields of nanotubes, 
biomedical and other microporous materials. 
 A new branch of CL modification through sulfur chemistry has been developed.  
 Methionine derivatives were stabilized by oxidation to the sulfone. It was found that 
modified Met and Mso side chain were easily eliminated to alkane and vinyl compounds. 
 CLs are readily linked to fluorophores, proteins and solid matrices through  modifications 
to the methionine.  
 CL-conjugates were completely characterized using NMR and MS methods. These CL 
conjugates were successfully tested in various applications. 
This work has provided a general protocol to isolate, extract and chemically modify CLs. 
The availability of sufficient quantities will also allow for chemical modification of naturally 
isolated CLs and carrying out biological assays to establish potential pharmaceutical 
applications. The modification of the CLs will be necessary in order to increase their utility 
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before they can be effectively used in any application. The above examples clearly show that 
these CLs can be used in the fields of fluorescence, affinity purification and producing 
antibodies. This methodology can also be used to generate various analogs for structure activity 
relationship studies. These applications will be a value added products for the flax industry 
because it will benefit both farmers and consumers. The extraction protocol can be used to 
remove the bitter flavour CL 5 from flax oil and these CLs can be sold as nutraceuticals. 
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